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ABSTRACT
The present study was primarily designed to test whether 
adding a relaxation training technique to the medical 
treatment of diabetes would lead to an improvement in the 
diabetic condition. A secondary purpose was to determine 
whether the State and Trait anxiety of individuals suffering 
from diabetes would be affected by participating in this 
program. Two separate main studies were developed, both 
involving patients with Type I and II diabetes mellitus. Forty- 
eight patients participated in the first study and they were 
randomly allocated to either an Experimental or a Standard 
Control group, for eight weekly sessions. The Experimental 
group participated in 8 sessions of relaxation training, 
while the Control group did not receive any training or any 
additional instructions.
The subjects in both groups continued their regular medical 
treatment during the experimental period. In addition the 
State and Trait Anxiety Inventory was administered to the 
participants before and after the experimental period, also 
various physiological variables, which were good indices of 
diabetic control, were measured. The participants in the 
Experimental group filled the Daily Diary Check List and the 
Mood Adjective Check List.
As expected the dependent psychological and physiological 
variables revealed significant differences for the patients 
in the Experimental group, between the pre- and post­
measurements. While non-significant differences were found
for the Control group.
The second study was developed to ensure that the 
experimenter has a similar level of interaction with both 
Experimental and Control groups. In case any effect in the 
first experimental study has caused any differences between 
the two groups.
Forty-Eight diabetics^were the participants of the second study, 
allocated to either an Experimental or a Placebo group, for 
eight weekly individual sessions. The same procedure was 
followed for the second study. The patients in the Placebo 
group received 8 sessions of blood circulation exercises. 
Furthermore, the same psychological and physiological 
measurements, as the ones measured in the first study, were 
collected during the second study. As expected, the 
psychological as well as the majority of the physiological 
variables revealed significant differences for the patients 
in the Experimental group. In addition emotions and mood 
improved over time. Non-significant changes were found for 
the Placebo group. These results give support to the findings 
of the first study.
A follow-up study was carried-out 18 months, after the end of 
the second experimental study, which indicated that patients 
in the Experimental group maintained their gains while this 
was not the case for the Placebo group.
The study's major finding that relaxation training can help 
to reduce a diabetic's state anxiety as well of some of the
main metabolic parameters, has implications for the treatment 
of diabetes. Explanations of the possible relationships of 
the results obtained are provided. Clinical applications and 
recommendations for future research are also included.
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1. An Introduction to Diabetes Mellitus 
Diabetes mellitus is a universal health problem 
affecting human societies at all stages of development, 
(Gustafsson et al.,1990 ; Dechamp-Le-Roux-C et al., 1990).
At least 30 million people are involved throughout the world, 
and the number of cases reported is increasing rapidly. This 
rise is concomitant with the aging of populations, changes in 
life style and improvements in education (Me Donald et al., 
1965) .
In this chapter an attempt will be made to give an outline of 
of the major clinical issues associated with Diabetes 
Mellitus. Subsequent chapters will then be concerned with 
developing these issues further to examine the psychosocial 
aspects of the disease.
1.1 Pathophysiology of Diabetes
Diabetes seems to be a prominent health problem in developed 
countries, however, it would be erroneous to consider 
diabetes a disease of affluent societies. Epidemiological 
studies indicate high rates universally, but little is known 
of the real extent of diabetes and its sequence in developing 
countries (Pickup, 1991).
In some societies, obesity is a major correlate of 
diabetes; in others, malnutrition is probably an important 
determinant; infection and toxic conditions are also 
believed to play a part, through mechanisms that are now 
being elucidated (Gustafsson et al.,1990).
In addition, it is apparent that environmental determinants of 
diabetes interact with varying degrees and types of inherent 
susceptibility (Gonder-Frederick, 1990).
Observation and research have shown that the development of 
diabetes mellitus may be arrived at by diverse routes. Once 
established, environmental influences and genetic 
constitution again interact to determine the course and the 
complications of the disease. With increasing knowledge of 
the nature of susceptibility and better identification of 
pathogenic factors, exciting possibility arise for the 
development of practical preventative measures.
Diabetes is an example of a chronic disorder in which 
affected individuals must take major responsibility for 
their own health with the support of the medical profession 
and the community.
1.2. Definition
Diabetes mellitus is a state of chronic hyperglycaemia 
(i.e. the state of having an excessive concentration of 
glucose in the blood), which may result from many 
environmental and genetic factors often acting jointly. The 
major regulator of glucose concentration in the blood is 
insulin, a hormone synthesized in and secreted by the B 
cells of the islets of Langerhans in the pancreas (sometimes 
called beta cells). Hyperglycaemia may be due to a lack of 
insulin or to an excess of factors that oppose its action.
This imbalance leads to abnormalities of carbohydrate, 
protein and lipid metabolism. Serious symptoms that often 
occur in patients suffering from the disease may include 
ketoacidosis (diabetic "coma"), the progressive development 
of disease of the capillaries of the kidney and retina, 
damage to the peripheral nerves and excessive 
arteriosclerosis.
1.3. Diagnosis
In making a diagnosis of diabetes the clinician has a 
number of indicative symptoms to consider.
Diabetes may be present with severe thirst, increased 
urine volume, rapid weight loss and sometimes coma.
Blood glucose concentration is highly elevated.
Glucose will be excreted in the urine, usually in large 
amounts. In this situation diagnosis is simply confirmed 
from blood glucose estimation.
Random blood glucose concentrations exceeding 2.0 mmol/L 
are diagnostic. The presence of specific microvascular 
disease, usually retinopathy, also establishes the diagnosis.
The interpretation of diagnostic tests is hindered by a 
lack of uniformity in procedures and in the criteria of 
determining abnormality. There is little agreement on the 
dosage of glucose and its relation to age and weight, the 
time of day at which tests are carried out, prior period of 
fasting, frequency of blood sampling, nature of the fraction 
of blood used (capillary or venous, plasma or whole blood) 
and method of expressing results or criteria of
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interpretation. Furthermore, results in an individual are 
variable from day to day despite standardisation of methods 
and conditions.
The glycaemic response to ordinary meals has been 
recommended as a more physiological metabolic test for 
diabetes, but the meals are difficult to standardize. 
Furthermore there are few valid data to serve as a basis for 
diagnostic standards.
It has been argued that the diagnosis of diabetes 
should not be made in the absence of fasting hyperglycaemia. 
However, the evidence suggests that a diagnosis of diabetes 
is justifiable even when fasting glucose levels are normal, 
if the impairment of glucose tolerance is substantial.
1.4. Classification
The first report of the WHO Expert Committee on 
Diabetes Mellitus published 15 years ago (cited in the 
"World Health Organization" Technical Report Series,1980), 
contained a classification of patients according to age of 
recognised onset.
Since that time research has brought to light several 
pathogenic mechanisms leading to diabetes mellitus 
(Pickup, 1991; Shillitoe, 1988). In this 
way new information has led several groups to review the 
existing types of classification of the disease. (There are 
2 types of diabetes, the insulin dependent type or Type I 
and the non-insulin dependent type or Type II).
-4-
The diabetes data group of the National Institutes of 
Health of the U.S. [cited in the "World Health Organization"
Technical Report Series, 1980] produced a classification
1
scheme of which a simplified version is gives in Table 1.
Table 1 : Presents a Classification Scheme in relation 
to the Types of Diabetes Mellitus
A. CLINICAL CLASSES
Diabetes Mellitus 
Insulin-dependent type - Type I 
Non-insulin-dependent type - Type II:
(a) non-obese
(b) obese
Other types including diabetes mellitus associated 
with certain conditions and syndromes: (1)
pancreatic disease, (2) diseases of hormonal 
aetiology (3) drug-or chemical induced conditions, 
(4) insulin receptor abnormalities, (5) certain 
genetic syndromes.
Impaired glucose Tolerance
(a) Non-obese
(b) Obese
(c) Impaired glucose tolerance associated with 
certain conditions and syndromes.
B. STATISTICAL RISK AND CLASSES (subjects with normal
glucose tolerance but substantially increased risk 
of developing diabetes.
Previous abnormality of glucose tolerance 
Potential abnormality of glycose tolerance.
1.5. Methods and techniques for screening diabetes
a) Urine tests
Urine glucose testing is convenient and remains a 
screening technique appropriate for some circumstances and 
retains an important place in clinical routine (Mayer and 
Freedman, 1983). With previous diagnostic criteria the 
method had low sensitivity and only moderate specificity, but 
few subjects meeting the suggested new criteria for diabetes 
mellitus will fail to have postprandial glycosuria. However 
there will be many false positives, especially cases of 
patients with lesser glycosuria. These could include pregnant 
women, younger males and subjects with mild impaired glucose 
tolerance.
b) Blood tests
The higher diagnostic specificity of blood glucose 
determination usually makes this the method of choice, 
particularly when large numbers of people are to be 
examined (Mayer and Freedman, 1983) .
Screening blood glucose measurement are usually made 
at any time of day without special preparation, but fasting 
samples are sometimes used and occasionally samples are 
collected at a fixed time, after a meal or a glucose load.
1.6. Causes and Mechanisms of Diabetes
It is being increasingly recognized that the syndrome 
of diabetes mellitus includes a number of clinically and 
genetically heterogeneous disorders, with the common
denominator of elevated blood glucose concentrations, either 
in the fasting state or in response to a glucose challenge 
(Mayer and Freedman, 1983).
The B-cell of the pancreas is responsible for the 
production of insulin. More knowledge of the natural history 
of the B-cell in humans is required, in order to understand 
the pathological effects of various genetic and environmental 
influences. B-cells are long-lived and the rate of cell 
division is slow; the signals for B-cell replication remain 
unknown. Genetic susceptibility of the B-cell to destructive 
environmental factors will therefore result in diabetes 
mellitus when it is also associated with a lack of 
replication of these cells. Fibroblasts and smooth muscle 
cells obtained from subjects with a strong genetic 
background for diabetes age more rapidly than those from 
subjects without this genetic background. In addition, 
collagen in people suffering from diabetes shows premature 
ageing, which could be a general factor that also affects the 
B-cell , making it more vulnerable to environmental 
influences (Jackson et al., 1964; Cahill, 1977) .
In both insulin-dependent and non-insulin -dependent 
diabetes, studies of identical twins have shown a strong 
genetic influence (Pyke, 1979). In half of the pairs with 
insulin-dependent diabetes , both twins had diabetes, while 
in 88% of the pairs with non-insulin-dependent diabetes both 
twins had the disease (Pyke, 1979).
At the present, there is no universal explanation of 
the causes of diabetes. Because the pathology of diabetes
varies by type, it is reasonable to suppose that there is 
probably no single aetiology. Generally five factors have 
been implicated as possible causes: heredity (e.g., Leslie 
and Pyke, 1980), viral infections (Craighead, 1978), 
autoimmunity (Cahill and McDevitt, 1981) and psychological 
stress (Gonder-Frederic et al., 1990; Hinkle and Wolf, 1952a, 
1952b) in Type I diabetes; prolonged obesity (Bondy and 
Rosenberg, 1980) and psychological stress ( Halford et al., 
1990; Hinkle and Wolf, 1952a, 1952b) in Type II diabetes.
1.7. Management of Diabetes
The life of the recently diagnosed individual with 
diabetes may depend on regular injections of insulin or oral 
medication, a regular pattern of meals and a suitably 
adjusted life-style. Some form of dietary advice will be 
needed by all types of people suffering from diabetes (Mayer 
and Freedman 1983). In many non-insulin dependent patients 
dietary restriction will be the only "treatment" required. In 
all insulin or oral agent takers, it will involve learning 
basic facts about the composition of foods and meal-time 
strategy previously taken for granted (Gustafsson et al., 
1990) .
Insulin-dependent people with diabetes or as so called 
Type I, take insulin to try to maintain their blood glucose 
concentration as closely within the normal physiological 
limits as is practicable and safe. Good control can usually 
be best achieved by taking more than a single injection each 
day, usually two or three. Insulin may be used in simple
solution or modified in various ways to delay absorption and 
prolong its action.
Some non-insulin-dependent individuals with diabetes or so 
called Type II, respond inadequately to restricted food 
intake and dietary advice. In these patients the oral 
sulphonylureas and biguanide preparations often reduce 
hyperglycaemia and relieve symptoms. Furthermore 
exercise improves metabolism and also increases well-being
.  ^L _
in the well-controlled person" with' diabetes, (Cassar et al., 
1978). It is important to recognise at this point that people 
suffering from either Type I or Type II diabetes belong to 
two different groups and it is possible to have individual 
differences within each of these groups and respond 
differently in relation to medical regime, diet habits and 
life-style.
1.8. Acute Metabolic Problems
Hyperglycaemia with ketoacidosis and hypoglycaemia 
account for significant morbidity and mortality (Mayer and 
Freedman, 1983).
Hypoglycaemia most commonly occurs as a side-effect in 
people with diabetes injecting insulin. It may also result 
from the over-reaction of oral anti-diabetic agents, if the 
anti-diabetic preparation has not been properly excreted or if 
its use was unwarranted. Severe hypoglycaemia is normally due 
to imperfect understanding of the treatment, to change or 
irregularity in habit or to consumption of alcohol. Self 
monitoring of blood glucose supported by adequate advice and
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instruction helps the individual with diabetes to understand 
his/her own metabolic pattern of response and to minimize 
the risk of hyperglycaemia (Mayer and Freedman, 1983).
Diabetes may first appear with coma caused by lack of 
insulin action. In people with diabetes already under 
treatment, ketoacidosis, most often results from failure to 
take adequate insulin. Furthermore severe stresses like heart 
attack and trauma may precipitate ketoacidosis even in people 
with mild diabetes through the release of hormones opposing 
insulin action. Comas associated with severe hyperglycaemia 
may occur without ketoacidosis. Hyperventilation is absent 
and plasma and urine show little or no evidence of ketone 
bodies. Lactic acidosis in diabetes is particularly 
associated with biguanide (especially phenformin) therapy 
but may also result from shock, septicaemia or anoxia. The 
degree of acidosis is more severe than ketone body 
measurements indicate and mortality is high.
1.9. Complications
The clinical course of diabetes and the prognosis for 
health and life of the person with diabetes are now 
determined by the complications of the disease. The 
characteristic progressive damage to the eyes, kidneys and 
nerves and the susceptibility to heart disease (microvascular 
complications), gangrene and stroke are widely considered a 
consequence of inadequate control of the metabolic disorder 
(Mayer and Freedman, 1983).
This issue of diabetes control is important because it 
influences the nature and intensity of the treatment of 
diabetes.
Many clinical studies, most of them retrospective, 
strongly suggest that individuals with diabetes with less 
severe degrees of metabolic disorder are less liable to 
develop microvascular and neuropathic complications (Pirart, 
1977, Mayer and Freedman, 1983). However, it is also possible 
that the freedom from complications may be due to the 
effectiveness of the treatment rather than the lesser 
severity of the metabolic abnormality and it is difficult to 
assess the degree to which each factor is responsible. In 
animals rendered experimentally with diabetes and maintained 
at different levels of control, changes analogous to human 
complications are directly related to the degree of control 
(Engerman et al., 1977). Rapid restoration of disturbed 
microvascular function can be achieved by improved metabolic 
control.
In this first Chapter the pathophysiological and clinical 
picture of Diabetes Mellitus has been discussed. In the 
following chapters the present examination will turn more to 
those issues of psychological relevance to the disease.
2. Psychological-Emotional Factors in the Control of
Diabetes
In this chapter a literature review will be presented in which 
the relevance of psychological factors to Diabetes Mellitus 
will be discussed. The chapter will be presented as a brief 
history of the area and will, hopefully, show the developing 
trends in this growing area.
The first description of diabetes mellitus was by 
Araetaeus (about 1000 AD) who coined the term diabetes (from 
the Greek word for "siphon” or "to go through") who 
characterized it as a rare disorder associated with "a 
melting down of flesh and limbs into urine". The impact of 
emotion was first speculated on by the English physician, 
Thomas Willis, who wrote the first important medical 
treatise on diabetes in English in 1679. In this book 
entitled "Pharmaceutice Rationalis", he stated that in 
addition to "strong wine and nervous system juice, prolonged 
sorrow", was one of the etiological factors in this 
disorder.
The concept of a CNS (central nervous system) influence 
on diabetes can be traced to the French scientist Claude 
Bernard, whose 1877 book "Lecons sur le Diabete", described 
how in 1859 he observed glycosuria in animals after puncture 
of the fourth ventricle (Macleod, 1907; Dinsted,1953). His 
work describing the action of vasomotor nerves, and how 
blood vessels were under nervous system control, set the 
stage for later psychosomatic theories of an internal 
environment in relation to health and disease.
The possible influence of emotion on the aetiology of 
diabetes was noted by the German diabetologist B. Naunyn, 
who in 1870 noted a case of diabetes mellitus that developed 
under the severely stressful condition of bombardment of a 
city (Cannon et al., 1911). In 1878, Boehm and Hoffmann, 
first demonstrated that cats, when bound to an operating 
board and tracheotomized without anaesthesia, would have 
glycosuria within half an hour. They termed this "Fesselungs 
diabetes", and this became the basis of classic experiments 
on "emotional glycosuria " by Cannon (Cannon, 1911). He 
confirmed the result of Boehm and Hoffmann, but thought that 
this resultant glycosuria was not due to such stimulants as 
pain, cooling or being bound but was due to metabolic 
effects induced by fright or rage. Cannon believed that the 
underlying mechanism was a primitive physiological reflex, 
activated by stress induced stimulation of the sympathetic 
nervous system with resultant increase in adrenaline 
secretion (Cannon, 1911).
Clinical observation of the relationship between 
diabetes and mental illness was frequently recorded in the 
late 19th century. Savage (1891) wrote that in insanity 
proper, diabetes is rare; but when these two illnesses which 
have familiar trends, coincide, the mental illness is of a 
depressive type. He further quotes Maudsley, who pointed out 
that "nearly all diabetic patients with insanity were 
melancholic". Gawo (1912) in his.classification of 
glycosuria, noted "psychic strain or stress" as a 
contributing factor. In 1914 Folin discussed two experiments
involving medical and college students, where the stress of 
an examination resulted in transient glycosuria.
The suggestion that coexisting diabetes and depression 
tend to parallel each other in terms of clinical severity is 
attributed to Naumy and Lepine cited by Allen (1913) . The
relationship of diabetes to emotional deprivation was 
described by Pike (1921) in a report of a patient who lost 
his wife to another man. With supportive therapy his 
adjustment improved and the glycosuria remitted but returned 
after his departure from the hospital. The role of emotional 
deprivation was further supported by the observations of 
Neilson (1927) and Masson (1923). In 1924 Cowie reported 
that he had been impressed with depression in diabetic 
children and that "the most noticeable reaction from the use 
of insulin was the clearing of the depression”.
However, Schultz (1925) observed that juveniles 
with diabetes were more difficult to treat than adults and 
that psychological reactions in this age group were not 
unusual.
The major diabetologists of that era minimized the role that 
psychogenic factors had in the aetiology and course of 
diabetes as no proof had been offered (Oklahoma State Med. 
Ass., 1953). Conflicting opinions regarding this issue 
continued to appear in the literature. Bowman and Kasanin 
(1929) noted several studies, including their own, showing 
no relation between stress and blood glucose levels.
Daniels (1939) noted that only 23 of 3,333 articles on
diabetes, published from January 1934 to March 1939, dealt 
with emotional aspects. Gendel and Benjamin (1946) reported 
no increases in the frequency of diabetes as a result of 
severe stress induced by two world wars and concluded that 
stress had no role in the precipitation of the disease. 
Although, how one identifies the specific stress of war 
independently of all other concomitants eg. diet, access to 
medicine etc., is not clarified in this report. Others, 
however, did not share this view.
Pike (1921) argued that diabetes could occur incidental to 
psychiatric illness. One of the first systematic studies in 
this area was reported by Menninger in 1935. He postulated 
the existence of psychogenic diabetes and described a 
"diabetic personality". He suggested that such people 
exhibited diminished alertness, poor memory, apathy, no 
ability to concentrate, indifference, hypochondriac 
complaints, anxiety and (in women) erotic impulses. Such 
patients were considered to be especially prone to 
depression. Dunbar (1936, 1946) wrote of "personality 
configuration peculiarly susceptible in the development of 
diabetes".
Dunbar et al., (1936) and Benedek (1948), on the 
basis of undocumented observation, also concluded there was 
clinical evidence for stress influencing the course of a 
patient's diabetic condition. Meyer et al. (1945) related
this to severe frustration resulting from psychological 
trauma during the weaning period. Such a concept linking the 
neonatal time with later development of diabetes has also
been postulated by Falstein and Judas (1955). Daniels (1948) 
in an important summary, concluded that a few cases of 
diabetes may be precipitated by severe emotional trauma, but 
that this was unusual. Hinkle and Wolf in 1952c, observed 
that, when applied to humans, stress usually resulted in a 
lowered blood glucose and increased blood ketone level which 
they related to increased metabolic activity and glucose 
uptake. Though this pattern was noted in both people with 
diabetes and without diabetes, it was more pronounced in the 
individual with diabetes. They also observed that a less 
frequent response was glycosuria related to increased 
adrenaline secretion and mobilization of glycogen from the 
liver. This study is one of the few that uses detailed 
measurements of blood glucose level, glycosuria and ketone 
levels, seeking to show a correlation with the application of 
stress.
Measurable effects of stress in humans were also noted 
by VandenBergh et al., (1966), who demonstrated that stress, 
induced under hypnosis, led to a reduced blood glucose 
level, increased plasma, increased free fatty acid 
concentrations and urine volume. Thus, it seems that emotion 
may produce physical change that could influence the course 
of diabetes (Knowles, 1964). Such a concept fits into the 
well known and more generalized theories of emergency 
response of Cannon et al., (1911) the general adaptation 
syndrome of Selye (1946), and the concept of adrenocortical 
function in relation to stress as noted by Engel (1953) and 
Prugh (1963). These theorists noted that multiple
etiological factors are involved in disease. Thus Mirsky 
(1948), thought that diabetes represented a failure of the 
patient to adapt physiologically and psychologically to 
environmental stresses. Danowski (1963) noted that stress may 
be a "crystallisable factor" that precipitates this 
illness in a physiologically susceptible individual. Stein 
and Charles (1971) concluded that juvenile diabetes occurs 
secondary to psychological stress in a physiologically 
susceptible individual.
During the last 40 years of research several studies have 
emphasised the contradiction and lack of essential agreement 
that surround the interface between the diabetic condition 
and the associated "diabetic personality".
Initially, a good deal of research was focused on the 
search for a "diabetic personality", which would predispose 
the individual to the development of the disease; specific 
personality traits were presumed to be associated with 
particular organic illnesses (Bruch, 1948; Kravitz et al., 
1971). Dunbar (1954), for example, believed the patient with 
diabetes had certain personality characteristics which 
differentiated him/her from other illness groups. These 
characteristics included dependence-independence conflicts, 
poor sexual adjustment, anxiety, depression and paranoid 
suspicion. Although the search for the "diabetic personality" 
has declined, many investigators contend that the overall 
incidence of emotional and behaviourial problems in persons 
with diabetes is higher than in healthy people ( Katz, 1957; 
Swift et al., 1967).
Several studies have examined the "diabetic personality" 
as a global factor which can be identified and which is 
thought to be a characteristic of individuals with the 
disorder. It is difficult to compare all these studies, since 
there is no uniformity in methodology and many of the 
judgments are based on subjective data. Attempts to define 
personality have been inconclusive. Baker and Barcai (1970), 
in their review of work in this area, have stated that the 
literature still contains many conflicting and contradictory 
reports and that there is little agreement. One assumption 
that could be related to people suffering from diabetes could 
be that the constant demands made on the person by the 
management of the disorder may shape his or her whole 
attitude to life and this may override normal variations in 
temperament. The diabetic population therefore, may thus be 
thought to be more homogeneous than the non-diabetic 
population.
In recent years first, there is a change of focus from 
the search for the "diabetic personality" towards greater 
appreciation of individual differences in beliefs about 
diabetes (Bradley 1985); and second, a recognition of 
the need to evaluate the potential of new technology such as 
blood glucose monitoring, continuous subcutaneous insulin 
infusion and newly developed biochemical measures, not only 
for glycaemic control but also for patients' quality of life 
and general well being.
Bradley and Cox (1987) based on the many observations from a 
number of studies, noted a differentiation among the people
suffering from diabetes as far as their personality types are 
concerned. She claimed that introverted diabetics tend to be 
more careful in balancing food intake to match insulin 
administration, more careful in maintaining sterile 
precautions and be able to regulate their life style 
according to the requirements of their disorder. While, 
extroverted diabetics tend  ^to hold more easy-going attitudes 
towards the disorder, to underrate the importance of careful 
dieting and to be less concerned about the accuracy and 
timing of their insulin injections.
Studies of the relationship between psychological stress and 
fluctuation in the course of diabetes have received added 
impetus from the publication of Holmes and Rahe's Schedule of 
Life Events (1967), which weights recent life events in terms 
of their relative impact on an individual's life, thereby 
allowing inter-subject comparisons of continuing life stress.
In conclusion, it appears that, although a physical disease 
entity, diabetes has clear psychological concomitants that may 
be important in the the course and control of the disease.
This chapter has intended to provide a relatively 
chronological outline of the role of psychology in Diabetes. 
The following two chapters will take this concern further by 
examining, explicitly, the role of psychological stress in 
physical disease in general and then specifically in the 
course of Diabetes Mellitus.
3. The Concept of Stress
In this chapter we will attempt to establish the salience of 
stress in physical disease. In order to emphasise the 
generality of this argument we will briefly examine three 
non-diabetes diseases where there is a huge and established 
link between the ailment and stress. The chapter following 
will then expand the discussion here to show that these 
arguments are equally true of diabetes mellitus.
People all over the world live in an age of anxiety, 
and are confronted with more and more situations that 
produce stress. Increasing numbers of people at younger ages 
are suffering from high blood pressure, heart attacks and 
strokes, (Benson, 1975). In addition people must deal with 
their own emotional upset and tension caused by the every day 
pressures of living.
There is little agreement on how the term stress should be 
defined. Researchers (for example, Lazarus, 1966; Levine and 
Scotch, 1970; Cox, 1975), define it differently depending on 
their orientations. Approaches to studying stress fall 
however, into three broad categories.
One approach defines stress as a response; researchers are 
interested in identifying the patterns of psychological and 
physiological responses that occur in difficult situations 
(Cox, 1987). When a response is emphasised, a state of 
stress is meant or an organism is being under stress. One of 
the pioneers in stress research, Hans Selye, defined stress 
as the "non specific response of the body to any demand made
-20-
upon it" (Selye, 1979). By "non specific" he meant that the 
same pattern of responses could be produced by any number of 
different stressful stimuli, or stressors.
Another approach focuses on the stimulus, conceptualizing 
stress in environmental terms as an event or a set of 
circumstances that requires an unusual response (Cox, 1987). 
Within this framework, researchers have studied catastrophic 
events such as tornadoes, earthquakes or fires as well as 
more chronic stressful circumstances such as imprisonment or 
crowding. They have also studied the relationship between 
the accumulation of stressful life events (such as job loss, 
divorce or the death of a spouse) and the risk of subsequent 
physical illness. They have tried to identify the 
characteristics of a situation that make it stressful (Kagan 
and Levi, 1971).
A third approach views stress as neither a stimulus nor a 
response but as a transaction-or relationship- between the 
person and the environment that taxes or exceeds the person's 
resources (Lazarus and Folkman, 1984). The transactional 
approach argues that focusing on stimuli and responses is not 
sufficient. While some situations are stressful for everyone 
(natural disaster, life threatening illness, or the loss of a 
loved one) many less dramatic experiences (taking an 
examination, arguing with a spouse, getting stuck in 
traffic) are stressful for some people but not for others. 
Responses to stressful situations, even physiological 
responses to painful stimuli, can be powerfully influenced by 
psychological factors. To understand stress, it is important
to know how a person appraises a situation in terms of his or 
her particular motives and needs and resources for coping. 
From a transactional perspective, stress reflects a 
relationship between a person and the environment that is 
appraised by the person as taxing his or hers resources and 
endangering his or her well being (Lazarus and Folkman,
1984) .
Two critical processes that determine the stressfulness of 
the person-environment relationship are cognitive appraisal 
and coping. Cognitive appraisal is an evaluative process that 
determines why and to what extent a person views a situation 
as threatening. Coping refers to the behaviourial and 
cognitive strategies used to manage the demands of the 
situation that are appraised as stressful and the emotions 
generated by it.
3.1 Stress in Physical Disorders
Physical health is closely related to emotional and 
mental health, a fact documented by a multitude of studies 
(Palmore and Luikart, 1972; Larson, 1978). It is a common 
assumption that the experience of stress is often associated 
with the impairment of health. The World Health Organisation 
defines "health" as the presence of physical and emotional 
(psychological) well-being. The cost of stress is expressed 
in terms of its effect on that well-being, (Bradley and Cox, 
1987).
Evidence is accumulating that stress reactions are likely
to occur in certain environments. The effects of some 
environments in which threat is realistic and inescapable 
(such as a wartime city under siege or an earthquake) may be 
so overwhelming as to produce stress in virtually everyone 
exposed to them. Most environments, however, produce variable 
effects. Some people manifest stress reactions, while others 
seem to suffer no such consequences. Therefore, some people 
are more susceptible to stress than others.
Thus the experience of stress can reduce the sense of well­
being, but does not inevitably contribute to the development 
of more serious psychological or physical disorders. However, 
for some the experience of stress may well affect this 
process. Such an effect will be one part of a two way 
interaction between the experience of stress and the state of 
the person's health. Thus, while stress may affect health, 
there is also evidence that a state of ill health can act as 
a significant source of stress in itself or sensitise the 
person to other sources of stress by reducing his or her 
ability to cope (Cox, 1987).
However, individuals differ in their adjustment to both acute 
and chronic physical disorders. Coping efforts have been 
proposed as one means of accounting for these differences in 
adaptation, and numerous studies have documented the 
importance of individual coping efforts in helping ill adults 
maintain reasonable levels of emotional well-being, (Cohen 
and Lazarus, 1979; Moos, 1982). More systematically 
controlled studies have also demonstrated a role for coping 
in explaining the psychological adjustment of ill adults
(Weisman and Worden, 1976; Lambert, 1981).
Recent research by Maddi et al., (1987) strongly supported
the idea that stressful events do indeed correlate with 
concurrent and prospective illness.
Referring earlier to the resistance stage of the General 
Adaptation Syndrome, it was noted that the body's attempts to 
adapt to the continued presence of a stressor deplete the 
body's resources and make it vulnerable to illness. Chronic 
stress can lead to such physical disorders as ulcers, high 
blood pressure and heart disease. It can also impair the 
immune system, decreasing the body's ability to fight 
invading bacteria and viruses. The above disorders with that 
of neuroses have been in recent years perhaps, the health 
areas-which have attracted most research attention.
With the evidence available, there can be little doubt that 
the experience of stress is important in these disorders, 
contributing to their aetiology and in producing an 
unfavourable prognosis. However, stress is possibly 
important for a large number of other conditions, including 
diabetes mellitus and bronchial asthma, (Bradley and 
Cox, 1987).
The present chapter examines briefly three particular 
physical disorders: hypertension, coronary heart disease and 
ulcers. The three rather different disorders have been 
chosen in order to make the point that stress is not only 
important in disorders of psychological origin, 
but also in a narrow group of disorders characterised as 
psychosomatic in which emotions are believed to play a
central role in their aetiology and progress. We will then 
turn to a more detail account of its role in the development 
and process of Diabetes Mellitus.
3.1.1 Stress and High Blood Pressure.
Hypertension, or high blood pressure, is a silent but 
deadly disease. Hypertension develops slowly over the years 
and often produces no noticeable symptoms until it is in the 
advanced stages. This condition of increased fluid pressure 
within the coronary arteries which can damage the heart and 
kidneys, is a direct cause of strokes and is a prime 
contributor to hardening of the arteries. This serious health 
problem has as one of its major causes psychological stress. 
One of the concomitants of the fight-or-flight response is an 
elevation of blood pressure. There is evidence that 
individuals, experiencing the kinds of stress that produce 
this arousal reaction, show temporary increases in blood 
pressure if the stress is over, becoming a permanent 
increase. The research literature is full with examples of 
the ability of psychological stress to produce a hypertensive 
pattern. A number of the earliest investigations have shown 
fluctuations in blood pressure during various kinds of 
interviews. One of these studies is that of O'Hare (1920) in 
which he reported that his patients reacted to the discussion 
of relevant life problems with an elevation in blood 
pressure. Alexander (1939) noticed that, when his patients 
had particularly disturbing sessions in analysis, their blood 
pressures were markedly elevated.
Later research showed that stressful living conditions can 
cause hypertension. An example of this, are the studies 
carried out with black Americans indicating that high blood 
pressure among blacks was most probably a direct result of 
the stressful and demoralizing conditions in the ghetto. A 
study of black residents of middle class neighbourhoods 
revealed a hypertension rate one-half that of their ghetto 
counterparts, (Johnson, 1977).
Another example is the air traffic controllers whose demanding 
work, in which a mistake can result in great loss of life, has 
long had a reputation for debilitating those who attempt it. Not 
surprising a study (Griffiths and Langton, 1968) revealed that 
air traffic controllers had an incidence of hypertension five 
times greater than was expected in a comparable control group.
3.1.2 Stress and Coronary Heart Disease.
Heart disease was quite uncommon in western 
societies as late as the 1920's. Since that time it has 
become so widespread that more individuals now die each year 
from heart attacks than from any other single cause. In the 
public mind heart disease is linked with hereditary 
predisposition, improper diet, cigarette smoking and lack of 
exercise. The results of recent research point that changes 
in the functioning of the cardiovascular system are commonly 
associated with emotional arousal. Fear, anxiety, anger, 
elation and excitement are all accompanied by changes in the 
rate, rhythm, output and stroke volume of the heart; changes 
in arterial blood pressure and changes in other indices of 
cardiovascular function, (Lipowski, 1981).
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In the research on coronary disease there is much evidence to 
support the contention that stressful environments create 
their damage by too often stimulating the physiological 
arousal of the fight-or-flight response. Not only does 
arousal increase the amount of fatty substance in the blood, 
but it also causes other changes that can lead to 
arteriosclerosis, (Woolfolk and Richardson, 1979).
Research on CHD has focused upon two primary issues. The 
first has been the identification and modification of 
individual factors presumably involved in the development of 
CHD (that is cigarette smoking, obesity, hypertension), while 
the second has involved the study of a complex pattern of 
coronary prone behaviours typically conceptualised as the 
Type-A behaviour pattern (Friedman and Rosenman, 1959, 1974).
Diagnosis of the type A or type B behaviour pattern involves 
a standard semi-structured interview aimed at eliciting 
information on different individual aspects like level of 
drive, ambition and competitiveness, degree of involvement in 
work, intensity of the sense of time urgency.
Several long-range studies indicate that people who exhibit 
Type A behaviour are more likely to suffer a heart attack 
than are type B individuals, (Rosenman et al., 1975; Haynes 
et al., 1980). How exactly Type A behaviour affects the 
cardiovascular system is still not understood. The 
physiological effects of the kind of stress that Type A 
individuals experience may involve increased blood 
cholesterol levels, an enhanced tendency to form blood clots,
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elevated blood pressure or increased secretion of the hormone 
noradrenaline, which can trigger abnormalities in heart 
rhythm. Studies indicate that type A individuals, compared 
with type B individuals, show greater changes on all the 
above measures when confronted with stressful tasks (Wright 
et al., 1985) .
Current research concerning the modification of CHD risk 
factors and the Type A behaviour pattern could be considered 
as a first step toward the systematic use of cognitive and 
behaviourial intervention strategies for the promotion of 
health, (Chesney et al.,1981).
3.1.3 Stress and Ulcers
Peptic ulcer is one of those diseases that is highly 
identified with stress in the public mind. The stereotype of 
the hard-driving businessman in living his high-pressure life 
and nursing his ulcer along the way is a part of Western 
society life bearing resemblance to reality. A peptic ulcer 
is created when the juices of digestion burn a hole in the 
lining of the stomach or duodenum. The enzymes and 
hydrochloric acid that aid digestion in the stomach are also 
secreted in times of emotionality. These substances, when 
present in an empty stomach for prolonged periods, begin to 
digest the stomach lining itself. A number of factors can 
cause an increased secretion of hydrochloric acid and 
psychological stress appears to be one of them.
Stress ulcers have been observed for centuries. There are 
documents describing a high incidence of ulcers in roman
soldiers during especially difficult military campaigns.
Since the nineteenth century, physicians have recorded acute 
peptic ulcers in patients who had undergone the rigors of 
severe burns or major surgery (Woolfolk and Richardson,
1979.)
Laboratory research has shown that the predictability of an 
unpleasant consequence is an important factor in determining 
how stressful the consequence is.
Animal studies have shown that stress can cause ulcers. In a 
famous series of experiments with rats conducted by Weis 
(1972), stress was produced by administering a mild electric 
shock to the tails of three rats. The rats who could do 
something to control the electric shocks showed much less 
ulceration than their helpless, yoked companions. The control 
animals who received no shocks, showed no ulceration.
This and similar experiments suggest that prolonged exposure 
to uncontrollable stress does contribute to the development 
of ulcers. Although one cannot generalise from animal 
subjects to humans without further research, it seems likely 
that stress is one factor that leads to ulcers, particularly 
in individuals who are biologically predisposed to secrete a 
high level of hydrochloric acid.
As a conclusion on the sections of Hypertension, Coronary 
Heart Disease and Ulcers it can be noted that not all 
available research on stress and these disorders has been 
presented in this section. However, there is sufficient 
evidence to argue that stress cannot be ignored as a potent
factor in these type of physical disorders and how it might 
contribute to their aetiology. Some simple preventive 
measures towards these diseases could be changing life-style 
patterns (for eg., getting more exercise and having low-fat 
diets). Relaxation exercises and biofeedback training could 
be some additional form of therapy to help block different 
aspects of the physiological and psychological response to 
stress.
Even if one is very conservative in evaluating the available 
evidence, the list of physical maladies in which stress 
probably plays a role is quite long. Migraine headaches, 
backaches, asthma, constipation acute dermatitis, menstrual 
pain, diarrhoea, arthritis, colitis and even disorders like 
cancer and diabetes mellitus have been linked to stress.
In Chapter 3, the area of stress and psychosomatic diseases 
was discussed and an attempt was made to define stress.
4. Stress and Diabetes Mellitus 
This chapter will attempt to build on the previous one by 
elaborating upon the specific links of psychological stress 
with Diabetes Mellitus. It is hoped that this will then lead 
naturally into the next chapter in which the role of 
relaxation as a means of mediating stress, and thus as a 
potential factor in the control of diabetes, is introduced.
There is much evidence, both observational and 
experimental, which suggests that stress is intimately linked 
with both the onset and the course of diabetes mellitus. 
Diabetes mellitus is a disorder of carbohydrate metabolism, 
characterised by hyperglycaemia and glycosuria, affecting a 
significant proportion of the population. Figures published 
in 1976 by the British Diabetic Association estimated that 3 
per cent of adults in Britain suffer from some form of this 
disorder, (Bradley and Cox, 1987)
4.1. Influence of Stress on the Pathophysiology of Diabetes.
The physiology of diabetes is quite complex, and a 
detailed description is beyond the scope of this thesis. 
However, a brief description of the mechanisms involved in 
the pathophysiology of diabetes is essential in order to 
understand the disease process and its relation to stress. 
Insulin is a protein hormone that is secreted by the beta 
cells of the pancreas. In healthy individuals the amount of 
insulin synthesis is regulated by the concentration of 
glucose in the blood. When food enters the body it is broken 
down in the intestines into glucose. From the intestines,
glucose is absorbed into the blood stream and transported to 
the liver where 60% of it is retained and the other 40% of it 
goes to the general circulation. When glucose is circulated 
in the arteries it enters the pancreas where the 
glucose levels are monitored and insulin is secreted in 
response to increases in glucose levels, (Turk and 
Speers,1983).
For years, physicians have known that when insulin is not 
available or inappropriately used, glucose levels in the 
blood increase and Ketosis (breakdown of fatty tissue) 
results. In fact, Ketosis and its consequences-acidosis and 
coma-are often the first signs of diabetes. When glucose is 
not used by the cells and the blood glucose level rises, the 
muscles are deprived of needed energy.
In the absence of insulin both fat stored in adipose tissue 
and muscle protein are broken down. Amino acids derived from 
muscle protein are used to glucose synthesis in the liver; 
fat (triglyceride) is used as an energy source. The formation 
of ketone bodies and keto-acids result from the excessive use 
of fat as an energy source.
Diabetic ketoacidosis is characterised by high levels of 
both glucose and ketoacids in the blood. The hyperglycaemia 
results in an osmotic diuresis and dehydration, with the loss 
of large amounts of both water and electrolytes. The 
accumulation of ketoacids leads to a dangerous metabolic 
acidosis.
As it has already been mentioned, in the section "Causes and
Mechanisms of Diabetes", one of the factors implicated as a 
possible cause of diabetes is psychological stress (Hinkle 
and Wolf, 1952a, 1952b). It has long been known that 
stress can aggravate hyperglycaemia in diabetes mellitus (Porte,
1983). Cannon (1941) described hyperglycaemia in non-diabetic 
animals as part of the fight and flight response.
Furthermore, he demonstrated that the emotional reaction of 
fear and anxiety can provoke glycosuria in non-diabetic 
humans Hinkle, Wolf and their associates (1949a, 1949b, 1952c) 
referred to emotional stress conditions that produce a rise 
in the concentration of blood ketones in nori-diabetic 
subjects. Furthermore, non-diabetic persons exposed to 
emotional situations do experience changes in their blood 
glucose level (Lachman, 1972).
Surwit et al., (1983) have summarised the mechanisms by which 
environmental, emotional or physical stress can affect 
glucose metabolism. He reviewed the relationships between 
the central nervous system, autonomic nervous system and 
hypothalamic adrenal cortical axis in controlling glucose 
metabolism. This is summarised in Figure 1.
The autonomic nervous system is intimately involved in the 
regulation of carbohydrate metabolism. The effects of the 
autonomic nervous system on insulin action are both 
facilitory and inhibitory. Branches of the right vagus nerve 
innervate the pancreatic islet cell beta adrenergic receptors 
thus facilitating insulin secretion. Conversely , insulin 
secretion is inhibited by stimulation of the sympathetic 
nerves of the pancreas through the activation of alpha
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FIGURE 1: Schematic diagram summarising the major effects of the sympathetic ner­
vous system (SNS) on glucose metabolism. The diagram oversimplifies the p roem  Involved 
In order to provide a genenfj overview of how behavioral manipulation of the SNS can 
influence glucose metabolism in the normal and diabetic individual. It should be noted that 
the important contributions of the hypothalamic-pituitary axis and tho parasympathetic 
nervous system have been omitted for the sake of simplicity. CNS central nervous system.
(From: Surwit, et al., 1983)*
adrenergic receptors. This sympathetic and parasympathetic 
innervation of the pancreas may modulate insulin secretion 
in the normal regulation of carbohydrate metabolism 
(Williams and Porte 1974; Young and Landsberg 1979; Clutter et 
al., 1980;) .
The autonomic nervous system has additional metabolic 
effects. Beta adrenergic stimulation facilitates the 
conversion of glycogen to glucose in the liver and as fat to 
free fatty acids in adipose tissue.
Neurogenic stimulation of the hypothalamic pituitary axis 
leads to secretion of cortisol from the adrenal cortex, which 
elevates blood glucose and impairs glucose tolerance.
Low-dose exogenous adrenaline infusions (to levels comparable 
to those achieved in minor stress) can also adversely affect 
glucose tolerance (Hamburg et al., 1980).
Thus, the autonomic nervous system, particularly the 
sympathetic branch, has both direct neural as well as 
indirect hormonal control pathways in the regulation of 
glucose metabolism (Williams and Porte, 1974). Yet, although the 
role of the sympathetic nervous system in the body's response to 
acute hypoglycaemia has been known for years, the importance 
of sympathetic nervous system activity in normal glucose 
metabolism is only beginning to be appreciated, (Young and 
Landsberg, 1979; Clutter et al., 1980).
At least in theory, behaviourial regulation of autonomic 
nervous system activity can contribute to the medical 
management of both types of diabetes. For the patient
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with insulin-dependent diabetes, a reduction in autonomic 
activity could decrease excess glucose production by the 
liver as well as decrease free fatty acid mobilization and 
consequent ketoacid production. The potential contribution of 
modulation of autonomic nervous system activity to the 
treatment of non-insulin-dependent diabetes is much greater. 
Because insulin secretion is itself under some degree of 
autonomic control, techniques to modulate autonomic activity 
might be of help in the control of blood sugar by enhancing 
the body's ability to secrete insulin as well as by 
decreasing the tendency to release additional glucose from 
the liver, (Williams and Porte 1974; Young and Landsberg 1979 
Cerich, 1978).
There are few studies on how stress and behaviour interact 
with the development of diabetes in animals. Although Cannon 
(1941) described stress induced hyperglycaemia in non­
diabetic animals a half century ago, the effects of stress on 
diabetic animals have not been extensively studied. Two 
existing reports on the effects of stress on animal models of 
diabetes appear; Capponi et al., (1980) studied the effect of
repeated restraint stress on rats that had been partially 
pancreatomised. While few of these animals developed diabetes 
spontaneously, restraint stress produced permanent diabetes 
in a significant percentage of pancreatectomised animals.
In contrast to this result, another recent study by Huang 
(1981) found that light-shock stimulation could inhibit the 
development of streptozotocin-induced diabetes in young mice 
receiving a single dose of streptozotocin. It is therefore
possible that the protective effect of shock upon the 
development of diabetes, observed in animals treated with a 
single dose of streptozotocin, may have been mediated through 
the adrenocorticotrophic effects of stress. These two reports 
highlight the complex nature of the relationship between 
environmental stimulation and the development of diabetes in 
animals which were susceptible to the disease. However, they 
do not provide insight into how stress affects animals with 
established diabetes.
Recent studies by Surwit et al., (1984)have documented that 
stress can contribute to the expression of diabetes in the 
obese mouse, a common animal model of Type II diabetes. They 
observed that while blood glucose values were not 
consistently elevated in obese as compared to lean mice, 
however, during restraint stress and shaking or following the 
administration of exogenous epinephrine severe hyperglycaemia 
was developed. The response of obese animals to stress or 
epinephrine was clearly greater than that of lean animals of 
the same strain.
The investigation of the effects of induced stress on 
metabolism in diabetic patients was first undertaken by 
Hinkle and his coworkers (1951, 1952c). Their studies 
demonstrated changes in blood glucose and ketones in stressed 
people with diabetes; their work was criticised (Surwit and 
Feinglos, 1984) as poorly controlled and difficult to 
interpret. However, Hinkle's work was difficult to 
interpret because he looked at blood glucose levels in 
individuals. It could be said that one major point of this
study, was to give emphasis on the importance of individual 
differentiation.
VandenBergh et al., (1966) examined the impact of induced
stress in a controlled fashion on subjects, most of whom has 
insulin-dependent diabetes.
Coincident with nonsignificant increases in plasma free fatty 
acids, they observed blood glucose decreases. These findings 
were replicated in a subsequent study by VandenBergh et al., 
(1967). McLesky et al., (1978) found a clear hyperglycaemic 
response in insulin-dependent and non-insulin-dependent 
diabetic patients during surgical stress compared with the 
controls. Compared to non-diabetic, diabetic children have 
been shown to demonstrate elevated blood glucose and more 
rapid ketone release following adrenaline infusion (Baker, 
1960);subsequently, acute beta-adrenergic blockade with 
popranolol was shown to prevent both exogenous adrenaline 
and experimental stress-induced hyperglycaemia in children 
with diabetes (Baker,1975).
4.2. Stress and its Psychological Influence on Diabetes
When an individual is exposed to a problem, demand, or 
threat (either physiological or psychological), a complex set 
of physiological events is set in motion. Of particular 
importance to diabetes is the fact that exposure to a threat, 
problem, or demand leads to the secretion of a number of 
hormones known to increase blood glucose and /or ketone 
levels and suppress insulin production (e.g., cortisol,
catecholamines, glucagon, growth hormone). Following 
episodes of acute stress, a relatively rapid reduction of the 
counter regulatory hormones occurs with a concomitant increase 
of insulin in the blood. Under conditions of prolonged, 
intense, or recurrent demand, the level of counter regulatory 
hormones remains high, leading to insulin resistance and 
occasionally, diabetes (Selye, 1956).
Such permanent physiological effects have been called 
"diseases of adaptation" (Hinkle, et al., 1951; Selye,
1956). These permanent changes may result in one of two 
psychophysiological defects: a) an augmented stress response 
in the metabolic system, or b) a dysfunctional metabolic 
system that has difficulty returning to a homeostatic state 
(Tarnow and Silverman, 1981-1982). In support of these 
psychophysiological defects, data have shown that people with 
diabetes display abnormally high levels of catecholamines 
both at rest and during exercise (Christensen, 1970) and 
increased ketone and free fatty acid levels following 
catecholamine secretion (Baker et al., 1969).
Many investigations of the etiological effects of stress on 
diabetes have been reported; however, the data are 
divergent. Several authors (e.g., Hinkle and Wolf, 1952a, 
1952b; Slawson et al., 1963) have claimed that the onset of
 diabetes frequently occurs in response to stress, whereas
other investigators have been unable to find empirical 
support for this contention (e. g. ,.Growell, 1953; Geiger et 
al., Koch and Molnar, 1974).
The relationship between stress and the onset of diabetes
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remains confused. One problem has been the reliance on stress 
evoked in laboratory or clinical settings, with 
generalization to the natural environment. The obverse of 
this problem is seen in the studies that have relied on major 
stressful life events. This latter set of studies fails to 
consider individual difference in evaluation of the 
importance of standard sets of stressful events. Although 
there are some reports of diabetes onset following stressful 
life events such as death of a spouse there are many 
instances where no antecedent stressful event can be 
identified prior to onset of diabetes. It could be suggested 
that some factor either genetically based or related to 
a prior illness, predisposes an individual to diabetes. Under 
high levels of stress , these predisposed individuals might 
develop diabetes (e.g. Mirsky, 1948; Lebovitz, 1984).
Stress-related changes in immune function may increase the 
likelihood of viral or bacterial disease, which may provide 
the initial insult to the beta cells (Bradley, 1988). Another 
mechanism by which stress may play a role in diabetes onset 
may start to operate around the time when diabetes becomes 
symptomatic. Stress-related counter regulatory hormone 
activity may aggravate the metabolic disturbance that has 
already developed. If the already elevated blood glucose 
levels increase beyond the renal threshold, dehydration 
associated with glycosuria may then produce the first 
symptoms of overt diabetes (Bradley, 1988). Studies on life 
stresses could give support to the above aspect. Clayer's 
(1985) study could be an example of that. He followed 1526
-39-
victims who survived the bushfires in South Australia. The 
prevalence of a number of disorders, including diabetes, was 
significantly increased 12 months after the bushfires.
The stress explanation hypothesis, although intuitively 
appealing, has not been supported by some studies.
For example, Gendel and Benjamin (1946) noted no increase in 
the frequency of diabetes during war-induced stress.
Moreover, in the only large-scale prospective study, Cobb and 
Rose (1973) reported that North American air traffic 
controllers did not show an increased tendency to develop 
diabetes over a 2-year period when they were compared to a 
matched group of men who were employed in jobs that did not 
require rapid decision-making, high responsibility and high 
stress.
The stress explanation hypothesis would have 
predicted some increases in the frequency of diabetes onset 
in both air traffic controllers and military personnel 
assuming that these occupations produce greater stress. From
the evidence available it is difficult to support the
hypothesis that stress causes diabetes onset.
4.2.1. Effects of Major Life Events on the Course of Diabetes
In addition to examining the role of stress in the 
aetiology of diabetes, investigators have attempted to 
establish a relationship between stressful life events and 
episodes of diabetic decompensation (hypoglycaemia end severe 
hyperglycaemia).
Beginning with the classic studies of Hinkle and Wolf (1952a, 
1952b) investigators have attempted to link diabetic 
instability to major stressful life events, for example, loss of 
a significant other, marriage or legal problems (Grant et al., 
1974; Bradley, 1979).
Hinkle and Wolf (1952a, 1952b) interviewed a number of 
diabetic patients during a 3-year period in an attempt to 
determine the relationship between life events and 
fluctuations in diabetic control. Patients for whom a 
relationship between a specific stressful life event and 
diabetic control could be identified were interviewed 
extensively.
Hinkle and Wolf (1952a, 1952b) reported that during the 
discussion of the stressful topics, people with diabetes 
showed an increase in urine output, an increase in ketones in 
the blood and fluctuations in blood and urine glucose levels. 
During the supportive phase of the interview there was a 
reversal of the physiological changes with a return to base­
line levels in a relatively short period. Subjects without 
diabetes responded in an analogous manner; however, they 
differed in both the intensity of the physiological changes 
and the latency period required to return to base line. Thus, 
the healthy individuals' physiological responses were less 
extreme and required shorter periods to return to base line 
than the people's with diabetes.
Baker and his colleagues (Baker et al., 1969) employed a 
research strategy similar to that of Hinkle and Wolf and 
supported a relationship between physiological responsivity
and stress. They noted, particularly, that diabetic patients 
showed increases in free fatty acids during the stress 
interview and a relatively slow return to base-line levels.
In addition two other studies have examined the relationship 
between stressful life events, employing the Holmes and Rahe 
scale, (1967). Grant et al., (1974) and Bradley (1979) 
suggested that Holmes and Rahe-type life event measures were 
associated with disturbances of diabetes measured by a 
variety of indices, like glycosuria, changes in insulin and 
tablet prescription. Higher blood glucose levels, as expected 
correlated positively with incidence of glycosuria. Recent 
studies have investigated relationships between Glycosylated 
Haemoglobin (a measurement which reflects average blood 
glucose levels), and measures of perceived stress or impact 
of life events (Linn et al., 1983; Jacobson et al., 1985).
These studies indicated that life stress, measured in various 
ways, was associated with increased HbAl levels. Furthermore, 
Linn et al., (1983) compared Type I and Type II men and found 
that Type I men reported more life events as well as 
demonstrating a stronger association between perceived stress 
associated with life events and HbAl. Comparable findings 
were reported by Bradley (1979). On the basis of these 
studies it may be suggested that the association between life 
events and glycaemic control is a causal one, i.e. life 
events disrupt glycaemic control which in turn leads to more 
life events. There are two kinds of mechanisms which may 
account for life events causing raised blood glucose levels. 
One is when counter-regulatory hormones may mediate stress-
related increases in blood glucose levels and the other 
stress-related glycaemic fluctuations due to behaviourial 
mediation (Tarnow and Silverman, 1981-2; Cox, 1986).
The stressful life events approach, in general, has received 
a great deal of criticism (Radkin and Struening, 1976;
Sarason et al., 1978). A particular problem with research 
that focuses exclusively on physiological data is that one 
cannot determine whether the presence of stressful life 
events directly affects diabetic stability or indirectly 
affects stability by influencing patients' compliance 
behaviour. The latter alternative has received some support 
from studies reporting that up to 25% of ketoacidotic 
episodes may be attributed to the deliberate omission of 
insulin by patients (Beigelman, 1971; Cohen et al., 1960).
In this chapter we have attempted to elucidate the links
between psychological stress and diabetes mellitus. In the
following chapter stress management, with particular reference 
to its role in aiding the control of diabetes will be
discussed.
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5. Relaxation Training in Relation to Stress
This chapter will discuss relaxation training as a stress 
management technique and its relation to diabetes mmellitus. 
This will then lead into an account of the rationale for the 
subsequent research endeavour which forms the body of 
this thesis.
There are many methods used to reduce general anxiety.
These methods are used both in a clinical setting and in 
experimental investigations. Perhaps the most important among 
them is progressive relaxation based on the work of Wolpe 
(1958). The most important component of this method is the 
achievement of extensive and deep skeletal muscular 
relaxation. This technique seeks to achieve increased 
control over skeletal tension in the major muscle groups, 
such as in the arms and legs. Progressive relaxation was 
originally developed and effectively applied by Jacobson 
(1938) and subsequently modified for clinical use by Wolpe 
(1958). Jacobson taught the technique as a muscular skill and 
he tried to avoid suggestion; he argued that anxiety neurosis 
and other related diseases are caused or aggravated by 
skeletal muscle contraction, whereas muscular relaxation 
produces opposite physiological states. In recent years 
Benson and his colleagues (1975), have reviewed what is known 
about what they have termed the relaxation response. In 
describing it, they stated that it appears to be an 
integrated hypothalamic response which results in generalized 
decrease in sympathetic nervous system activity and perhaps 
also an increase in parasympathetic activity.
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A re-evaluation of Jacobson's work is attempted in a recent 
study, where the experimental literature is reviewed by 
Lehrer (1982) and shows that modified as "brief” progressive 
relaxation is not as effective as the original relaxation 
training by Jacobson.
The psychophysiological effects of suggestion are weaker than 
those of progressive relaxation. In progressive relaxation 
Jacobson reports results that are stronger and longer Lasting 
than are found among most modern studies. Glaister (1982) 
reviewing 24 studies (1960 to 1980) concluded that:
(a) muscle relaxation training can have an anxiety-reducing 
effect over a course of several sessions; (b) a course is 
capable of reducing autonomic arousal during rest and stress 
following the course; and (c) a course is capable of 
producing behaviourial change.
Relaxation training has been used to inhibit or reduce a 
stress response (Mathews and Gelder, 1969; Paul and Trimble, 
1970; Lindemann, 1973; Connor, 1974), facilitate systematic 
desensitization (Wolpe, 1958) and alleviate a variety of 
anxiety related disorders. Furthermore, there have been 
numerous reports of relaxation training being successfully 
employed in lowering blood pressure (Jacobson, 1938; Datey et 
al., 1969; Benson et al., 1973; Deablor et al., 1973; Brady 
et al., 1974; Klemchuk, 1974; Stones and Leo, 1976). However, 
it is relevant to point out that most of these studies have 
methodological weaknesses. For example in several the authors 
acknowledge that there were too few subjects to allow for any
strong generalization of results (Paul and Trimble, 1970; 
Tasto and Hinkle, 1973; Brady et al., 1974). In the study 
conducted by Kahn et al., (1968) there was no control group
and the only measures were retrospective self-reports. The 
Sherman and Plummer (1973) study also relied on self-report 
measures. The above criticism was made by Benlolo (1978) .
5.1. Relationship of Relaxation Training to Diabetes
Relaxation techniques are now employed in the treatment 
of a variety of autonomically mediated illnesses, e.g., 
migraine or hypertension (Shapiro and Surwit, 1976; Shapiro 
and Surwit, 197 9). There is some evidence that relaxation has 
a sympatholytic effect (Stone, 1976) and may reduce 
adrenocortical activity as well (Jerning et al., 1978; DeGood 
and Redgate, 1982).
As was previously mentioned, stress appears to be associated 
with elevation in blood sugar. Therefore, if one could 
counteract the effects of stress among people with diabetes, 
it would lead to an improvement in blood sugar control. In 
addition, from a physiological perspective, regulation of 
autonomic nervous system activity through relaxation can 
potentially contribute to medical management of diabetes 
(Surwit et al., 1983).
The earliest report on the experimental use of relaxation 
techniques to control diabetic symptoms has been attributed 
to Bauch (1935) . Bauch believed that tension and irritability 
were common to the person with diabetes and that sugar 
excretion was frequently the diabetic's reaction to
stressful stimuli.
He advocated reducing the overall tension experienced by 
people with diabetes through systematic directed relaxation 
on body parts. He reported on several cases of diabetic 
patients who significantly reduced their dosage of insulin as 
a result of relaxation. He also conducted a study in which 
four insulin-dependent people with diabetes and a group of 
healthy subjects were given relaxation exercises (cited in 
Daniels, 1939). The relaxation group responded with a 
significant decrease in blood glucose levels, which resulted 
in a 10-20 unit reduction in their insulin dosage. The 
control group,however, showed no notable changes in blood 
sugar, Jacobson (1938), in his classic book, "Progressive 
Relaxation", also called attention to the diabetic's 
restlessness and anxiety. He recommended the use of relaxation 
therapy in the treatment of people suffering from diabetes.
Studies of VandenBergh et al., (1966), reported decreases in
blood glucose levels of people with diabetes during 
hypnotically induced stress, whereas Pinter and his 
colleagues (1967) found no changes in blood glucose levels, 
but did note increases in free fatty acid. Subsequent studies 
have produced similar results indicating that stress can have 
destabilizing impact on diabetic control (VandenBergh et al., 
1967; Baker et al ., 1969). However, as Lustman and 
colleagues (1981) note, these studies had relatively little 
control over conditions, made few efforts to counterbalance 
the designs for order effects and had no means of confirming 
that the Ss were indeed stressed.
Luthe (1969), reported that he improved self regulation of 
blood sugar in people with diabetes through autogenic 
training. In more recent years Fowler et al., (1976) report
the effects of relaxation training in the case of an insulin 
dependent 20-year-old female with diabetes, who experienced 
repeated episodes of hyperglycaemia in response to periods of 
physical and emotional stress. Following a six-month 
programme of relaxation training assisted by
electromyographic (EMG) biofeedback, her insulin requirements 
were halved. Kershaw (1979) , tried to examine the effects of 
visual imagery and relaxation on insulin dose and urine sugar 
in 5 insulin- dependent people with diabetes. She found that 
visual imagery had no effect on mean insulin dose, clinitest 
measures of glycosuria or symptoms of hypoglycaemia or 
hyperglycaemia. However the subjects who completed the 
programme believed that the visual imagery and relaxation 
programme positively affected their emotional state.
Seeburg and DeBoer (1980) treated a 24-year-old patient with 
insulin-dependent diabetes mellitus using a procedure similar 
to that described by Fowler et al., (1976). The treatment
resulted in a significant reduction in the patient's insulin 
requirement from 24 to 18 Units, but was stopped as the 
subject became highly unstable. However, in both of these 
studies there was no report of blood or urine glucose levels. 
Surwit and Feinglos (1984) explored the effects of EMG- 
feedback assisted relaxation training on glucose 
tolerance, (insulin sensitivity) and glucose stimulated 
insulin secretion in twelve patients with non-insulin- 
dependent diabetes. All patients were hyperglycaemic at the
time of hospital admission. Six patients received one EMG 
feedback session per day and practised progressive relaxation 
exercises with taped instructions twice per day during their 
stay in hospital. Six patients were in hospital under 
similar conditions but did not receive relaxation training.
The six treated patients showed substantial improvement in 
glucose tolerance following relaxation training, whereas 
glucose tolerance in the control patients deteriorated. 
Insulin sensitivity and glucose stimulated insulin secretory 
activity were not affected by relaxation.
Koehler (1981) examined psychological and physiological 
changes in 21 juveniles with diabetes who underwent a 
relaxation programme. Subjects were assigned to a 
progressive relaxation, a self relaxation or an untreated 
control group. The results indicated that there were no 
statistically significant differences between any two groups 
on measures of trait anxiety or glycosylated haemoglobin.
An important study by Hartman (1982) showed that it is 
possible to alter physiological and psychological factors 
related to the control of diabetes, (the present 
experimenter got most of the information on Dr. Hartman,s 
work through personal communication with her). She tested the 
effects of a relaxation training programme on metabolic 
control, perceptions of tension and adjustment to diabetes, 
for 15 adults (both type I and II people with diabetes). The 
relaxation programme was presented in six 90 minute small 
group sessions. A five-month follow-up study was carried out. 
This showed that subjects who initially had elevated blood
glucose levels obtained significantly lower glycosylated 
haemoglobin values following treatment and these results were 
maintained at the five month follow-up. Also the average 
number of daily insulin units for the subjects overall 
decreased significantly at the five month follow-up compared 
to baseline levels. There were no significant changes 
obtained following treatment or at follow-up for the average 
percent of urine sugar levels.
Tension scores decreased from baseline to treatment and these 
results were maintained at follow-up.
It has already been noted that despite contradictory 
evidence, researchers generally agree that environmental and 
physical stress seem to be responsible for increasing 
hyperglycaemia and glucose intolerance in patients with 
diabetes mellitus. However, the reason that most researchers 
gloss over the cases where blood glucose levels decrease in 
response to stress, is that, while we have a theory that fits 
the data for cases where blood glucose increases there is not 
such a theory for the cases where blood glucose decreases. It 
would be important to recognise that stress is sometimes 
associated with decreased blood glucose levels and 
acknowledge that we have little idea of why or how this 
decrease occurs.
The idea that relaxation training could contribute to the 
medical management of both types of diabetes, has been 
supported (e.g., Luthe, 1969; Fowler et al., 1976; Surwit, et 
al., 1984; Hartman,1982).
However, it should be born in mind that the studies reported 
in this review are based on models which do not include the 
concept of individual differentiation. Furthermore, they have 
inherent limitations due to flawed methodology. For example 
studies like those of Luthe (1969), Fowler et al., (1976) and 
Seeburg and DeBoer (1980) employ only a series of case 
studies, lack any adequate control groups and lack reports of 
blood or urine glucose levels. Hartman's (1982) study is 
larger in scale than the other work referred to, but still 
does not employ adequate control groups.
Recent research work on the area of diabetes, mainly after 
the present study was started and completed, throw more light 
into the control of diabetes and put more emphasis on the 
individual differentiation.
A study conducted by Feinglos et al., (1987) involved type I 
patients suffering from diabetes mellitus. They found no 
significant differences in glucose tolerance between 
relaxation and control groups. This study was comparable with 
the study conducted by the same authors (Surwit and Feinglos,
1984) but in this research Type II patients with diabetes 
were studied. The differences between the two studies, 
according to the authors, can be attributed mainly to the 
fact that patients with type I diabetes may be heterogeneous 
in terms of glucose response to stress. They also pointed 
that type I individuals tend to show more baseline 
variability in glycaemic control, which may influence stress 
response.
A study that took into consideration the baseline variability 
was that of Landis et al., (1985). They used patients whose 
blood glucose levels were stabilised at the beginning prior 
to the relaxation training. The main finding of this study 
was that relaxation training and practice were associated 
with a clinically meaningful reduction of the daily range of 
blood glucose levels. An interesting finding was that of 
individual variability, for some patients the measurements of 
glycosylated haemoglobin, average blood glucose levels and 
daily insulin requirement decreased (four out of five) while 
for the fifth they remained constant.
Lammers et al., (1984) studied the impact of relaxation
training on blood glucose, stress activity and caloric 
intake. Four insulin dependent patients with diabetes were 
followed as single case reports. Two of the four subjects 
showed a significant decrease in blood glucose and stress 
levels during treatment as compared to baseline measures. The 
authors claimed that these differences may be due to the fact 
that these two subjects had elevated initial glucose levels 
and poorer metabolic control. In addition they felt that 
stress was a factor that disrupted their control.
An important study by Bradley et al., (1985) studied patients
who had poor glycaemic control who felt that stress was a 
factor which affected their blood glucose levels. There was 
a significant reduction of glycaemic control in all three 
groups, including the control group (two relaxation and one 
control groups), however differences between the two groups 
did not reach significance.
An interesting finding of this study was that it gave 
information on individual differentiation. It showed that 
half of the patients benefited from the treatment while the 
other half did not. The authors of this study claimed that 
this difference between these two groups of patients were 
due to different ratings at baseline. The ones who benefited 
had poorer glycaemic control at baseline and higher stress 
ratings. Bradley (1988) suggested that relaxation training, 
in offering a means of control over psychophysiological 
reactions which might otherwise disrupt glycaemic control, 
will be of most use to those people who initially feel least 
personal control over their diabetes.
A recent study by Cerpa (1989), employed three different 
groups, a relaxation, a placebo and a control group with War 
Veterans non-insulin dependent patients with diabetes. She 
found that only the patients belonging in the relaxation 
group had significant reductions in their measurements of 
anxiety and blood glucose levels.
As a conclusion it can be stated that all these studies 
support the notion that recent advances in the development of 
stress-management techniques can be a strong and viable aid 
in establishing greater diabetic control.
5.2. Rationale of the Present Study
The present study was undertaken with the above
limitations in mind. Firstly, the intention was to employ a 
larger sample size as well as a control group, in order to 
allow for a more reliable and generalizable analysis and 
interpretation. This study was primarily designed to test 
whether adding relaxation training to the medical treatment 
of people with diabetes would lead to an improvement in their 
diabetic condition. A secondary interest of the study was to
determine whether the psychological factors (e.g., anxiety)
of people with diabetes would be affected by participation in 
the programme. Therefore, the present research assesses 
individuals' responses to standardised tests before and after 
the intervention technique and attempts a comparison with 
control groups of diabetics' who have not undergone the 
relaxation training program. In addition an attempt will be 
made to identify means of assessing individual 
differentiation in the relationship between physiological 
and psychological factors.
CHAPTER 6 
THE FIRST STUDY
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6.1. Aims of the First Study
The aims of the present study were to investigate the effects 
of relaxation training on a number of psychological and 
metabolic parameters of a relatively large number of patients with 
diabetes mellitus. Another aim was to chart the changes in the 
metabolic and psychological state of individuals who did not 
receive this training. Finally, it is hoped to provide evidence on 
a potentially beneficial and low cost intervention which may help 
patients with diabetes achieve improved metabolic control by 
learning to incorporate relaxation training in their daily life.
6.2. Hypotheses and Predictions
The following general hypothesis is investigated in the 
present study.
It is believed that the post-treatment measurements will be 
influenced by relaxation treatment and they will show marked 
improvement over the pre-treatment measurements. No such changes 
are expected for the group receiving no relaxation training. On 
the basis of the literature, reviewed earlier, the following, 
more specific, hypotheses were formulated:
Hypothesis 1: Relaxation training will influence the post­
treatment values of the State scale of the State and Trait 
Anxiety Inventory. Specifically, it is expected that the 
patients' anxiety levels will decrease in the post-treatment 
measurement. This is expected due to evidence suggesting that 
relaxation training causes anxiety levels to
-56-
decrease in patients with diabetes mellitus. Therefore, 
patients in the relaxation group, are expected to show 
significantly greater reductions in state anxiety than the 
control group.
Hypothesis 2: Trait anxiety scales are expected not to show
such large changes from pre to post treatment measurements as State 
anxiety for either the Experimental or the Control 
groups. This is because it is not expected that the relaxation 
training will work at the trait level but will be more situational 
in effect. In other words the relaxation techniques will need to be 
built into a continuous daily programme in order to maintain the 
anxiety reduction benefit.
Hypothesis 3: In relation to the metabolic parameters,
relaxation training is expected to produce a considerable 
improvement in the post treatment measures. Therefore, a 
reduction is expected for the post treatment dependent 
measurements of blood glucose levels (BSL) glycosylated 
haemoglobin (HbAlC), cholesterol (Choi) triglyceride (TG), 
urine glucose levels (UGL) and high density lipoprotein 
(HDL), and for the independent measurements of blood 
pressure (BP) and body weight (BW).
Patients in the treatment group are expected to show 
significantly greater improvement on the above measurements, 
compared to the control group. This hypothesis is based on 
existing evidence that relaxation training seems to help patients 
with diabetes mellitus to improve their metabolic control 
(Luther, 1969; Fowler, 1976; Bradley, 1982).
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Hypothesis 4: In relation to the psychological tests 
administered to the Experimental Group, it is expected that 
relaxation training would influence patients' values, mood 
and experiences during the 8 week period. Specifically, it would 
be expected that emotional state should acheive a positive balance 
due to the effects of relaxation. For this reason a steady 
downward trend is hypothesised in negative emotional feelings 
across the 8 week training period.
Hypothesis 5: It is expected that an improvement in the
biological parameters would significantly correlate with the 
emotional state of the patient. The purpose here is to examine the 
pattern of this relationship between the biological and 
psychological factors within each patient across the eight week 
period of the study.
As has already been stated (Stone and DeLeo, 1976;
Jerning et al.-, 1978; Bradley, 1982), relaxation training is 
believed to have an influence on the biological control and 
the psychological state of the patient. In this study it is hoped 
to examine the degree to which relaxation is implicated in the 
relationship between psychological well-being and biological 
control.
6.3 Subjects 
Source of Sample
This research took place in Hippokation Hospital in Athens,
Greece. The catchment area was, thus, primarily urban although wide 
enough to include patients from the outer suburbs of Athens. 
Forty-eight patients (27 female and 21 male) with insulin
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dependent diabetes (Type 1 - 3 4  patients) and non-insulin dependent 
diabetes (Type II -14 patients) were selected from the outpatient 
clinic of the diabetic centre at the above hospital.
The age range of the sample was from 18 to 60 years with a 
mean of 35.5 and standard deviation of 9.7.
Subject Recruitment
All patients were outpatients and were approached for voluntary 
participation on their monthly visit to the clinic 
(appointments at Hippokration Diabetic Centre are 
arranged for most of the patients to be every 4 to 6 weeks).
Each diabetic patient visiting the diabetic centre was 
introduced by their doctor to the research project.
At this stage they were told that a medical psychologist was 
conducting a research project in the area of diabetes.
Patients who expressed interest in finding out more about 
the project were then guided by the nurse to a separate room 
and given further information about the study by the 
researcher.
Exclusion Criteria
Only literate patients were included in the study (four 
patients were excluded for reason of illiteracy).
Patients who had renal, cardiac or retinopathy problems or 
were pregnant were also excluded to prevent possible 
confounding with other variables. Eight patients were 
excluded under these conditions.
The study utilized a group of subjects who had been informed 
about their diabetic state at least a year earlier, so that had
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overcome the initial shock of diagnosis.
Procedure for Subject Briefing and Selection
Patients entering the office in the odd sequence (1st, 3rd 
etc.) were assigned to the Experimental Group, while those 
entering in the even sequence were assigned to the Control Group.
The patients in the Experimental Group were given full 
details of the research (see Procedure). The patients in the 
Control Group were told that this research was to monitor 
certain metabolic and psychological parameters.
Approximately 130 people were approached by their physician 
in their monthly visit, and were informed about this study. 
Roughly 50% of these subjects expressed interest to meet the 
psychologist and learn more about the study. After the 
subjects had been informed and briefed about the amount of 
the commitment expected from them, 50 patients agreed to take 
part in this research. The patients who did not agree to 
take part in the study claimed that they had busy time 
schedules and it was difficult to commit themselves to the 
demands of this research.
The 50 patients who agreed to participate in the research 
were given appointments for the following week. However, two 
patients dropped out (one from each group), at the beginning 
of the study (between the 1st and 2nd week of individual 
meetings).
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6.4. MEASUREMENTS AND MATERIALS USED
6.4.1 Psychological Measures:
The State-Trait Anxiety Inventory (STAI)
This test (Spielberger 1970) was administered to both 
experimental and control groups. The STAI consists of two 
separate self-report scales for measuring State and Trait anxiety 
separately. Both scales consist of 20 test items, with the A- 
state scale requiring subjects to indicate how they feel at 
the particular time of their assessment, and the A-trait 
scale requiring them to state how they generally feel. (The 
distinction between state and trait anxiety is central to the 
differential hypothese 3 and 4 above). Each test item is rated on 
a four-point response scale with some items in which a high score 
would indicate a high level of anxiety and others the reverse (see 
Appendix I).
Spielberger et al., (1973) claimed good validity of the STAI 
as its total score was found to be positively and 
significantly correlated with the Institute for Personality 
and Ability Testing Anxiety Scale, the Manifest Anxiety Scale and 
the Affect Adjective Check List. They also demonstrated that this 
inventory could successfully discriminate between stressful 
(watching a stressful movie and taking exams) and non-stressful 
(normal and relaxed conditions) situations. Additional evidence 
for the theoretical validity of the STAI, when used with patient 
populations, has been provided by Edwards (1969), Graham (1969) 
and Parino (1969).
The State-Trait Inventory used was translated and standardised in 
Greek by Liakos and Giannitso (1980).
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The Mood Adjective Check List (MACL)
This test (Nowlis and Green, 1964) was self-administered 
only to the experimental group, and had to be answered three 
times a week for the 8-week training period.
The MACL consists of 33 adjectives which describe mood 
feelings in the form of a checklist (see Appendix II).
Clusters of adjectives correspond to 12 mood or state 
factors which are as follows:
A - Aggression B - Anxiety
E - Concentration F - Fatigue
H - Sadness I - Scepticism
K - Vigour M - Surgency
This scale requires subjects to indicate how closely each of the 
adjectives apply to their feelings at the moment they read 
it.
The MACL was initially derived by factor analysis. The MACL 
as used in the present study is the shorter and more rigorously 
standardised version (Nowlis and Green, 1964).
The Mood Adjective Check List, was translated into Greek by 
the author of this thesis and a native english speaker, who 
was a Professor of Psychology in Athens, performed the back- 
translation into English. Both translators then collaborated on 
solving any incongruities that arose. These were minimal and were 
resolved readily by mutual agreement.
Daily-Diary Check List (D.D.C.L.)
This checklist was answered daily by the patients in the
D - Elation 
G - Social affection 
J - Egotism 
N - Nonchalance.
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experimental group only.
The Daily-Diary Check List was created by the experimenter 
and consisted of 8 self-rating scales. These scales are 
designed to assess a number of different factors such as 
patients' personal feelings, diet compliance, use of the 
relaxation tape and sleeping habits (see Appendix III).
Exactly the same procedure was followed for the translation 
of the Daily - Diary Check List into Greek as for the MACL.
6.4.2 Metabolic Measures
The following measurements were used as indices of the 
metabolic concomitants of diabetes for both experimental and 
control groups.
Blood Glucose
'’Random" blood glucose measurements were taken at the 
diabetic clinic. This was routine testing in most greek 
diabetic hospitals, where this sample was drawn from. 
(However, this is not the case any more for the U.K.)
These samples were taken with the patient in either the 
post-prandial or the fasting state.
Glycosylated Haemoglobin-HbAlC
The glycosylated haemoglobin concentrations tend to reflect 
metabolic activity during the previous 4 to 8 weeks (Pickup, 
1991).
All proteins in the body react non-enzymatically with 
glucose. The extent of this "glycation " of proteins depends
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upon the prevailing blood glucose concentration. Measurement 
of glycated haemoglobin has been widely used to assess 
glycaemic control. It has the advantage of being readily 
available and of having a useful half-life. (The life-span of 
the red cell is around 120 days). Measurement of glycosylated 
haemoglobin reflect the mean blood glucose concentration
during the life-time of the haemoglobin. The disadvantage of 
glycosylated haemoglobin include the fact that its half-life 
may be too long in some situation (e.g. pregnancy) and that, 
since it reflects mean glucose concentration, it gives no 
indication of swings in blood glucose. Indeed, poor diabetic 
control with frequent and prolonged hypoglycaemic episodes 
can result in a misleadingly good level of glycated 
haemoglobin. The advantages of glycosylated haemoglobin 
include the fact that its measurement is objective and does 
not rely upon patients' cooperation and honesty (Mayer and 
Freedman, 1983; Pickup, 1991).
Depending upon the method used, normal values for haemoglobin Ale 
are around 6-7% ; good diabetic control 8-9%, with values as 
high as 15% and above in poorly-controlled subjects.
Furthermore it is an objective measure, independent of the 
patient's cooperation and of the time of day and meals, and 
it reduces metabolic control to a single number (Mayer and 
Freedman, 1983).
Urine Glucose Levels (UGL)
Urine glucose levels were monitored by the patient at 
3 different times of the day. The first urine sample was 
taken on waking, the second was collected after lunch and
the last sample was collected before bed-time.
The recordings were kept in a daily dairy (see Appendix IV). 
To measure the urine glucose, patients used urine glucose 
strips (Diaburtest 5000) and recorded the result obtained by 
comparing the colour of the strip with the scale provided. 
Under normal circumstances urine should not contain glucose 
(Mayer and Freedman, 1983).
High Density Lipoprotein (HDL).
High density Lipoprotein (HDL) the smallest of the 
lipoprotein species, are composed predominantly of protein 
and phospholipid with 20% (approximately) cholesterol 
and very little triglyceride. HDL cholesterol concentrations 
are strongly and independently related to coronary heart 
disease (CHD) but, unlike low density lipoprotein (LDL),the 
relationship is inverse, i.e. a low HDL level being a 
predictor of CHD while a nigh HDL level most probably means 
an absence of CHD problems (Mayer and Freedman, 1983).
Cholesterol (Choi) Triqlyceride (TG)
The major lipids circulating in the plasma are cholesterol 
and triglycerides. Solubility of both is achieved by binding 
the carrier proteins (lipoproteins).
Cholesterol is derived from dietary sources (particularly 
meat and dairy products) and from de-novo synthesis in the 
liver. Most cholesterol from these sources is delivered to 
tissues bound to low-density lipoprotein (LDL). A proportion 
of cholesterol circulates bound to hight density lipoprotein 
(HDL); this fraction is believed to be involved in reverse 
cholesterol transport (i.e. from tissues to liver), and is
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believed to protect against the development of atherosclerosis.
Triglycerides are derived from either dietary sources or 
from de-novo synthesis in the liver. Dietary (exogenous) 
triglycerides are incorporated into and circulate as 
particles; endogenous triglycerides circulate bound to very 
low density lipoproteins (VLDL). Both are cleared from the 
circulation by capillary-bound enzyme lipoprotein lipase. 
Abnormalities of lipoprotein metabolism are common in 
diabetes, although the pattern of abnormality is not 
consistent. A raised level of VLDL triglyceride is 
frequently observed. Hypercholesterolaemia may also be 
found, frequently in association with low HDL cholesterol, 
the level of which tends to increase with improvements in 
control of diabetes and weight reduction, (Pickup, 1991).
Blood Pressure
Blood pressure is taken in most diabetic centres as a 
routine. Systolic and diastolic blood pressures were 
measured pre and post treatment, in the present research, 
for both experimental and control groups. High blood 
pressure (hypertension) is more common in people with 
diabetes than in the general population and is a risk factor 
for vascular disease.
Reference range for systolic blood pressure is usually taken 
as the age of the patient plus the number 100, and for 
diastolic is < 95 (mm Hg).
Body Weight
This measure is taken in diabetic centres as a routine. Body
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weight was recorded as a pre- and post - treatment measure 
for both experimental and control groups.
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6.5. PROCEDURE
The experimental procedure with each patient took place over 
a period of 8 weeks, in which the experimenter spent an hour 
per week with each patient individually.
The Daily Diary Check List was filled in every day and the 
Mood Adjective Check List every other day by the patients.
Relaxation exercises were administered by the researcher to all 
the participants of the experimental group. The relaxation 
sessions are described below as well as any information that was 
given in each session.
The Experimental Group
During the first week of individual meetings the first 
session took part in a quiet room of the Hippokration 
Hospital. The experimenter explained the self-monitoring 
procedure that each patient had to carry out every day, 
i.e., to record 3-times daily their urine glucose levels.
The MACL and Daily-DCL was given to the patients and 
explained thoroughly to them. At an introductory session the 
experimenter showed the basic breathing exercises involving 
tensing and relaxing the muscles (based on Jacobson' s 
technique, 1938). Any questions or problems were discussed 
in detail.
The necessary arrangements were made for patients' blood 
samples to be taken and their blood pressure and body weight 
to be recorded.
During the second week of individual meetings, the
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experimenter collected the daily DCL and MACL, for the first 
week and went over, with them in case there were still 
questions.
The importance of accuracy of self-monitoring was emphasised 
once again and the patients were reminded to bring in data 
each week.
The treatment rationale was explained by the experimenter 
who went over the main points; specifically, that if there 
was a possibility that stress is responsible for rises in 
blood sugar levels, then the individual can better regulate 
diabetes by learning alternative ways of coping with stress 
and learning relaxation methods to reduce physiological 
arousal and muscle tension.
The first relaxation session was conducted while the patient 
was lying down on a sofa. This session was taped for the 
participant so s/he could practice it every day at home (see 
Appendix V).
Any difficulties were discussed in detail and the practice 
of relaxation (at least five times during the week) was 
encouraged at home by the experimenter.
During the third week of individual meetings the researcher 
collected the questionnaires and discussed any difficulties 
and how much the patients practised at home.
The second relaxation session was then conducted. Home 
practice was again encouraged. During the fourth week of 
individual meetings again the previous week's questionnaires
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were collected and difficulties were discussed. In the 
relaxation session the second part of the relaxation 
exercise was introduced to the patient by the experimenter. 
This part involved relaxation exercises with no-tension (see 
Appendix V). The second tape was given to the patients and 
they were encouraged to practice this new phase at home. Any 
difficulties were discussed in detail. During the fifth week 
of individual meetings the questionnaires were collected and 
any difficulties were discussed. Once again the second part 
of the relaxation exercises were repeated in this session.
Practice at home was encouraged, with the use of the tape. 
During the sixth week of individual meetings questionnaires 
were collected. In the relaxation session the third part of 
the relaxation training was introduced to the patient, which 
involved teaching the patient to relax while sitting and 
standing-up (see Appendix V). This third tape was passed out 
and any problems were discussed.
The importance of using relaxation in everyday life 
situations was emphasised, home practice was also 
encouraged.
During the seventh week of individual meetings the 
questionnaires were collected. Home practice was discussed 
as well as the attempts to relax while sitting, standing-up, 
working, etc. Relaxation training while sitting and standing 
was again conducted. Information on the nature of stress and 
reactions to stress was presented by the experimenter, plus 
the rationale that in order to use stress management
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procedures individuals must learn to identify and react to 
stress. Some specific individual stressful situations were 
identified and discussed.
During the eighth week of individual meetings the last 
questionnaires were collected together with the daily urine 
tests. The daily practice schedule was reviewed and positive 
ways of coping with diabetic problems were discussed. The 
progress that individuals had made was emphasized and 
reinforced verbally. The patient's opinion of the technique 
was recorded and discussed. The necessary arrangements were 
made for the patient's blood-glucose levels to be taken, 
blood pressure, and body weight to be recorded and the STAI 
to be administered. At the end of the experimental sessions 
the experimenter encouraged the patients to think positively 
towards their disease and their every day life.
Each patient was thanked for participating in the research.
The Control Group
The patients who were assigned to the control group had only 
two meetings with the researcher.
The first meeting with each patient was during the first 
week of the study. The researcher explained the daily self­
monitoring procedure of recording the urine values to each 
patient and emphasized the importance of not forgetting to 
record it. Their blood sample was arranged to be collected 
and in addition their blood pressure and body weight were 
recorded. The STAI was administered and a second meeting was 
arranged with them 8 weeks later.
The last session took part during the eighth week of the 
individual meetings. The sample form of the daily urine 
glucose samples was collected. Their blood sample, blood 
pressure and body weight were recorded. The STAI was 
administered for a second time. At the end of this session 
the researcher explained to each participant what the 
research was about, especially to those in the control group 
and thanked them for participating.
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6.6 STATISTICAL METHODS
The design of the present study allows for the examination of three 
main effects. The independent variables defining these effects 
are:
a) Time
b) Group (Experimental and Control)
c) Type of Medication (Insulin and Non-Insulin)
An Analysis of variance (ANOVA) strategy was considered appropriate 
for the analysis of the resulting data in which the dependent 
variables are:
a) Anxiety (State and Trait)
b) Blood glucose (HbAlC, HDL, Cholesterol, Triglyceride,
U.G.L.)
ANOVA was utilised to investigate the significance of both the main 
effects and the interaction effects. More specifically, ANOVAs 
were used in order to investigate the possible influence of 
relaxation treatment on the diabetic patients metabolic and 
psychological state and furthermore to identify those pre­
treatment measurements which could explain significant main 
and interaction differences in the post-treatment 
measurements.
The baseline differences between the Experimental and Control 
groups, for each of the dependent variables, were 
assessed before the analysis in order to see if there are any 
group differences prior to treatment. If such differences are to be 
found a different emphasis would be placed on the interaction 
effect.
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It is important to take into account the different types of 
medication since varied dosages of insulin could be an 
underlying factor to bias the results. Consequently a 
crosstabulation between the dosages of the two groups was 
carried out in order to check for the presence of any such bias.
In addition to the ANOVAs, Pearson's correlation 
coefficients were calculated to explore within-subject covariation 
across time between the physiological parameters of daily 
urine glucose samples and specific psychological parameters from 
the MACL and D.D.C.L. In this way the correlation coefficient 
becomes an index of the coincidence of physiological and 
psychological change for each subject. The order 
(negative or positive) and the magnitude (0 to 1) of this 
physiology-psychology relationship may be viewed at an individual 
level. It may also be aggregated across the group.
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6.7. RESULTS
Tables of results are given in the text where significantQ
(p<0.50) interactions and or main effects are encountered.
A
The results of all the other analyses are reported in the 
Appendix (VII). The tables give not only the ANOVA results 
but the relevant means and standard deviations and these are 
also broken down by the basic form of medical treatment 
(i.e., insulin or non-insulin).
The first thing that emerges with these data is that some dependent 
variables have apparent baseline differences between the two 
groups. It was felt that this imbalance was probably due 
to different insulin dossages, therefore a series of 
crosstabulation analyses were performed (results of these analyses 
are reported in appendix IX). These results showed that, there 
were no statistically significant differences across the two groups 
by dosage and therefore dosage was not deemed to be a biasing 
factor in this case.
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State Anxiety
The first dependent variable examined was the State Anxiety 
scale. Table 2 shows the means and standard deviations of 
the pre- and post- treatment measures, baseline analysis and 
the results of the ANOVA.
There is a baseline difference in the pre-measurements of 
State anxiety levels. The Experimental group starts with 
lower State anxiety than the Control. This difference is 
significant (t=2.53, p<0.05).
On the basis of these differences at the baseline not a great 
deal will be made of the main effects but emphasis will be 
given on the interaction effect.
There is a significant interaction between Groups and Time.
In addition, significant main effects were shown for groups
and time factors. It can be seen from the means that the
interaction results from patients in the experimental group 
becoming less state anxious over time, while the mean 
for patients in the control group are unchanged. An a- 
posteriori test given in Appendix VI showed significant 
differences for the mean scores in the experimental group 
but not for the control.
It can be seen that both types of patients became less state 
anxious over time in the experimental group while no change
was observed for the control group.
Table 2: Analysis of Variance and Summary data between the
scores of the State Anxiety Subscale and
Experimental/Control, Type of Medication and Time.
Table 2A: STATE Anxiety scale pre and post measurements (mean 
and standard deviations), and Baseline Difference
Pre Measurements 
Mean
Standard Deviation 
Baseline Difference
Experimental
45
8.6
t= 2.53
Control
53
12.5 
p <.05
Post Measurements 
Mean
Standard Deviation
32
8.4
50
12.0
Pre measurements 
Insulin Mean
Standard Deviation
Experimental
51
11.1
Control
50
11.0
Non-Insulin Mean 40
Standard Deviation 6.1
55
14.1
Post Measurements
Insulin Mean 38 46
Standard Deviation 13.4 10.7
Non-Insulin Mean 27 54
Standard Deviation 3.4 13.3
Table 2B: STATE Anxiety scale (ANOVA)
Source Ss df MS F Sg
Group 2664.0 1 2664.0 10.3 p <. 05
Type 60.0 1 60.0 .2 NS
Group x Type 1204.0 1 1204.0 4.6 p <. 05
Error 1311.0 44 257.0
Time 1006.0 1 1006.0 44.2 p <.001
Time x Group 439.0 1 439.0 19.2 p <.001
Time x Type 8.5 1 8.5 .3 NS
Time x Group x Type 5.7 1 5.7 .2 NS
Error 1001.0 44 22.7
Total 1769.0 95
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Trait Anxiety
Table 3 gives the results for the Trait Anxiety scale.
There is a baseline difference in the pre-measurements of 
Trait anxiety between Experimental and Control groups. The 
Experimental group starts with lower trait anxiety than the 
Control. The Student t-test revealed a significant 
difference (t=3.33,p,.05). Therefore, emphasis will be given 
on the interaction effect.
There is a significant interaction effect between the Groups 
and Time. The main effects of Group and Time were also found 
to be significant. The mean values indicate that there 
is a reduction over time for the experimental group but not 
for the control group. That is, people with diabetes in the 
experimental group experience less Trait anxiety after the 
relaxation treatment. An a posteriori test performed on the 
mean scores revealed significant differences for the 
experimental group but not for the control (see Appendix 
VI).
Furthermore, a significant interaction effect was revealed 
between Group and the Type of diabetes factor. It can be 
seen that people with diabetes in the experimental group seem 
to experience less Trait anxiety for both types over time 
while no differences are observed in the control for both 
types over time. It seems that the Type of diabetes seems to 
affect anxiety levels in the experimental group but not in 
the control.
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Table 3: Analysis of Variance and Summary data between the
scores of the Trait Anxiety Subscale and
Experimental/Control, Type of Medication and Time.
Table 3A: TRAIT Anxiety scale pre and post measurements (mean 
and standard deviations), and Baseline Difference
Pre Measurements 
Mean
Standard Deviation 
Baseline Difference 
Post Measurements
Experimental
46
12.2
t= 3.33
Control
57
10.1
p <. 05
Mean 35 54
Standard Deviation 31.4 12.0
Pre measurements Experimental Control
Insulin Mean 53 55
Standard Deviation 11. 9 9.1
Non-Insulin Mean 40 58
Standard Deviation 7.4 11.8
Post Measurements
Insulin Mean 43 51
Standard Deviation 13.3 11.0
Non-Insulin Mean 28 58
Standard Deviation 3.4 12.9
Table 3B: TRAIT Anxiety scale (ANOVA)
Source Ss df MS F Sg
Group 3686.0 1 3686.0 14.4 P <.001
Type 365.0 1 365.0 1.4 NS
Group x Type 1504.0 1 1504.0 6.1 P <.05
Error 10818.0 44 45.0
Time 744 . 0 1 744. 0 38.9 P <.001
Time x Group 329.0 1 329.0 17.2 P <.001
Time x Type 4 . 9 1 4.9 .2 NS
Time x Group x Type 47.9 1 47. 9 2.5 NS
Error 839.0 44 19.0
Total 1833.0 95
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Blood Glucose
Table 4 shows the analysis of the blood glucose levels. It 
is apparent that there is a difference between the Experimental and 
Control group, the Experimental group starting with higher 
blood glucose levels. A t-test revealed non-significant 
differences (t=1.4, p>.05). Therefore, emphasis will be given 
equally to the main effects as to the interactions.
It can be seen that there is a significant interaction effect 
between the Group and the Time factor. The mean values show that 
the nature of the interaction shows a reduction in the BGL for the 
experimental group while there is no change of BGL for the 
control group over time. None of the remaining variables (or 
subscales) yielded any significant interaction or main effects.
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Table 4: Analysis of Variance and Summary data between the
scores of the Blood Glucose Levels (mg %) and
Experimental/Control, Type of Medication and Time
Table 4A: BLood Glucose Level pre and post measurements 
(mean and standard deviations), and Baseline 
Difference
Pre Measurements 
Mean
Standard Deviation
Experimental
2.05
0.7
Control
1.75
0.75
Baseline Difference t= 1.4 p >. 05
Post Measurements 
Mean
Standard Deviation
1.77
0.7
1.78
0.6
Pre measurements 
Insulin Mean
Standard Deviation
Experimental
2.34
.91
Control
1.88
.49
Non-Insulin Mean 1.80
Standard Deviation .80
1.61
.57
Post Measurements 
Insulin Mean 1.87
Standard Deviation .87
1.86
.84
Non-Insulin Mean 1.74
Standard Deviation .61
1.63
.30
Table 4B: Blood Glucose Levels (mg %) (ANOVA)
Source Ss df MS F Sg
Group .378 1 .378 .412 NS
Type 1.19 1 1.19 1.30 NS
Group x Type .01 1 .01 .01 NS
Error 40.34 44 0. 916 0.01 NS
Time .26 1 .26 .81 NS
Time x Group 2.83 1 2.83 8. 67 p <.001
Time x Type .24 1 .24 .74 NS
Time x Group x Type .11 1 . 11 .35 NS
Error 14 .39 44 .32 . 81 NS
Total 59.7 95
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Glycosylated Haemoglobin
Table 5 gives the results for the Glycosylated Haemoglobin 
A1C. There is slight baseline difference in haemoglobin, the 
Experimental group starts with higher glycosylated 
haemoglobin than the Control. A t-value showed a significant 
difference (t=4.06, p<.05).
An interaction effect was significant between the 2 Groups 
and the Time factor. There are no significant main effects.
It can be seen from the mean values that there is a drop for 
the HbAlC over time for the experimental group, 
while there is a slight increase for the HbAlC value, for 
the control group.
In addition, the interaction effect for the Groups and Type factor 
is significant. It can be seen from the mean values, that both 
types of diabetes in the experimental group show a decrease in 
their HbAl over time while the HbAlC either remained the same or 
increased for the control group.
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Table 5: Analysis of Variance and Summary data between the
scores of the Glycosylated Haemoglobin (%) and
Experimental/Control, Type of Medication and Time
Table 5A: HbAlC (%) pre and post measurements (mean and 
standard deviations), and Baseline Difference
Experimental Control
Pre Measurements
Mean 6.9 6.3
Standard Deviation 0.5 0.5
Baseline Difference t= 4.06 p <.05
Post Measurements
Mean 6.3 6.8
Standard Deviation 0.5 0.6
Pre measurements Experimental Control
Insulin
Non-Insulin
Mean
Standard Deviation 
Mean
Standard Deviation
Post Measurements 
Insulin
Non-Insulin
Mean
Standard Deviation 
Mean
Standard Deviation
7.1
0.6
6.7
0.2
6.7
0.6
5.9
0.4
Table 5B: HbAlC (%) (ANOVA)
Source Ss df MS F Sg
Group .08 1 .08 .17 NS
Type .58 1 .58 1.15 NS
Group x Type 2. 94 1 2.94 5.79 P <•'
Error 22.31 44 .50
Time .06 1 .06 .28 NS
Time x Group 4.89 1 4.89 23.41 P <•'
Time x Type .01 1 .01 .06 NS
Time x Group x Type .34 1 .34 1.63 NS
Error 9.18 44 .20
Total 40.30 95
6.3 
0.5
6.3 
0.4
6.6
0.4
7.0
0.8
HbAlC = Glycosylated Haemoglobin
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Urine Glucose Levels
Table 6 gives the analysis for the Urine Glucose Levels. The 
means and standard deviations of weekly urine scores for the 
3 different times of the day are shown (Table 6.B) plus the 
significant effects of the analysis (Table 6.A). There is a 
significant interaction effect between the Type of diabetes, 
the Time scores and the weekly measures for U.G.L. It can be 
seen from the means that Type I patients have a decrease in 
urine glucose through-out the day, while in Type II patients 
non-systematic changes are observed through-out the day.
This not unexpected since when patients wake-up do not have 
insulin in their blood.
In addition, there is a significant interaction effect for Time 
and Week and Time and Type factors. The change across time 
for the insulin group gives a fairly even distribution across 
the day but with a gradual decreased over the weeks. With 
the non-insulin group there is fairly even distribution 
across the day but with non evidence of decrease across the 
weeks. The type main effect was significant.
It can be seen from the mean values in Table 6.A , that the 
nature of the interaction shows a reduction of UGL over time 
for the insulin dependent people with diabetes and there is a 
constant decrease through the weeks. There is an increase of 
UGL over time for the non-insulin dependent people with 
diabetes and constant increase through the weeks.
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Table 6: Analysis of Variance and Summary data between the 
scores of the Urine Glucose Levels (mmol/L) by 
Experimental/Control Group, Type of Medication and 
Week of Urine measurements over Time
Table 6A: Weekly Urine Glucose Levels (mg/littre) (ANOUA)
Source Ss df MS F Sg
Group 1.50 1 1.50 1.06 NS
Type 24.23 1 24.23 17.12 P <.001
Group x Type .62 1 .62 .43 NS
Error 62.29 44 1.41
Time .59 2 .29 2.47 NS
Time x Group .02 2 .01 .08 NS
Time x Type 2.3 2 1.16 9.68 P <.001
Time x Gr x Type .22 2 .11 .95 NS
Error 10.56 88 .12
Week .20 7 .02 .73 NS
Gr x Week .03 7 .00 .11 NS
Type x Week .51 . 7 .07 1.83 NS
Gr x Type x Week .18 7 .02 .66 NS
Error 12.35 308 .04
Time x Week 1.94 14 .13 2.56 P
LOoV
Gr x Time x Week .66 14 .04 .87 NS
Type x Time x Week 2.74 14 .19 3.60 P <.001
Gr x Time x Week .37 14 .02 . 48 NS
Error 33.45 616 .05
Total 154.76 1151
Table 6B: Urine Glucose Level (mmol/L) for Group, Type and 
Week over Time (Mean and Standard Deviations)
Group (x) Group (s) Type (x)(s) Type(x)(s)
Exper. Control Exper. Control Insulin Non-Insulin
W1T1 44 42 .64 .50 55.53 07.83
T2 33 33 .44 .53 43.51 10.11
T3 30 24 .36 .33 67.34 18.16
W2T1 49 37 .72 .44 42.52 08.11
T2 35 28 .46 .45 41.47 14.11
T3 32 21 .42 .26 60.33 10.20
W3T1 46 39 .48 .39 42.38 11.30
T2 32 18 .36 .33 33.35 13.17
T3 33 12 .34 .28 55.28 -5.27
W4T1 37 33 .46 .34 60.34 10.15
T2 33 20 .39 .28 42.34 11.38
T3 26 20 .27 .29 33.27 13.20
W5T1 37 32 .36 .33
T2 38 19 .47 .21
T3 31 20 .30 .19
W6T1 41 31 .36 .30
T2 39 18 .37 .23
T3 38 19 .39 .23
W7T1 34 28 .41 .25
T2 30 21 .30 .21
T3 32 19 .33 .16
W8T1 31 31 .40 .30
T2 26 23 .30 .19
T3 25 24 .30 .19
55..32 15.61
41..35 16.18
30..24 21.17
51..29 21.26
36..61 21.30
36..32 20.27
52.28
38.24
36.22
10.19
13.20 
14.22
53.32 09.16
33.23 15.27
34.23 15.23
x = Mean
s = Standard Deviation
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Remaining Variables
None of the remaining variables of High Density Lipoprotein , 
total Cholesterol and Triglyceride yielded any significant 
interaction or main effects (see Appendix VII).
Insulin Mono Evening
The ANOVA for the independent variable of medication 
revealed one significant difference. Table 7 shows the 
results of the Monotard insulin during the evening dosage 
over Time.
There is a significant Group main effect which indicates 
that patients in the experimental group differ in their mono 
evening dosage in comparison with the patients in the 
control group. In addition, an a-posteriori test (the 
Studentized Range test) revealed that the mean 
differences over time in both groups are not significant 
(see Appendix VI).
There are no other interaction or main effects significant 
for insulin mono evening. None of the remaining medication 
variables revealed any significant differences (see Appendix
VII). Furthermore, the same applies for the independent 
factors of blood pressure and body weight (see Appendix
VIII) .
The Crosstabulation analysis showed that there was no a 
prior difference in the 25 crosstabulation , (see Appendix
IX). Therefore, it can be reasonably surmised that the 
dosage is randomly distributed between the experimental and 
control groups, since there are no significant differences.
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Table 7: Analysis of Variance and Summary data between the
units of the Insulin Mono Evening by Experimental
Control Group over Time.
Table 7A: Isulin Mono Evening pre and post measurements (mean 
and standard deviations), and Baseline Difference
Experimental Control
Pre Measurements
Mean 5.8 2.1
Standard Deviation 9.3 5.4
Post Measurements
Mean 6.6 1.2
Standard Deviation 1.2 3.6
Table 7B: Insulin Mono Evening (ANOVA)
Source Ss df MS F Sg
Group 495.0 1 495.0 6.1 p <. 05
Error 3721. 0 46 80.0
Drug .0 1 .0 .0 NS
Drug x Group 16.6 1 16.6 .8 NS
Error 970.0 46 21.0
Total 5202.0 95
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Relationship between Urine Glucose and 
Psychological Parameters
The physiological state has psychological concomitants. In 
order to explore this a number of measures over time were 
taken. Some were physiological like urine glucose and some 
were psychological derived from the D.D.C.L. and MACL. The degree 
of relationship of these variables can be assessed over the 8 
weekly intervals by generating Pearson-Bravais correlations for 
each person independently.
It would be expected that a high level of urine glucose will 
correlate negatively with a subjective sense of relaxation for a 
particular patient. It must be born in mind that this part of the 
analysis is descriptive and its major focus is to asses the 
feasibility of identifying physiological and psychological 
interdependence within individuals.
Thus, in an attempt to find out if there is any relationship 
between biological and psychological parameters, the Product Moment 
Coefficient of Correlation was used to examine the relationship 
between the urine glucose levels and certain items of the Mood 
Adjective Check List (M.A.C.L.) and the Daily Diary Check List 
(D.D.C.L.).
/
It was decided, in consulation with staff in the diabetic clinic, 
that the average weekly urine sample collected after lunch (UrT2) 
by the participant was a good indicator of diabetes control. The 
questions chosen from the D.D.C.L. to correlate with the UrT2 
(mg/litre) value, were those related directly with how the patient 
felt emotionally. The items chosen from MACL were also in relation
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to such feelings (e.g. Vigour, Anxiety, Sadness). The
average weekly ratings of Daily-DCL and MACL were correlated with 
Ur T2 for the Experimental group only.
Table 8 shows the r-values between UrT2 (mg/litre) and Q1 
(degree of Relaxation) from the DDCL. These correlations are 
calculated over the 8 week period. Thus each patient has 8 
pairs of measures, in this case urine glucose and self 
reported relaxation. These pairs of measures are correlated 
with the Pearson formula resulting in a correlation 
coefficient (r) for each patient which indicates the strength 
of the relationship between relaxation and urine glucose 
level for that patient. In the case of relaxation and urine 
glucose a positive r value signifies that low glucose level 
coincides with greater relaxation. Of these 24 values 
there are only 5 which are significant at p<.05 level.
There is one negative correlation (r=-0.70, df=7,p<.05)for 
the patient with the number 18. Four positive correlations 
(r=0.70, df=7 , p<.05) for patient 11, (r=0.70,df=7,p<.05)
for patient 17, (r=0.71 , df=7 , p<.05) for patient 12 and
(r=0.73 ,df=7,p<.05) for the first patient.
Table 9 shows the r-values between UrT2 AND Q2 (degree of 
Depression) from daily -DCL. A true r indicates that high 
glucose coincides with low depression. From these 24 values , 
four are significant. There is one negative correlation (r=-
0.77, df=7,, p<0.5) for patient number 8 . There are three 
positive correlations (r=0.66 , df=7 , p<.05 )for patient 
number 10, (r=0.70 ,df=7 ,p<.05) for patient 13 (r=0.81,
df=7, p<.05) for patient 1.
Table 10 shows the r-values between UrT2 and Q2 (Anxiety 
factor) from MACL. A true r indicates that low glucose 
coincides with low levels of anxiety. It can be seen that only 
two values are significant . The first correlates negatively 
(r=-0.72,df=7, p<.05) for subject 13 and the second 
correlates positively (r=0.96, df=7, p.05) for subject 4.
Table 11 shows the r-values between UrT2 and Q3 (Surgency 
factor) from MACL. A true r- indicates that high-glucose is 
related to high surgency. Five values are significant.
There are 6 positive correlations (r=0.69 , df=7 , p<.05) for 
subject 18 (r=0.71, df=7 , p<.05) for subject 6. (r=0.71 ,
df=7 ,p<.05) for subject 11 . (r=0.78 , df=7 , p<.05) for
subject 23, (r=0.88, df=7 , p<.05) for subject
21,(r=0.70,df=7,p<.05), subject 2.
Table 12 shows the r-values between UrT2 and Q4 (Elation 
factor) from MACL. A true r indicates that high glucose is 
related to high elation. From this table only one value is 
significant , it has a positive correlation (r=0.88 ,df=7, 
p<.05) for subject 14.
Table 13 shows the r-values between T2 and Q7 ( Social 
Affection factor) from MACL. A positive r indicates that high 
glucose is related to high affection. The only value that 
shows a significant correlation is (r=0.92 , df=7, p.05) for 
subject 16.
Table 14 shows the r-values between UrT2 and Q8 (Sadness 
factor) from MACL. A true r indicates that high glucose is
related with low sadness. Only one value is significant ( 
r=0.93, df=7, p<.05) and it is a positive correlation for 
subject 17.
Table 15 shows the r-values between UrT2 and Qll (Vigour 
factor) from MACL. A true r indicates that high glucose 
coincides with high vigour. Only four values are significant . 
They are all positive correlations (r=0.81 ,df=7, p<.05) for 
subject 23 , (r=0.87,df=7 , p<.05) for subject 21,(r=0.73,
df=7 ,p<.05) for subject 11 , (r=0.68,df=7 ,p<.05) for
subject 2.
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Table 8: Correlation Coeffecients between Urine (T2)
(mmol/L) measurement and degree of Relaxation (Q.l)
from Daily-Diary Check List, By Subject
Subjects' Identification Number r-values
1 . .73 *
2. .62
3. .52
4 . .21
5. .20
6. .46
7 . .37
8. -.65
9. -.02
10. .09
11. .70 *
12. .71 *
13. .64
14.. -.19
15. . 65
16. -.12
17. .70 *
18. -.70 *
19. -.22
20. .60
21. -.11
22. .49
23. -.19
24 . —
Number of Negative Correlations : 8 
Number of Positive Correlations : 15
Key : * = significant values 
- = missing data
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Table 9: Correlation Coefficients between Urine (T2)
(mmol/L) measurement and degree of Depression (Q.2)
from Daily-Diary check List, by Subject
Subjects' Identification Number r-values
1. .81 *
2. .62
3. .40
4. .20
5. .34
6. .35
7. .14
8. -.77 *
9. -.43
10 . .66 *
11. .17
12. .51
13. .70 *
14. -.33
15. -.12
16. -.13
17. .24
18. -.47
19. -.15
20 .12
21. .47
22. .27
23. -.11
24.
Number of Negative Correlations : 8 
Number of Positive Correlations : 15
Key : * = significant values 
- = missing data
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Table 10: Correlation Coefficient between Urine (T2)
(mmol/L) measurement and Anxiety factor (Q.2) from
Mood Adjective Check List, by Subject
Subjects' Identification Number r-values
1. .19
2. -.32
3. .27
4. .96 *
5. -.05
6. -.12
7. -.32
8. .07
9. -.33
10. .54
11. -.26
12. -.19
13. -.72 *
14. -.11
15. -.34
16. -.25
17. .44
18. -.24
19. .47
20. -.19
21. -.09
22. .54
23. .10
24.
Number of Negative Correlations : 14 
Number of Positive Correlations : 9
Key : * = significant values 
- = missing data
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Table 11: Correlation Coefficient between Urine (T2)
(mmol/L) and Surgency Factor (Q.3) from
Mood Adjective Check List, by Subject
Subjects' Identification Number r-values
1. .37
2. .70 *
3. -.55
4. -.20
5. -.17
6. .71 *
7. .43
8. -.15
9. .47
10. .63
11. .71 *
12. .20
13. .41
14. .17
15. .37
16. .02
17. .02
18. .69 *
19. .25
20. .38
21. .88 *
22. .48
23. .78 *
24.
Number of Negative Correlations : 4 
Number of Positive Correlations : 19
Key : * = significant values 
- = missing data
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Table 12: Correlation Coefficient between Urine (T2)
(mmol/L) and Elation Factor (Q.4) from Mood
Adjective Check List, by Subject
Subjects' Identification Number r-values
1. -.25
2. -.55
3. -.32
4. .15
5. -.16
6. -.12
7. -.37
8. .42
9. .42
10. .00
11. -.42
12. -.09
13. -.28
14. .88 *
15. -.50
16. -.16
17. -.07
18. .12
19. .23
20. -.16
21. .52
22. -.21
23. .23
24.
Number of Negative Correlations : 15 
Number of Positive Correlations : 8
Key : * = significant values 
- = missing data
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Table 13: Correlation Coefficients between urine (T2)
(mmol/L) and Social Affection factor (Q.7)
Mood Adjedtive Check List, by Subject
Subjects' Identification Number r-values
1. .21
2. -.31
3. -.35
4. -.19
5. -.26
6. -.10
7. -.40
8. .07
9. -.23
10. -.21
11. -.50
12. -.24
13. -.23
14. .04
15. .37
16. .92 *
17. -.14
18. .49
19. -.43
20. -.41
21. -.11
22. -.31
23. -.13 
24 .
Number of Negative Correlations : 17 
Number of Positive Correlations : 6
Key : * = significant values 
- = missing data
from
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Table 14: Correlation Coefficients between Urine (T2)
(mmol/L) and Sadness factor (Q.8) from Mood
Adjective Check List, by Subject
Subjects' Identification Number r-values
1. .10
2. -.08
3. .22
4. .00
5. -.59
6. .31
7. -.39
8. .47
9. .39
10. -.25
11. .14
12. -.26
13. -.10
14. -.03
15. -.35
16. -.16
17. .93 *
18. -.28
19. -.45
20. -.48
21. .22
22. -.30
23. -.27
24.
Number of Negative Correlations : 14 
Number of Positive Correlations : 9
Key : * = significant values 
- = missing data
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Table 15: Correlation Coefficients between Urine (T2)
(mmol/L) and Vigour factor (Q.ll) from Mood
Adjective Check List, by Subject
Subjects' Identification Number r-values
1 . r .33
2. .68 *
3. .57
4. -.27
5. -.35
6. -.56
7. .51
8. -.35
9. .42
10. .57
11. .73 *
12 . .31
13. .42
14 . .16
15. .53
16. -.04
17 . -.01
18. .21
19. -.25
20. -.28
21. .87 *
22. -.23
23. .81 *
24. —
Number of Negative Correlations : 9 
Number of Positive Correlations : 14
Key : * = significant values 
- = missing data
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6.8 DICUSSION
A brief summary of the results so far given indicates that 
as a result of psychological intervention, levels of anxiety 
decreased over time and significant improvement is also 
visible in the metabolic parameters.
Psychometric investigations of statistical analysis of STAI 
revealed that there are significant post-treatment 
differences between experimental and control groups for the 
State subscale. This result is in agreement with Hartman (1982) 
who reports that anxiety levels can be altered with 
the aid of relaxation training. The same result was found 
for the Trait subscale, which was significant in the post­
treatment differences between experimental and control 
groups.
One of the main hypotheses was that diabetic patients , 
participating in the experimental group, would have lower 
post-treatment scores on the State scale than their pre­
treatment measures. The other hypothesis was that state 
scores of the patients in the experimental group would be 
significantly less than those of the control group. The 
present findings are in line with the hypotheses. Therefore, 
the initial hypothesis regarding changes in State scale 
scores is accepted.
i
However, patients' scores on the Trait subscale were 
expected by definition to remain at similar levels. It was 
found, however, that Trait scores at the post-treatment 
measurements were lower than the pre-treatment ones. This
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certainly differs from expectation, and provides evidence 
against Spielberger's (1974), notion that the Trait subscale 
assesses individual's relatively stable vulnerability to 
different kinds of stress. Therefore, the initial hypothesis 
regarding Trait anxiety scores.
It is quite likely that the changes in Trait scores over time 
could be attributed to the psychological intervention, in 
this case relaxation training. This suggests that relaxation 
training may have a more deep seated effect on the individual than 
was, at first, expected. An alternative explanation is to bring 
into question the independence of Speilberger's Trait and State 
Anxiety constructs.
It was hypothesised that patients' post treatment 
measurements in relation to blood glucose levels would be 
significantly lowered in the experimental as compared with 
those of the control group subjects.
Statistical analyses seemed to offer support for the above 
hypothesis. Patients' blood glucose level results showed, 
that there was a significant interaction between group and time on 
the blood glucose level scores. This describes the significant drop 
of blood glucose levels for the patients in the Experimental group, 
while there is no such significant change in glucose levels for the 
patients in the Control group.
This finding seems to agree with those of Luthe (1969),
Fowler (1976) and Seeburg and DeBoer (1980). However, these 
studies did not have control groups and so spontaneous changes 
cannot be ruled out. These finding give emprical weight to the
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claim that relaxation training helps blood glucose levels decrease 
in patients with diabetes mellitus.
With regard to the rest of the interactions (group and type 
of diabetes and time) and main effects, none was statistically 
significant.
It was hypothesised that patients' post-treatment 
measurements in relation to HbAlC would decrease in the 
experimental group while no significant changes were 
expected for the control group. The statistical analyses seems to 
support the above hypothesis. HbAlC has a significant 
interaction effect over time for the experimental group but 
not for the control. There is a significant drop in 
glycosylated haemoglobin over time in the patients in the 
Experimental group while the the glycosylated levels do not change 
appreciably for the patients in the Control group. There 
is also a significant interaction effect between the group 
factor and the type of diabetes, although the main effects in 
this analysis revealed no significant results.
This study agrees with the findings of Hartman (1982) and 
Surwit (1983) in the sense that relaxation training helped 
glycosylated haemoglobin to drop. Therefore, the suggestion 
that relaxation training helps HbAlC levels decrease over 
time in patients with diabetes mellitus is supported by these 
results.
It was hypothesised that patients' post-treatment 
measurements in relation to urine glucose levels would 
significantly decrease more for the experimental group over
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time, than for the control group.
Statistical analysis seems to partially support the above 
hypothesis. Urine glucose level interacts with type of 
diabetes, time of collecting the sampe, scores and weekly 
measures for both groups. There is also a signicant 
action effect for the time and week and the week, time and 
type of diabetes, also the type main effect is significant.
The fact that there is a significant interaction between time 
and week means that the amount of glucose in the urine across 
the 3 times of the day become less over the weeks for both 
groups. The significant interaction of week, time and type of 
diabetes means that there is a change across time, for the 
insulin dependent patients, with a fairly even distribution 
across the day but with a gradual decrease over the weeks.
With the non-insulin dependent patients there is a fairly 
even distribution across the day but with no evidence of 
decrease across the weeks.
This finding seems to agree with those of Hartman (1982), 
and suggests that physiological measurements can be changed 
over time, in this case urine glucose levels is modified by 
relaxation training. Although these results show a 
significant drop of urine glucose levels over the 8 week 
period, there are no significant differences between the 
groups main effect. This is an unexpected finding suggesting that 
changes in urine glucose levels are modified just as well by the 
standard control methods espoused by the clinic as the relaxation 
techniques used by the experimental group. It may be necessary to 
use a larger sample before the suggestive, though non-significant,
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group differences observed here produce a statistically significant 
main effect between the two groups.
Therefore, the initial hypotheses, which suggest that there will be 
changes only in the experimental group have produced mixed 
acceptance. With regard to the measurements of Cholesterol, 
Triglyceride, High Density Lipoprotein, Blood Pressure and Body 
Weight neither main effects nor the interaction were significant. 
It is perhaps not surprising that no significant differences were 
found for the above variables, since these measurements are very 
constant over time. This finding seems to be in contrast to the 
hypothesis since it was expected that patients in the experimental 
group would exhibit significantly greater improvement over 
time for the measurements of Cholesterol, Triglyceride, High 
Density Lipoprotein, Blood Pressure and Body Weight as compared to 
the control group. Therefore this hypothesis is rejected. However, 
measurements like cholesterol, T.G, and B.W. are not easily 
susceptible to change (Mayer and Freedman, 1983).
Although medication was not controlled for in this study and 
hypotheses have not been based on this factor, statistical 
analysis revealed one significant main effect for the mono 
evening dosage. This suggests a difference in dosage between 
the 2 groups. This difference could be attributed to the 
fact that patients in the experimental group inject 
themselves more with the Mono type of insulin than patients 
in.the control group who use various types of insulin.
It was also hypothesised that patients' physiological measures of 
weekly Urine T2 would correlate with certain items from 
Daily-Diary Check List and Mood Adjective Check List for the
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experimental group. Analyses of the UrT2 scores and Q1 
(weekly average ratings of relaxation feelings) from 
D.D.C.L. revealed that there was one significant negative 
correlation and four positive correlations.
This finding indicates that the trend for the positive 
correlations (i.e., low UrT2 is accompanied with low stress 
ratings and vice-versa). However, this is not the case for 
the negative correlations since such a trend is against the 
expectation (i.e., high UrT2 scores go with low stress 
ratings and vice versa). Statistical significance aside, the ratio 
of 8:15 for negative and positive correlations suggests that the 
trend is for subjective feelings of relaxation to be related in the 
expected direction with the physiological index of UrT2.
The statistical analysis between weekly UrT2 and Q2 (weekly 
average ratings of depressive feelings) from Daily-D.C.L. 
revealed that there is one significant negative correlation 
and three positive correlations. The direction of scoring for 
the depression variable indicates that this relationship will 
have a majority of negative correlations. Therefore, when 
there is a low score in UrT2 then there will be a high score 
on the depression scale and when there is a high score in 
UrT2 then there will be a low score on the depression scale.
Due to the actual scoring system a high score in depression 
means very cheerful (Appendix III).
Therefore, the present negative correlation suggests a 
general trend which does support this hypothesis. This is not 
the case for positive correlations because the direction here 
will be against the expectation. The ratio of negative to positive
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correlations (8:15) do not give support for the expected 
general relationship between psychological affect and UrT2.
From these two results it could be concluded that 4 out of 
the 24 patients for Q1 (relaxation feelings) and 1 out of
the 24 patients for Q2 (depression feelings), showed
significant relationships between their average weekly 
emotional feelings and their weekly urine sample over the
period of the 8 weeks. This seems to agree with the
findings of Bradley (1988), who argues that patients V
emotions with diabetes mellitus could be influenced by 
metabolic parameters over time although it highlights the large 
individual differentiation in this relationship.
The correlations between weekly UrT2 and Q2 (anxiety factor) 
from MACL showed that there is one significant negative and 
one positive correlation. The way scores go, on the anxiety 
factor, indicates a majority of positive correlations. Thus 
a low score in UrT2 is accompanied by a low score on the 
anxiety rating and vice versa. The positive correlation 
agrees with the expectation and lends support to the 
hypothesis, while the negative correlation does not. Overall, the 
negative to positive ratio (13:10) is not supportive of the general 
expectation.
The analysis for weekly UrT2 and Q3 (surgency factor) from 
MACL showed 6 positive correlations which were significant.
The direction of scoring in this case indicates that low 
glucose score relates to a high surgency score. Therefore we would 
expect a majority of negative correlations. The
-107-
present findings do not seem to support the notion that UrT2 
correlates in the expected direction with surgency and, indeed, it 
suggests that there is a fairly consistent relationship between 
high surgency and high levels of glucose. Thus, surgency among 
some patients may be predictive of poor glucose control.
The analysis for UrT2 and Q4 (elation factor) from 
MACL revealed 8 positive correlations, and one was 
significant. However, in this case the direction of scoring 
should indicate a majority of negative correlations. Thus a 
low glucose in urine relates to a high score in the feelings 
of elation. The present finding based solely on statistical 
significance is against this expectation but the general trend with 
a negative to positive ratio of 15:8 is generally supportive. 
Again, this highlights the wide individual differentiation possible 
in this relationship and it suggests quite strongly that such 
relationships are best examined at an individual level.
The analysis for UrT2 and Q7 (social affection factor) 
of MACL revealed one significant positive correlation.
The direction of scoring in this case should indicate a 
majority of negative correlations. Thus a low glucose score 
in urine relates to a high score in the feelings of 
affection. Therefore the findings here suggest the same 
interpretation as for elation above.
The correlations between weekly UrT2 and Q8 (sadness factor) 
from MACL showed one significant positive correlation. In 
fact, the direction of scoring for the sadness factor 
entails a majority of positive correlations. Thus a low
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score in urine glucose correlates to a low score in sadness.
In this case there is one positive correlation which seems to 
be in agreement to the general notion and expectation. However, 
the overall ratio of negative to positive (14:9) support the 
general unexpected finding with surgency described above.
The analysis for weekly UrT2 and Qll (vigour factor) from 
MACL revealed 14 positive correlations from which 4 were 
significant. This result indicates that the way the majority 
of positive correlations go, tend to support the general 
trend, thus a high feeling of vigour will corelate with high 
glucose in urine. It could be said that 4 patients out of 
the 24 for Qll showed a significant relationship between 
their average weekly emotional feelings and their weekly 
urine sample, which seems to support the general expectation.
From these findings it is difficult to draw final conclusions 
in relation to mood feelings and physiological measures over 
time. It is acknowledged that these analyses were descriptive in 
tone and a greater sensitivity could be obtained by using more time 
intervals in the computation of the relationship index. 
Nevertheless, the- results here have highlighted the importance of 
individual differentiation in such relationships suggesting that 
aggregation over individuals is not particularly feasible or 
informative.
However, the ANOVAs seem to give support to the literature and 
the findings of Hartman (1982), who supported the notion that 
both physiological and mood feelings improve over time with 
diabetic patients when they undergo relaxation training.
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The present findings, for the first part of the analysis, 
showed that the interaction of group (experimental and 
control) time (pre and post measurements) and type (insulin , 
non-insulin patients) had significant effects for the 
variables of State , Trait ,Blood Glucose and Haemoglobin Ale
It is suggested here that these results strongly indicate 
that, as a result of relaxation training, levels of anxiety 
decreased over time and significant improvement is also 
observed in the metabolic parameters over time, for the 
diabetic patients in the experimental group. These findings 
support the hypotheses stated for the present research and 
already mentioned previously in the present section.
The second part of the analysis only provides the most tentative 
support for the above main ANOVA findings as well. However, it 
does provide the novelty of emphasising within-subject 
relationships between weekly urine glucose levels for the 
second urine measurement of the day (UrT2) and the weekly 
ratings of certain emotional factors for each diabetic 
patient in the experimental group. It has been suggested here 
that, in future research, daily rather than weekly measurements 
should be correlated between urine glucose levels and 
emotional ratings. This analysis might throw light on the 
results in a more efficient and detailed way.
The above findings seem to agree, as it has already been 
mentioned, with those of Luthe (1969), Fowler (1976),
Seeburg (1980) and Hartman (1982). However, in the first 
three studies only a series of single case studies have been 
presented and there is thus a need for caution in the
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interpretion of the findings, especially since diabetes is a 
heterogeneous and complicated disorder. Hartman's study is 
larger in scale than the other work referred to, but still 
only 15 subjects were involved.
Furthermore, none of these studies included a control group in 
their reseach. In the present research the sample size is larger, 
24 diabetic patients were studied in each group, a control group 
was included in the study. This allows for a more secure 
interpretation of the analysis.
There are at least three interpretations of this data. The 
first is that relaxation training produced a change in the 
metabolic parameters and as a result anxiety levels 
decreased. This would seem to agree with the type of 
prediction which would follow from the James-Lange theory 
(1884,1992). In this case, better metabolic control could be 
the cause of the psychological improvement. A second 
interpretation could be that relaxation training produced a 
change in both anxiety levels and metabolic parameters, 
independently. A third interpretation could be that a change 
in the psychological state, induced by relaxation training 
improved metabolic control. This would seem to agree with 
the type of prediction which could follow from the Cannon 
and Bart theory (1928). Therefore an association 
could be established between the improvement of the 
psychological variables with that of the metabolic 
parameters, which reflect the quality of the control of 
diabetes.
If metabolic parameters precipitate the anxiety factor, then
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they should change first. If anxiety and metabolic 
parameters occur at the same time, this suggests parallel 
changes. Finally, if the anxiety factor partcipates, then 
anxiety changes should be visible before metabolic changes.
At present data are not available to allow interpretation of 
the above theoretical problems.
Some independent theoretical considerations and problems that 
occured in the present study, were the following:
First, patients were assigned to a an experimental or a 
control group before they were told about the study. Then 
they were given different information about the study 
depending on what group they-had been assigned to. Although 
the selection process of these subjects was related with the 
practicalities of the clinic, one has to mention that the 
reasons why experimental group subjects agreed to participate 
in the study might not have been the the same as those 
of control group subjects. It could be argued that subjects 
agreed to participate in the monotoring only group were 
motivated differently from those who agreed to participate in 
the relaxation group. This potential problem in the design 
has been recognised by the researcher and has been corrected 
in the second study.
A second problem noticed, were baseline differences between 
the two groups. In certain physiological parameters i.e. 
patients in the experimental group started with higher blood 
glucose levels and HbAlc levels than the patients in the 
control. Therefore it should be recognised that the 
significant drops that are obvious in the Experimental group
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could be due in part to their relatively elevated initial 
levels and poorer metabolic control. Therefore, in case of 
baseline differences present in the parameters of the second 
study would be controled.
A third possible problem of this study was the fact that in 
the analysis of the data, two different types of people with 
diabetes Type I and Type II were lumped together. This might 
have influenced the results and therefore in the second study 
this problem was redressed.
An additional consideration which occurred to the researcher 
was a possible significance of the level of personal 
interaction between the patients and the researcher; it is 
possible that, apart from relaxation training , another 
factor in the treatment of the 2 groups contributed to these 
results, a " non specific attendance factor” . This arises 
from the fact that the experimental group was seen for 8 one 
hour weekly meetings, while the control group was seen only 
for 2 one hour meetings. It, therefore, seems necessary to 
control for any such placebo effects, by ensuring that the 
experimenter has a similar level of interaction with both 
experimental and control groups.
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CHAPTER 7 
SECOND STUDY
7.1 Aims of the Study
A possible difficulty of interpreting the results of the 
first study is that the experimental and control groups 
received different amounts of attention from the researcher. 
Therefore, the main aim of the second study was to control 
for this difference, with the aid of a placebo group in 
which blood circulation exercises will be administered. In 
this way patients in the Placebo group will also receive 
treatment which is hypothesised to be non-effective but to 
have a similar social interaction profile.
7.2 Hypotheses and Predictions
The specific hypotheses were the following:
Hypothesis 1 : Relaxation training will influence the post
treatment values of the state scale. It is expected that the 
patients' anxiety levels will decrease in the post-treatment 
measurement. It is believed that relaxation training helps 
anxiety levels to decrease in patients with diabetes 
mellitus.
Hypothesis la: The patients in the placebo group are
expected not to show any significant changes in their State 
Anxiety scale for the post exercise measurements. It is 
hypothesised)^ that blood circulation exercises, cannot help 
anxiety level's to decrease in patients suffering from 
diabetes.
Hypothesis 2 : Trait Anxiety scales are expected not to be
significantly different in the post measurement for both 
experimental and placebo groups. This hypothesis arises 
because , Trait Anxiety scale is intended to assess 
individual characteristics which are expected to remain 
stable and not to be influenced by external factors.
Hypothesis 3 : In relation to the metabolic parameters 
relaxation training is expected to produce a significant 
change in the post treatment measurements.
Therefore a significant change is expected for the post 
treatment dependent measurements of Blood Glucose Levels, 
Glycosylated Haemoglobin (HbAlC) , Cholesterol, High Density 
Lipoprotein, Fructosamine and Urine Glucose Levels and for 
the independent measurements of Blood Pressure and Body 
Weight.
A non-significant change is expected for the same post 
measurements in the Placebo group. It is believed that 
relaxation training seems to help patients with diabetes to 
improve their metabolic control.
Hypothesis 4 : In relation to the Daily-Diary Check List
(Daily-DCL) and the Mood Adjective Check List (MACL) 
administered to both experimental and placebo groups, it is 
expected that for the experimental group relaxation training 
will influence significantly patients ' values and 
psychological state over time, while , the blood circulation 
exercises are expected not to influence significantly 
patients' psychological state over time, for the placebo 
group.
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This hypothesis arises because it is believed that 
relaxation training can influence patients emotional state 
and therefore towards the end of the 8 week' s training 
period patients should feel more relaxed in comparison to 
when the training period started.
Hypothesis 5 : It is expected that the improvement in the
metabolic parameters for the experimental group will 
significantly correlate with the improvement in the 
emotional state of the diabetic patient.
It is believed that relaxation training can help diabetics 
to improve their metabolic and psychological state.
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7.3. SUBJECTS
Source of Sample
This study took place at St Luke's Hospital in Guildford, 
Surrey. Forty-eight patients (26 in an experimental group 
and 22 in a placebo group) with insulin dependent (Type I ,
46 patients), and non-insulin dependent (Type II, 2 
patients) were selected from the outpatient clinic 
of the diabetic centre.
Twenty one female and 27 male with ages from 18 TO 60 years 
(x=35.5 , s=9.7) were participants in this research.
Exclusion Criteria
The same limitations applied in the first study in respect 
of literacy, renal, cardiac, or retinopathy and pregnancy 
problems, were also applied in this study. Six patients were 
excluded.
Procedure for Subject Briefing and Recruitment
The diabetic outpatient clinic of St. Luke's hospital was 
held one day per week. It was arranged with the medical staff 
that each diabetic patient who had an appointment for that 
day would be given a covering letter. However, this letter 
was given with two limitations, first to those patients who 
had been diagnosed suffering from diabetes at least a year 
earlier and to patients whose age was between 18 to 60 years, 
so the sample of this research would have the same basic 
characteristics as the one taken in the first study.
The covering letter gave background information on
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diabetes and full details about the research (see Appendix X 
and X (a) ). In case patients were interested in learning
more about the programme and possibly in participating, they 
were informed by the letter that the researcher would be in 
the clinic on the day of their appointment. Patients who 
expressed interest were guided by a nurse into a separate 
room, where the researcher gave them more details, and 
arranged appointments. Patients entering the office in an 
odd sequence were assigned to the Experimental group, while 
those in an even sequence to the Placebo group.
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7.4. MEASUREMENTS AND MATERIALS USED
7.4.1. Psychological Measures
The same psychological measurements were used in this study 
as in the first piece of research. Thus, State and Trait 
Inventory, MACL and Daily-DCL were administered to the patients in 
both the experimental and placebo groups (please see first study).
7.4.2.Metabolic Measures
The measurements used as indices of metabolic control of 
diabetes were the same as those of the first research, for 
both experimental and placebo groups. However, instead of 
the Triglycerides (TG), the Fructosamine variable was 
measured.
Triglyceride was a measurement considered by the medical 
staff of St.Luke's Hospital, as a poor and highly, 
unreliable indicator of control and so the measurement of 
Fructosamine was introduced instead.
Fructos amine
Non-enzymic glycosylation of proteins occurs in proportion 
to the prevailing concentration of glucose. The extent of 
glycation of proteins in blood, therefore, reflects the 
blood glucose concentration averaged over their life span.
Because of the long and rather constant 120 day life span of 
the erythrocyte, glycosylation of haemoglobin has proven a 
useful parameter for assessing long term glycaemia in 
diabetes Mayer and Freedman, (1983) .
The majority of fructosamine is glycated albunim which has a 
half-life in blood of around 20 days, and has been used as a
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clinically useful objective measure of intermediate term 
glycaemia. It is therefore of value, for example during the 
institution of a new therapeutic regimen as during pregnancy. 
Non-specific changes in albumin levels may result in 
unpredictable changes in fructosamine levels. (Fruckiger et 
al, 1987).
The normal values used for fructosamine are around 6-7%, good 
diabetic control 8-9%, values as high as 15% and above is 
poor control.
More recently, measurement of fructosamine has been 
introduced and used as an index of shorter-term glycaemic 
control. The precise nature of fructosamine is not fully 
understood. The majority represents glycosylated albumin but 
precise standardisation has proved difficult.
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7.5 PROCEDURE
Data Collection took place in a soundproof room at the 
University of Surrey. The experimenter spent one hour with 
each patient per week, over a period of 8 weeks.
A range of questionnaires were filled in every week by 
the patients. Relaxation exercises were given by the 
researcher to all the participants in the experimental 
group, while blood circulation exercises were given to all 
the participants for the placebo group.
For the Experimental group the same procedure was followed 
as the one in the first study.
At the end of the experimental sessions the patients in the 
experimental group were encouraged to think positively towards 
their disease and their every day life. Because of the nature 
of biofeedback it requires that the patients should maintain 
positive thinking and practice in a self motivated fashion 
and this was explained to these patients. A later study, 
Chapter 8, attempts to asses the degree of continuation of 
relaxation training.
The patients in the Placebo Group were given advice about how 
to take care of their feet, e.g. to wear comfortable shoes 
and only cotton socks or cotton tights, to wash feet often 
and keep them clean, and so on.
During the eighth individual sessions the patients in the 
placebo group were taught by the experimenter how to 
practice Blood Circulation Exercises, (see Appendix XI).
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These exercises are often sent to diabetic clinics, as an 
advertising poster by the "Novo" Industry Incorporation, 
which show how to improve blood circulation in the lower 
limbs. Any European diabetic clinic, which has a 
collaboration with "Novo" , has this poster for patients to 
read.
These exercises were taped for each patient separately and 
the same procedure was followed for the Placebo as the one 
for the Experimental group, (please see "Procedure Section" 
in the first study).
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7.6. STATISTICAL METHOD
The Time factor (Before and After) and the Group factor 
(Experimental and Placebo) were the independent variables of 
this study. A 2-way Analysis of Variance (ANOVA) strategy was 
used in this study in which the dependent variables are:
a) State and Trait Anxiety scores
b) Blood Glucose
c) Glycosylated Haemoglobin
d) High Density Lipoprotein
a) Cholesterol
f) Fructosamine
g) Urine Glucose Levels,
h) Body Weight
i) Medication
The ANOVAs in this research investigated the significance of 
the interaction and main effects for group (experimental— 
placebo) and time factor (pre and post treatment 
measurements).
The baseline differences for each of the dependent variables 
were assessed before the analysis in order to see if there 
were any group differences prior to treatment. If they were 
significantly different more emphasis was given to the 
interaction effect.
In addition to the ANOVA Pearson' s coefficient 
correlations were calculated in order to investigate the 
possible significant relationship between the physiological 
parameter of Urine Glucose Levels and psychological
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parameter of Mood Adjective Check List and Daily-Diary Check 
List.
In order for this analysis to be performed 2 non-insulin 
dependent diabetics (one from each group) were excluded, in 
order for the sample to be homogeneous as far as the 
medication is concerned and so not to add confusion to the 
results.
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7.7.RESULTS
The Multivariate Analyses of Variance routine (MANOVA) in SPSSx was 
used to investigate the repeated measures of physiological and 
psychological parameters which have been tested over time.
Only significant (p<0.05) interactions and main effect 
analysis are referred to in the text. All the other analyses 
are reported only in the Appendix section (XII).
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State Anxiety Scale
Table 16 shows the means and standard deviations of the pre- 
and post- treatment measures, baseline analysis and the 
results of the Anova for the State Anxiety Scale.
There was a slight baseline difference in the pre­
measurements of the State anxiety levels, the experimental 
group starts with higher State anxiety. However, this 
difference was not significant (t=.81, p>0.05).
There was one significant main effect, that of Time.
The mean values showed that there is a significant decrease 
of the State Anxiety Scale for the pre- and post- treatment 
measurement for both experimental and placebo groups. None' 
of the remaining scales revealed any significant interaction 
or main effects.
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Table 16: Analysis of Variance and Summary data of the
scores of the State Anxiety Subscale and
Experimental/Placebo Group over Time
Table 16A: STATE Anxiety Scale (Mean and Standard 
Deviations)
Experimental Placebo
Pre Measurements
Mean
Standard Deviation
41.2
9.6
39.5
6.0
Baseline Difference t= .76 p >.05
Post Measurements 
Mean
Standard Deviation
34.4
8.0
35.5
8.9
Table 16B: STATE Anxiety Scale (ANOVA)
Source Ss df MS F Sg
Error 5316.6 44 120.8
Group 14.8 1 14 . 8 0.12 NS
Time 386.8 1 386.8 14.5 p <.001
Group x Time 73.9 1 73.9 2.8 NS
Error 1169.7 44 26.5
Total 1989.6 91
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Trait Anxiety Scale
Table 17 shows the results of the Trait Anxiety Scale.
There was a baseline difference between experimental and 
placebo group. The subjects in the experimental group start 
with higher Trait anxiety levels than the placebo. However, this 
difference was not statistically significant (t=1.53, p>0.05).
The interaction effect between group and time was statistically 
significant and there were no significant main effects.
The mean values seem to indicate that the nature of the 
interaction showed a reduction of the Trait Anxiety over time 
for the experimental group, while there is a slight increase in 
the Trait Anxiety for the patients in the placebo group.
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Table 17 : Analysis of Variance and Summary data of the
scores of the Trait Anxiety Scale and
Experimental/Placebo Group over Time
Table 17A: TRAIT Anxiety Scale (Mean and Standard 
Deviations)
Experimental Placebo
Pre Measurements
Mean 42.4 40.0
Standard Deviation 10.0 7.2
Baseline Difference t= 1.62 p >. 05
Post Measurements
Mean 38.8 41.0
Standard Deviation 9.2 8.6
Table . 17B: TRAIT Anxiety Scale (ANOVA)
Source Ss df MS F Sg
Group 31.4 1 31.4 .21 NS
Error 6507.4 44 147. 8
Time 52.4 1 52.4 3.33 NS
Group x Time 216.6 1 216.6 13.76 p <.001
Error 692.7 44 15.7
Total 7501.24 91
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Glycosylated Haemoglobin
Table 18 reveals the analysis for the Glycosylated 
Haemoglobin. There was a baseline difference in the 
experimental group which starts with higher glycosylated 
haemoglobin than the placebo group. However, this difference 
was not significant. The analysis revealed a significant 
interaction effect between the two Groups and the Time 
factor. There were no significant main effects. It can be 
seen from the mean values that there was a fall of HbAlC over 
time for the experimental group, whereas there was an 
increase for the placebo group.
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Table 18 : Analysis of Variance and Summary data of the
scores of the Glycosylated Haemoglobin (%) and
Experimental/Placebo Group over Time
Table 18A: HbAlC (%) (Mean and Standard Deviations)
Experimental Placebo
Pre Measurements
Mean 10.4 9.3
Standard Deviation 1.8 1.5
Baseline Difference t= 1.00 p >.05
Post Measurements
Mean 9.1 10.4
Standard Deviation 1.6 2.1
Table 18B: HbAlC (ANOVA)
Source Ss df MS F Sg
Group 3.5 1 3.5 .73 NS
Error 209.59 44 4.7
Time .25 1 .25 .19 NS
Group x Time 16.0 1 16.0 11.94 p <.001
Error 59.1 44 1.3
Total 288.35 91
HbAlC = Glycosylated Haemoglobin
High Density Lipoprotein
In table 19 the analysis for H.D.L. is revealed. The slight 
baseline difference between experimental and placebo group 
proved not to be significant (t=.27, p>0.05).
This analysis showed a significant interaction effect between the 
two groups and the Time factor. In addition the Time main effect 
was significant, but no other main effect was significant.
The mean values showed that there is a significant increase 
of HDL for the experimental group, while the HDL remained 
almost unchanged for the placebo group over time.
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Table 19: Analysis of Variance and Summary data of the
scores of the High Density Lipoprotein (%) and
Experimental/Placebo Group over Time
Table 19A: H.D.L. (%) (Mean and Standard Deviations)
Pre Measurements 
Mean
Standard Deviation
Experimental
1.32
0.36
Placebo
1.29
.38
Baseline Difference t;= .27 p >. 05
Post Measurements 
Mean
Standard Deviation
1.52
.36
1.20 
. 41
Table 19B: H.D.L. <%) (ANOVA)
Source Ss df MS F Sg
Group .42 1 .42 1.2 NS
Error 15.26 44 .35
Time .14 1 .14 7.0 p <. 05
Group x Time .32 1 .32 16.0 p <.01
Error 1.04 44 .02
Total 17.18 95
H.D.L. = High Density Lipoprotein
-134-
Cholesterol
Table 20 shows the analysis for the Cholesterol variable. In 
this analysis there was also a baseline difference which was 
not significant (t=l,66, p>.05).
An interaction effect was significant between the two Groups and 
Time factor. There were no significant main effects. It can be 
seen from the mean values that there was a significant drop for the 
cholesterol levels in the experimental group while the scores 
for the placebo group remain almost unchanged over time.
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Table 20 : Analysis of Variance and Summary data of the
scores of the Cholesterol (mmol/litre) and
Experimental/Placebo Group over Time
Table 20A: Cholesterol (mmol/litre) Mean and Standard 
Deviations)
Experimental Placebo
Pre Measurements
Mean 5.2 5.0
Standard Deviation 1.0 .9
Baseline Difference t= 1.66 p >. 05
Post Measurements
Mean 5.2 5.6
Standard Deviation 1.0 0.9
Table 19B: Cholesterol (mmol/litre) (ANOVA)
Source Ss df MS F Sg
Group .88 1 .88 .39 NS
Error 100.13 44 2.27
Time 1.04 1 1. 04 2.97 NS
Group x Time 2.10 1 2.10 6.00 p <. 05
Error 15.23 44 0.35
Total 119.38 91
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Fructosamine
Table 21 shows the Fructosamine analysis. The experimental 
group had higher levels of Fructosamine than the placebo 
group. However, this baseline difference proved not to be 
significant (t=1.04, p>.05).
There was a significant interaction effect between the Groups and 
the Time factor. None of the main effects was significant. Mean 
values showed that there was a significant drop in the Fructosamine 
levels in the experimental group, while there is a slight increase 
for the placebo group over time.
-137-
Table 21: Analysis of Variance and Summary data of the
scores of the Fructosamine (mmol/litre) and
Experimental/Placebo Group over Time
Table 21A: Fructasamine (mmol/litre) (Mean and Standard 
Deviations)
Pre Measurements 
Mean
Standard Deviation
Experimental
4.1
1.5
Placebo
3.8
1.5
Baseline Difference t= 1.04 p >.05
Post Measurements 
Mean
Standard Deviation
4.0
1.2
4.3
1.6
Table 21B: Fructosamine (mmol/litre) (ANOVA)
Source Ss df MS F
Group .81 1 .81 .15
Error 236.52 44 5.37
Time .62 1 .62 2.29
Group x Time 4.01 1 4.01 14.85
Error 11. 84 44 .27
Total 253.80 91
Sg
NS
NS 
p <. 05
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Blood Glucose Levels
Table 22 shows the analysis for Blood Glucose Levels. The 
experimental group had higher B.G.L. than the placebo group. 
However, this baseline difference was not significantly higher 
(t=.69, p>.05) than the placebo group.
There was an interaction effect between the Groups and the Time 
factor. None of the main effects were significant. It can be seen 
from the mean values that there was a drop in blood glucose 
in the experimental group while there was a slight increase
i / ‘7
for the placebo group over time.
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Table 22: Analysis of Variance and Summary data of the scores
of the Blood Glucose Levels (mmol/litre) and
Experimental/Placebo Group over Time
Table 22A: Blood Glucose Levels (mmol/litre) (Mean and 
Standard Deviations)
Experimental Placebo
Pre Measurements
Mean 12.6 11.5
Standard Deviation 6.1 5.5
Baseline Difference t= .69 p >.05
Post Measurements
Mean 10.0 11.4
Standard Deviation 5.0 4.2
Table 22B: Blood Glucose Levels (mmol/litre) (ANOVA)
Source Ss df MS F Sg
Group 4.2 1 4.2 .09 NS
Error 2069.0 44 47.0
Time 36.0 1 36.0 2.48 NS
Group x Time 61.6 1 61.6 4 .24 p <. 05
Error 639.0 44 14.5
Total 2810.89 91
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Urine Glucose Levels
Table 23 reveals the Urine Glucose Levels analysis. There was 
a significant interaction between the Weeks and the Time of 
the urine factor.
There was also a significant time main effect. It can be seen 
from the mean values (Table 23.B) that the urine glucose 
time samples decrease for both experimental and placebo 
group over the 8 week period. None of the remaining 
interactions and main effects yielded any significant 
results.
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Table 23: Analysis of Variance and Summary data of the scores 
of the Urine Glucose Levels (mmol/L) by 
Experimental/Placebo Group, week of Urine 
measurements over Time
Table 23.A: Urine Glucose Levels (mmol/L) (ANOVA)
Source Ss df Ms F Sig.
Group 12.8 1 12.8 2.62 NS
Error 205.9 42 4.9
Time 42.5 2 21.2 11.26 p <.001
Group x Time 1.4 2 0.7 .39 NS
Error 158.8 84 1.9
Week 2.4 7 .35 .89 NS
Group x Week L. 6 7 .24 .61 NS
Error 117 .5 299 .39
Time x Week 15.7 14 1.12 3.03 p <.001
Group x Time x Week 7.6 14 .55 1.48 NS
Error 224.2 600 .37
TOTAL 792.61 1072
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Table 23.B: Urine Glucose Levels (mmol/L) over Time (Mean 
Values and Standard Deviations
EXPERIMENTAL PLACEBO
Mean Standard Deviations Mean Standard Deviations
W1T1 .67 .70 1.27 1.58
W1T2 .52 .94 1.20 1.79
W1T3 1.00 1.42 1.08 1.59
W2T1 .59 .65 .87 1.19
W2T2 .40 .63 .61 .68
W2T3 .64 .88 .76 1.18
W3T1 .71 1.34 .82 1.17
W3T2 .50 1.37 .75 1.88
W3T3 .41 .50 .65 .63
W4T1 .53 .99 .66 .90
W4T2 . 14 .25 .27 .34
W4T3 .45 .62 .41 .39
W5T1 .48 .55 .59 .49
W5T2 .50 .97 .53 . 61
W5T3 .34 .32 .65 .48
W6T1 .41 .82 .41 .48
W6T2 .17 .42 .11 .12
W6T3 .19 . 42 .44 .53
W7T1 .17 .40 .34 .34
W7T2 .14 .31 .21 .31
W7T3 .17 . .29 .35 .35
W8T1 .12 .22 .65 .69
W8T2 .10 .28 .36 .63
W8T3 . 17 .25 .85 .92
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Body Weight
Table 24 shows the analysis for Body Weight. The subjects in 
the placebo group had higher B.W. than those in the 
experimental group, however, this baseline difference was not 
significant (t=.ll, p>.05).
The time main effect was significant, which implies a change of 
Body Weight over time. The mean values showed a very slight 
decrease in the post treatment measurements.
None of the remaining main effects or interactions were 
significant.
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Table 24: Analysis of Variance and Summary data of the
scores of the Body Weight and Experimental/Placebo
Group over Time
Table 24A: Body Weight (Mean and Standard Deviations)
Experimental Placebo
Pre Measurements
Mean
Standard Deviation
67.5 
110. 4
71.9
96.2
Baseline Difference t= .11 P >.05
Post Measurements 
Mean
Standard Deviation
66.8
110.5
70.0
98.1
Table 24B: Body Weight (ANOVA)
Source Ss df MS F Sg
Group 22419.5 1 22419.5 1.0 NS
Error 986317.2 44 22416.3
Time 605.7 1 605.7 9.2 P <.05
Group x Time 118.3 1 118.3 1.8 NS
Error 2890.8 44 65.7
Total 1012351.3 91
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Short Acting Insulin
Table 25 shows the analysis for the Short Acting Insulin 
during the morning dosage. The subjects in the experimental 
group had less short acting insulin in their morning dosage 
than the placebo group subjects. However, this baseline 
difference was not significant (t=.36, p>.05).
There was a significant interaction between the two Groups and the 
Time factor. None of the main effects revealed any significant 
results. In fact the mean values showed a drop in the insulin 
dosage for the patients in the experimental group while they 
showed an increase for the patients in the Placebo group.
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Table 25: Analysis of Variance and Summary data of the scores
of the Short Acting Insulin (Morning Dosage)
and Experimental/Placebo Group over Time
Table 25A: Short Acting 
Deviations)
Insulin (Mean and Standard
Pre Measurements 
Mean
Standard Deviation
Experimental
9.6
8.2
Placebo
10.9
8.3
Baseline Difference t= .36 p >.05
Post Measurements 
Mean
Standard Deviation
7.6
7.0
10.1
7.9
Table 25B: Short Acting Insulin (ANOVA)
Source Ss df MS F Sg
Group 92.71 1 92. 71 .66 NS
Error 6181.01 44 140.47
Time .39 1 .39 .06 NS
Group x Time 4 6.28 1 46.28 7.12 p <. 05
Error 286.40 44 6.50
Total 6346.85 91
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Long Acting Insulin
Table 26 shows the results for the Long Acting Insulin 
during the evening dosage. The placebo group subjects had 
more L.A.I. in their evening dosage compared with that of the 
experimental.
The baseline difference was significant (t=2.38,p<.05). Since 
this difference is significant emphasis should be put on the 
interaction effect. However in this case there was only a 
Group main effect, which was significant and none of the 
remaining interaction and main effects were significant. The 
mean values showed that the long acting insulin mean values 
for the experimental group differ from those in the placebo 
group in both pre and post measurements. The actual insulin 
evening dosage was for the patients in the experimental 
group and is higher for the patients in the placebo group. 
None of the remaining medication variables revealed any 
significant differences (see Appendix XII). Additionally , 
there were no significant changes for the dependent 
variables of systolic and diastolic blood pressure (see 
Appendix XII).
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Table 26: Analysis of Variance and Summary data of the
scores of the Long Acting Insulin (Evening Dosage)
and Experimental/Placebo Group over Time
Table 26A: Long Acting Insulin (Mean and Standard 
Deviations)
Experimental Placebo
Pre Measurements
Mean 5.6 12.9
Standard Deviation 9.7 11. 6
Baseline Difference t= 2.38 A o cn
Post Measurements 
Mean 6.2 13.0
Standard Deviation 9.3 12.3
Table 26B: Long Acting Insulin (ANOVA)
Source Ss df MS F Sg
Group 1410.02 1 1410.02 cn 00 tl A
Error 10623.34 44 241.44
Time 0.03 1 .03 .02 NS
Group x Time 1.02 1 1.02 .69 NS
Error 65.40 44 1. 48
Total 12099.91 91
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Relationship between urine glucose and 
psychological-parameters
It was decided that characteristics of the urine sample 
after lunch were to be correlated with chosen questions from 
Daily-Diary Check List and Mood Adjective Check List. This is in 
order to replicate the findings of study 1. In this case more 
interval points are used to improve the sensitivity of the 
measurement.
In order to find out if there was any relationship between 
biological and psychological parameters in this study it was 
decided that the everyday measures for UrT2 (mg/littre) and 
emotional ratings would be calculated for the means of the 
1st, 5th and 8th week of the research across the two groups.
The questions chosen from Daily-Diary Check List and Mood 
Adjective Check List were the same as the ones chosen for 
the first study with the additional mood factor of Aggres­
sion from MACL.
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Anxiety
Table 27 shows the r-values between UrT2 (mmol/L) and Q2 
(Anxiety factor) from the MACL. These correlations are 
calculated over the 3 week period (1st, 5th, 8th). Thus each 
patient has 12 pairs of measures (4 measurements per week); 
in this case urine glucose and anxiety factor. These pairs of 
measures are correlated with the Pearson formula resulting in 
a correlation coefficient (r) for each patient which 
indicates the strength of the relationship between anxiety 
and urine glucose level for that patient. In this case a 
true r indicates that a low glucose score coincides with low 
levels of anxiety. From these 26 values for the experimental 
group there is one negative correlation which is significant 
(r=-0.69, df=7, p<.05) for subject 10.
None of the remaining correlations revealed any significant 
results. There are missing values for 8 patients.
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Table 27: Correlation Coefficients between Urine (T2) 
(mmol/L) and Anxiety factor (Q.2) from Mood 
Adjective Check-List for the Subjects in the 
Experimental group
Subjects' Identification Number r-values
1. .41
2 .
3. .05
4. .19
5. -.63
6 .
7. .45
8. .19
9. .14
10. -.69 *
11. .15
12 . .00
13. -.46
14. .05
15.
16. .14 
17 .
18.
19. .18
20.
21. .41
22.
23. .00
24. .43
25
26
Number of Negative Correlations : 3 
Number of Positive Correlations : 14
Key : * = significant values 
- = missing data
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Elation
Table 28 shows the r-values between UrT2 and Q4 (Elation 
factor) from MACL. A true r indicates that low glucose is 
related to high elation. From these 26 values for the 
experimental group there is one negative correlation which is 
significant (r=-0.84, df=7/p<.05) for subject 3. None of the 
remaining r's are significant. There are missing values for 8 
patients.
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Table 28: Correlation Coefficients between Urine (T2)
(mmol/L and Elation factor (Q.4) from the Mood 
adjective Check-List, for the Subjects in the 
Experimental group
Subjects' Identification Number r-values
1. -.27
2 .
3. -.84 *
4. -.07
5. .17
6.
7. -.59
8. .25
9. .28
10. -.19
11. -.47
12. .46
13. -.45
14. -.47
15.
16. -.05
17. -
18.
19. .37
20.
21. -.36
22 .
23. .07
24. -.15
25. -
26.
Number of Negative Correlations : 11 
Number of Positive Correlations : 6
Key: * = significant values 
- = missing data
Surgency
Table 29 shows the r-values between UrT2 and Q3 (surgency 
factor) from the MACL for the placebo group. A true r 
indicates that low glucose is related to high surgency.
From these 22 correlations, there are two negative 
correlations(r=-0.77, df=7, p<.05) for subject 22 and (r=—
0.73, df=7,p<.05) for subject 20, and there are two positive 
correlations (r=0.79, df=7,p<.05) for subject 17 and 
(r=0.85,df=7, p<.05) for subject 10. There are missing values 
for 7 patients.
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Table 29: Correlation Coefficients between Urine (T2)
(mmol/L) and Surgenty factor (Q.4) from the Mood 
Adjective Check-List, for the Subjects in the 
Placebo group
Subjects' Identification Number r-values
1. -.03
2.
3. .13
4.
5. .00
6. .00
7.
8 .
9. .49
10. .85 *
11.
12. .00
13. -.17
14. -.06
15. .34
16. .59
17. .79 *
18.
19.
20. -.73
21. -.05
22. -.77 *
Number of Negative Correlations : 6 
Number of Positive Correlations : 9
Key: * = significant values 
- = missing data
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Social Affection
Table 30 shows the r-values between UrT2 and Q7 (Social 
Affection ) from the MACL for the placebo group. A true r 
indicates that low glucose is related to high elation. From 
these 22 correlations there is one significant positive 
correlation (r=0.73, df=7, p<.05) for subject 17. None of 
the remaining r's showed any significant correlations. There 
are missing values for 2 patients.
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Table 30: Correlation Coefficients between Urine (T2)
(mmol/L) and Social Affection factor (Q.7) from the 
Mood Adjective Check-List, for the Subjects in the 
Placebo group
Subjects' Identification Number r-values
1 . -.12
2 .
3. -.24
4. -.32
5. .19
6. -.07
7. .29
8. .30
9. .00
10. .45
11. -.46
12. -.09
13. -.55
14. -.27
15. -.06
16. .00
17. .73 *
18. .19
19.
20. .08
21. .27
22. -.14
Number of Negative Correlations : 10 
Number of Positive Correlations : 10
Key: * = significant values 
- = missing data
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Remaining Variables
The remaining questions from MACL and the two questions from 
D.D.C.L. which did not reveal any significant correlations 
are shown in the Appendix XIII.
In addition to the previous analysis, it was decided to look 
at the mean, daily, every day values for Q3 and Q4 from the 
daily diary check list between the 2 groups for Wl, W5 and 
W8. Table 31 shows these values. Q3 is related to a diet 
compliance question, the answer varies from Yes Very 
Strictly = 4 to Not At All =1. Q4 is related with the 
practising of the exercises which varies from Yes = 1, No =
3 and A Little = 2.
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Table 31: Mean Values for Responses to Question 3 (diet
Compliance) and Question 4 (Exercise Compliance) 
from Daily-Diary Check-List, for both Experimental 
and Placebo Groups
Q3 Q4
EXPERIM. PLACEBO EXPERIM. PLACEBO
D1 2.4 2.1 1.6 1.7
D2 2.3 2.1 1.6 1.5
D3 2.2 2.4 1.8 1.6
W 1 D 4  1.9 2.3 1.8 1.3
D5 2.0 2.2 1.7 1.6
D6 2.2 2.3 1.7 1.7
D7 2.1 2.1 1.7 1.6
D1 1.9 2.2 1.6 1.6
D2 2.1 2.2 1.9 1.5
D3 2.0 2.2 1.8 1.8
W 5 D 4  2.2 2.3 1.6 1.6
D5 2.1 2.2 2.0 1.7
D6 2.0 2.1 1.7 1.6
D7 1.9 2.2 1.7 1.5
D1 1.8 2.6 1.7 1.7
D2 2.1 2.1 1.9 1.3
D3 2.0 2.2 1.8 1.5
W 8 D 4  2.0 2.2 1.7 1.4
D5 1.8 2.0 1.7 1.6
D6 1.8 2.3 1.9 1.5
D7 2.2 2.5 1.8 1.4
W = Week 
D = Day
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7.8.DISCUSSION
Statistical analysis of the State Anxiety scale data 
showed a significant change of the time main effect. There 
is a significant decrease of the State Anxiety scores over time 
for both experimental and placebo groups.
The main hypothesis in relation to the State Anxiety scale 
was that diabetic patients participating in the experimental 
group would decrease their State Anxiety levels in the post 
treatment measurement, while the patients in the placebo 
group would not show any significant changes over time in 
their State Anxiety scores. The present findings seem to 
partly support the above hypothesis in relation to the 
significant change of State Anxiety scores over time.
However, it seems that patients in both groups, experimental 
and placebo showed a decrease iij^heir State Anxiety scores 
over time. This could suggest that relaxation training in 
the experimental group and fact that the researcher 
spent the same time with the placebo group, could both give 
an explanation of the overall reduction of the State Anxiety 
scores. Therefore, the attention factor might have had an 
effect on this variable, as well as relaxation training 
showed to be effective in the previous study.
The hypothesis of the Trait Anxiety scale was that no
\
significant differences in the post measurements for both 
experimental and placebo groups were expected. However, it 
was found that there was a significant interaction between
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the Trait scores and the time factor for both groups.
Patients in the experimental group decreased their Trait 
anxiety scores while there is a slight increase in the Trait 
anxiety scores for the patients in the placebo group.
This is certainly different from the general expectation but it 
replicates the results of study one. This result provides evidence 
against Spielberger' s (1974) notion that the Trait subscale 
assesses individuals' relatively stable vulnerability to different 
kinds of stress. This finding supports the findings of the first 
study for the Trait subscale.
The changes in Trait scores over time could realistically be 
attributed to the psychological intervention, in this case 
relaxation training which could reduce patients' overall 
generalised Trait anxiety. It is interesting that blood 
circulation exercises did not yield comparable changes since 
they were non-specific to anxiety reduction.
It was hypothesised that patients' post treatment measurements in 
relation to Glycosilated Haemoglobin would be lower in the 
experimental group while no significant improvement was 
expected for the placebo group. Statistical analyses seems 
to offer support for the above hypothesis. There is a 
significant interaction effect between group and time and,
jU~as it can seen, patients m  the experimental group had 
lower HbAlC levels at their post treatment measurement, 
while patients in the placebo group had an increase in their 
HbAlC levels. This finding seems to agree with those of 
Luth (1969) , Hartman (1982) , Surwit (1983) and Bradley 
(1988). Therefore, it could be suggested that relaxation
-162-
significant interaction between group and time for the 
experimental group was shown for fructosamine but not for 
the placebo group. This finding is in agreement with Seeburg 
and De Boer (1980) ,Surwit (1983) and trucking (1987) . 
Therefore, relaxation training seems to help fructosamine | 
levels drecrease over time.
It was hypothesised that patients' post -treatment 
measurements in relation to blood glucose levels would 
decrease in the experimental group while a non- significant 
improvement was expected for the placebo group. Statistical 
analysis seem to support the above hypothesis, since there 
was a significant interaction between group and time for 
blood glucose levels in the experimental group but not for 
the control. This result agrees with those of Luthe (1969), 
Fowler (1976) and Seeburg and De Boer (1980). Therefore , it 
could be suggested that relaxation training can help BGL to 
decrease over time. This seens to be in agreement with the 
results of the first study.
It was hypothesised that patients' post - treatment 
measurements in relation to urine glucose levels would 
decrease in the experimental group over time, while non­
significant improvement was expected for the placebo group.
Statistical analysis showed that there is a significant time 
main effect and no interaction between time (of the urine 
sample) and the week. There is a decrease of Urine Sugar 
levels for both groups over the 8 weeks for the 3 different 
time urine samples per week. Although this finding was
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expected only for the urine glucose levels in the 
experimental group, there is also a change in the placebo 
group.
This may be axplained because:
a. The researcher devoted the same attention and spent the 
same amount of time with both groups. However, it is 
possible that patients in the placebo group might have 
acquired compliance behavior i.e. dieting, keeping a daily 
record of Urine Glucose Levels, which somehow helped them 
(though feedback) improve their metabolic control as far as 
urine glucose is concerned. However , Bradley (1988) found 
that all the groups in her work significantly improved 
their urine glucose control whether or not they received 
relaxation training.
b. There are limitations in measuring urine glucose 
levels, because there is no direct way sensitive enough to 
the variations of urine glucose levels. The measurement of 
glucose can be used only as an indirect indication of the 
level of glucose in the urine. This notion is in agreement 
with the findings of Mayer (1983).
Although body weght was not controlled in this study, it is 
one of the dependent variables used although no strong directional 
hypothesis was based on it. Statistical analysis revealed one 
significant time main effect, between the pre and post- treatment 
measurements in general, for both groups. This finding 
suggestes that there is a drop of body weight for patients in 
both groups for the post-measurements. This might suggest 
that patients throughout thir training period kept a good
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control over their diet habits.
Medication was another dependent variable on which no specific 
hypothesis was formulated. However, there is a significant 
interaction between group and time factor for the morning 
short acting insulins. This finding may suggest that, there 
is a decrease of the dosage of short acting insulin over 
time for the experimental group, while there is an increase 
for the placebo group. Therefore, it can be said that 
relaxation training helped patients in the experimental 
group drop their short acting insulin dosage over time.
Furthermore, statistical analysis revealed that, in relation 
to the evening long action insulin, there is a significant 
group main effect. It can be observed that the dosage of the 
evening long acting insulin is higher for the placebo group 
as a whole than the dosage for the experimental group. This 
could be attributed to the fact that patients in the 
experimental group, during the evening dosage, take less 
long acting insulin compared with the placebo group.
It was also hypothesised that patients' physiological measures of 
Urine T2 for weeks 1 , 5 and 8 would correlate with certain items 
from Daily-Diary Check List and Mood Adjective Check List 
for the same weeks in the experimental and placebo groups.
The correlation between UrT2 and Q2 (Anxiety factor) from 
MACL showed that there is one negative correlation for the 
patients in the experimental group. Due to the direction of scoring 
on the anxiety variable, this relationship will be an indication of 
a majority of negative correlations. Therefore, when there is a low
score in urine (UrT2) then a high score on the anxiety reply and 
vice versa. A negative correlation suggests a trend which does 
support the notion that low UrT2 correlates with high anxiety. In 
fact, the overall ratio of negative to positive (13:10) does not 
support this notion and is in opposition to the findings from the 
previous study.
Present analysis for Q3 (Surgency factor) and UrT2 from MACL 
for the placebo group showed that there are two negative 
correlations and two positive. The direction of these 
positive correlations supports the notion of the hypothesis 
that UrT2 correlates with psychological ratings, in this 
case Surgency. However, Surgency is not a strong predictor 
since half of the significant correlations are positive and 
the other half negative. This is also born out by the almost equal 
negative to positive ratio of 6:9.
The analysis for Q4 (Elation factor) and UrT2 from MACL for 
the experimental group showed one negative correlation.
However, the direction of scoring for the elation factor 
indicates that this relationship will have a majority of 
positive correlations. Therefore, the present result 
indicates that the negative correlation show a general 
trend which does not seem to support the notion that UrT2 
correlates with the Elation factor. This is also born out by the 
negative to positive ratio of 11:6 which is consistent with the 
first study.
Furthermore, the analysis for Q7 (Social Affection factor) and UrT2
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from MACL revealed one positive significant correlation for the 
placebo group. The direction of this positive correlation seems to 
support the notion that UrT2 correlates with the Social Affection 
factor but the even negative to positive ratio 10:10 is less 
supportive.
Since almost all four analyses refer to very few statistically 
significant correlations and the results are not always consistent 
with those from the previous study one must be cautious not to 
overgeneralize from these results.
The present findings indicate that the interaction of groups 
and the time factor had significant changes for the 
variables of State Trait, Glycosilated Haemoglobion, High 
Density Lipoprotein, Cholesterol, Fructosamine and Daily 
Urine Glucose levels.
It could be strongly suuggested that these findings indicate that 
as a result of relaxation training levels of anxiety decreased over 
time and significant improvement is found in the metabolic 
parameters, over time for the diabetic patients in the 
experimental group relative to those in the placebo group. Although 
the attention factor, concerning the placebo group, was controlled, 
there was no significant improvement, at least for the main 
metabolic factors, for the patients in this group. The above 
results support the hypotheses stated for the present research and 
come in line with the findings of the first study, where 
patients in the relaxation group had significant changes for 
the dependent psychological and metabolic variables as 
compared with the patients in the control group.
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The above results are supported by the literature: Hartman
/
,r
(1982) and Bradley (1988). However, it could be suggested \
that the attention factor might have an influence on the s
/
significant results of the STAI scores and urine glucose 
levels.
Furthermore, the second part of the analysis i.e. the 
individual correlations between the urine glucose level and 
the ratings of emotional factors for the 1st, 5th and 8th 
week of the training period, showed some significant 
correlations, which suggest that for some individuals these 
expectations are viable. However, due to the few significant 
results revealed in this analysis, it is difficult to differentiate 
between the two groups.
One mechanism by which relaxation techniques may be beneficiant to 
glycaemic control is by reducing mood swings which in turn may 
reduce variability in skin blood flow and hence decrease 
variability in the absorption rates of subcutaneously injected 
insulin. There has been considerable interest in the role of skin 
blood flow and insulin absorption in accounting for subject 
variation in glycaemic control, but the effects of stress 
and stress management on these parameters have not been 
conclusive (Bradley, 1988).
The evidence presented above suggests that individuals 
differ in the extent to which they can benefit from stress 
management techniques. Although patients had relaxation 
training, adverse conequences (refers to the individual 
correlation data) were experienced by a minority of 
individuals. This finding is in agreement with those of
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Seeburg and De Boer (1980), who suggest that adverse 
consequences may be due to inappropriate inhibition of the 
parasympathetic nervous system activity at a time when 
there is no stress-induced sympathetic nervous system 
activity to counteract. However, positive benefits of 
relaxation are seen more often than negative, even among 
subjects with good glycaemic control prior to relaxation 
training (Landis , 1985).
Furthermore, it is interesting to add a more recent study, 
published by Cerpa (1989), after the present research was 
concluded. She had a relaxation , a placebo and a control 
group with War Veterans Type II diabetics and found similar 
results to the present study, i.e. only the patients in the 
relaxation group had lower measurements of anxiety and blood 
glucose levels compared to the other two groups.
/ ' \
Therefore, there are a number of possible mechanisms that 
can be indentified by which stress management may influence 
diabetes control. One such mechanism i.e. skin blood flow, 
which may be increased through relaxation training, may also 
result in more rapid insulin absorption.
As a final note, it could be added that the majority of the 
patients, who participated in the present study, reported to 
the researcher at the end of their training sessions that 
their emotional state had improved greatly over the 8 week 
training period. Patients who participated in the 
experimental group additionally referred to improvement in 
their metabolic state.
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CHAPTER 8 
FOLLOW-UP STUDY
8.1 Aims of the study
The follow-up was designed to test the long-term 
implications of the intervention, 18 months after the end of 
the second study. Specifically, the study examined whether the 
subjects in both experimental and placebo groups continued to 
maintain or improve their gains or alternatively deteriorate 
as reflected in measurements on the psychological and 
metabolic parameters.
HYPOTHESES AND PREDICTIONS
In view of the fact that the effects of the main study 
might not necessarily continue due to the fact that 
relaxation training is a self administered technique the 
follow-up study was developed in order to test:
a) whether the self-administered relaxation training 
continued to prove beneficial to patients in achieving 
control over their diabetes, physiologically and 
psychologically
b) the two groups (Experimental and Placebo) continued to 
differ significantly on the metabolic and emotional 
parameters.
The specific hypotheses may be viewed as between-group and 
within-group hypotheses. They may be formulated as follows:
A. Between-Group
Hypothesis-1: Patients with diabetes in the experimental
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group would:
a) have practised and incorporated the exercises in their 
daily routine
b) felt better control over their diabetes.
Hypothesis-la: Members of the placebo group would not have 
done the above and would have differed significantly from 
those of the Experimental.
Hypothesis-2: On all significant measurements of State and 
Trait Anxiety scales and Glycosylated Haemoglobin there would 
be significant differences between experimental and placebo 
groups.
B. Within-Groups
Hypothesis-3: Patients in the Experimental group who were 
classified as improvers in relation to their Trait and HbAlc 
measurements, would significantly differ from the patients 
who were classified as non-improvers.
Hypothesis-4: The post metabolic measurements of State, Trait 
and HbAlc, collected during the second study when correlated 
with the same parameters in the follow-up study, within each 
group, were expected to show that members of the experimental 
group would have continued to maintain their improvement 
while those of the placebo group would have remained the same 
or deteriorated.
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8.2 Measurements and Materials
The main measurement in the study of the follow-up was 
made by means of a questionnaire designed by the experimenter 
(see Appendix XIV) .
It was divided into two sections, the first being a checklist 
in which the participants gave their opinion of the long term 
benefits of the exercises and their effective control of 
diabetes and the second eliciting information of 
physiological measurement.
The State and Trait Anxiety Inventory (Spielberger, 1970) was 
also employed. Both the questionnaire and the inventory plus a 
covering letter, which informed the patients about the follow-up 
study, were posted to the 48 participants in the 2nd study, with 
a stamped addressed envelope for return.
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8.3 Subjects and Procedure
The subjects who participated during the second study, 
were approached in a uniform manner during the follow-up 
study and were followed-up at a period of 18 months. This was 
based on the generally accepted view (Gerard and Saenger, 
1959) that one year and a half follow-up is fairly 
satisfactory for conclusions to be drawn.
Of the 48 questionnaires which were sent out, 38 were 
returned. The attrition rate was 23% for the experimental 
group and 18% for the placebo group.
Concerning the experimental group one of the participants 
died, two moved to a different town, two did not reply at all 
and one replied after the present results were analyzed. In 
the placebo group one of the participants died, one moved to 
a different area and two did not answer at all.
Therefore, 80% of the subjects returned the completed 
questionnaire and anxiety inventory and that the rate of 
return was comparable in the two groups.
In addition, self reports of all metabolic measurements were 
solicited. However, only the Glycosylated Haemoglobin was 
successfully reported compared with the rest of the values 
which were not reported consistently by the participants. 
Therefore, HbAlc was the only metabolic measurement analyzed.
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8.4 Statistical Method
In the analysis of the Follow-up study, the independent 
variable of sex was used as a demographic characteristic 
only. The STAI scales were used as dependent variables, as 
well as the physiological parameter of HbAlc.
As mentioned in the previous section, respondents, 
gave information selectively concerning their physiological 
measures and the available data were too few for statistical 
analyses with Haemoglobin being the only exception.
Chi-squared tests were applied to the categorical data of 
the follow-up questionnaire to examine differences between the 
Experimental and Placebo groups. For the dependent variables of 
Trait and HbAlc, participants were divided into improvers or non­
improvers depending on the difference between pre- and post­
measurements (at the end of the second study).
Diabetic patients whose Trait anxiety decreased by 1 point or 
more at the post measurement were operationally defined by 
the experimenter as having moved in the direction of 
improvement. Furthermore, when the dependent variable of 
HbAlc dropped by 1 point or more at the post measurement 
patients were operationally defined as moving in the same 
direction.
In cases where the expected frequencies dropped below 5, then 
Fisher's Exact Probability Test was applied (Siegel,1956).
In addition, t-tests were performed, on the interval level data 
of the experimental and placebo groups for the dependent
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variables of State, Trait and HbAlc, measured during the 
follow-up study.
The Pearson's Product Moment Coefficient of Correlation was 
used to investigate possible significant relationships 
between the parameters of State, Trait, HbAlc, received at 
the follow-up study and the post measurements of the same 
parameters, measured during the second experimental study, 
within the Experimental and Placebo groups.
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8^. 5 Results
It was decided th&t tables with dichotomised data which 
was sparse was to be reduced to full-category, (see Appendix 
XV) .
Table 32 shows the frequencies of the Experimental and 
Placebo groups in relation to the first question of the 
follow-up, which is related to the memory aspect of the 
respondents, taking part in either the Experimental or the 
Placebo group.
Table 32: Categorical data in relation to Q1 (patients memory 
of participation) from the Follow-up questionnaire between 
Experimental/Placebo groups.
GROUPS
Q1 EXPERIMENTAL PLACEBO
YES 20 17
NO 0 1
TOTAL 20 18
Inspection of this table shows that all the respondents in 
the experimental group remembered participating in the 
relaxation exercises and almost all with the exception of one 
patient did recall taking part in the blood circulation 
exercises.
Fisher's Exact Probability Test revealed non-significant 
differences between the two groups, (P=0.47). It is evident that
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patients' Memory of Participation is not dependent upon the group 
they were assigned to.
Table 33 shows the frequencies of the Experimental and 
Placebo groups in relation to the second question of the 
follow-up check-list, which is related to how many patients 
still continue practising the exercises across the two 
groups.
Table 33: Categorical Data in relation to Q2 (patients' 
practising the exercises) from the Follow-up questionnaire 
between Experimental/Placebo groups.
GROUPS
Q2 EXPERIMENTAL PLACEBO
STILL PRACTISE
THE EXERCISES 10 5
STOPPED PRACTISING 10 13
TOTAL 20 18
It can be seen that in the experimental group half of the 
participants are still practising the relaxation exercises, 
while the other half have stopped using them.
A higher percentage of the patients in the Placebo group have 
stopped practising the exercises. However, a Chi-square analysis 
revealed non-significant differences (X2=1.9, df=l, p>.05).
Table 34 shows the frequencies of the Experimental and 
Placebo groups in relation to the third question of the 
follow-up, which is related to the frequency with which 
patients practise their exercises in either group.
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Table 34: Categorical Data in relation to Q3 (frequency of 
practising the exercises) from the Follow-up questionnaire 
between Experimental/Placebo groups.
GROUPS
Q3 EXPERIMENTAL PLACEBO
ONCE EVERY 
SIX MONTHS
ONCE A MONTH
ONCE A DAY 
ONCE A WEEK
0
2
3
5
1
2
0
2
TOTAL 10 5
Fisher's Exact Probability Test revealed non-significant 
differences (P=.49). It is evident from this table that Groups 
and Frequency of practising the exercises are not dependent.
Table 35 shows the frequencies of Experimental and Placebo 
groups in relation to the fourth question of the follow-up, as 
to when the participants stopped using the exercises across 
the two groups.
Table 35: Categorical Data in relation to Q4 (termination of 
exercises) from the Follow-up questionnaire between 
Experimental/Placebo groups.
GROUPS
Q4 EXPERIMENTAL PLACEBO
IMMEDIATELY AFTER 1 7 
FEW WEEKS AFTER 
ONLY RECENTLY
5
4
5
1
TOTAL
A Chi-square analysis revealed a significant difference 
(X2=3.9, df=l, p<.05) between the two groups.
This table shows that the termination of the exercises are 
dependent on the two different groups Experimental and 
Placebo. From the data it is evident that a higher percentage 
of patients in the placebo group stopped the exercises 
immediately after the 2nd experimental study was ended, 
compared with the patients in the experimental group.
A higher percentage of patients in the Experimental group 
stopped only recently the exercises, compared with that of 
the Placebo group.
Table 36 shows the frequencies of the Experimental and 
Placebo groups in relation to the fifth question, from the 
follow-up questionnaire, which is related to whether patients 
have incorporated the exercises in their every-day life.
Table 36: Categorical Data in relation to Q5 (incorporation 
of the exercises) from the Follow-up questionnaire between 
Experimental/Placebo groups.
GROUPS
Q5 EXPERIMENTAL PLACEBO
YES 11 5
ONLY AT THE
BEGINNING 8 8
DID NOT INCORPORATE 1 5
TOTAL 20 18
Chi-square revealed non-significant differences
(X2=2.7,df=l, p>.05). The present result shows that the two
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Groups and the incorporation of the Exercises are not dependent.
Table 37 exhibits the frequencies of the Experimental and 
Placebo groups in relation to the sixth question of the 
follow-up which reports the participants' feelings in 
relation to the control of their diabetes.
Table 37: Categorical Data in relation to Q6 (patients' 
control over diabetes) from the Follow-up questionnaire 
between Experimental/Placebo groups.
GROUPS
Q6 EXPERIMENTAL PLACEBO
A LOT IN CONTROL 12 5
A LITTLECONTROL 8 10
J. Ho BIT NOT BADLY . 0 3
I N O CONTROL AT ALL 0 0
TOTAL 20 18
Chi-square revealed a significant difference between the two 
groups (X2=3.9, df=l, p<.05). It is evident that patients' 
control over their Diabetes was dependent on the two different 
Groups. The data shows that a higher percentage of patients in 
the Experimental group feel in a good control of their diabetes, 
while a higher percentage of patients in the Placebo group feel 
in a little control of their diabetes.
Table 38 shows the frequencies of the Experimental and 
Placebo groups in relation to the seventh question from the 
follow-up questionnaire, which reports personal estimates of 
the participants in relation to whether the exercise had 
helped them to achieve control over their diabetes.
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Table 38: Categorical Data in relation to Q7 (whether 
exercises help achieve control) from the Follow-up 
questionnaire between Experimental/Placebo groups.
GROUPS
Q7 EXPERIMENTAL PLACEBO
EXERCISES HELPED 
ACHIEVE CONTROL 
DID NOT HELP
18 12
2 6
TOTAL 20 18
Fisher's Exact Probability Test revealed non significant
differences (p=.07). It is evident that Groups and the factor of 
whether exercises helped achievd control are not dependent.
In relation to the Chi-square analysis between the variables 
of Trait Anxiety scale and Glycosylated Haemoglobin (post­
measurements of the 2nd study), according to which patients 
were classified as improvers and non-improvers, and the 
personal responses to the follow-up check-list, it was 
decided to test the items which were related directly to 
patients incorporating the exercises and gaining control over 
their diabetes. Therefore, questions with the numbers 2,5,6, 
and 7, were selected.
Table 39 shows the frequencies for the improvers and non­
improvers for the variable of Trait Anxiety scale and the 
second question, which is related to the memory aspect of the 
respondents, from the follow-up questionnaire for the 
experimental group.
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Table 39: Categorical Data between Improvers/Non-Improvers of 
the Trait Anxiety scale and Q2 (patients' practising the 
exercises) from the Follow-up questionnaire, for the 
Experimental group.
EXPERIMENTAL GROUP
Q-2 IMPROVERS NON-IMPROVERS
STILL PRACTISE
THE EXERCISES 7
STOPPED PRACTISING 9
3
2
10
11
TOTAL 16 5 21
Fisher's Exact Probability Test on this table revealed non'
significant differences (P=.32).
Table-40 shows the frequencies for the improvers and
non-improvers for the variable of Trait Anxiety scale and '
fifth question, which is related to whether patients in the 
experimental group have incorporated the exercises in their 
every-day life.
Table 40: Categorical Data between Improvers/non-improvers of 
Trait Anxiety scale and Q5 (incorporation of the exercises) 
from the Follow-up questionnaire, for the Experimental group.
EXPERIMENTAL GROUP
Q-5
INCORPORATE THE 
EXERCISES
IMPROVERS
9
NON-IMPROVERS
11
ONLY AT THE 
BEGINNING
DID NOT INCORPORATE 
EXERCISES 2
TOTAL 16
2
21
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Fisher's Exact Probability Test revealed non-significant 
results, (p=. 0 6) .
Table-41 shows the frequencies for the improvers and non­
improvers for the variable of Trait Anxiety scale and the 
sixth question, from the follow-up questionnaire, which is 
related to the participants' feelings in relation to the 
control of their diabetes, in the Experimental group.
Table 41: Categorical Data between Improvers/Non-Improvers of 
the Trait Anxiety scale and Q6 (patients' control over their 
diabetes) from the follow-up questionnaire, for the 
Experimental group.
EXPERIMENTAL GROUP
Q-6
A LOT OF 
CONTROL
A LITTLE 
CONTROL
NOT BUT NOT 
BADLY
NO CONTROL AT ALL 
TOTAL
IMPROVERS
10
0
0
16
NON-IMPROVERS
13
21
Fisher's Exact Probability Test showed non-significant 
differences (P=.39).
Table 42 shows the frequencies for the improvers and non­
improvers for the variable of Trait Anxiety scale and the 
seventh question, from the follow-up questionnaire, which is 
related to personal estimates of the participants in relation 
to whether the exercises had helped them to achieve control 
over their diabetes for the experimental group.
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Table 42: Categorical Data between Improvers/Non Improvers of 
Trait Anxiety scale and Q7 (whether exercises help achieve 
control) from the Follow-up questionnaire, for the 
Experimental group.
EXPERIMENTAL GROUP
Q—7 IMPROVERS NON-IMPROVERS
EXERCISES HELPED
ACHIEVE CONTROL 13 5 18
DID NOT HELP 3 0 3
TOTAL 16 5 21
Fisher's Exact Probability Test showed non-significant 
difference (P=.42).
Table 43 shows the frequencies for the improvers and non­
improvers for the variable of HbAlc and the second question, 
which is related to the memory aspect of the respondents, 
from the follow-up questionnaire for the Experimental group.
Table 43: Categorical Data between Improvers/Non-Improvers of 
Glycosilated Haemoglobin value and Q2 (patients' memory of 
participation) from the Follow-up questionnaire, for the 
Experimental group.
EXPERIMENTAL GROUP
Q-2 IMPROVERS NONE-IMPROVERS
STILL PRACTISE
THE EXERCISES 8 2 10
STOPPED PRACTISING 8 3 11
--- --- ---
TOTAL 16 5 21
Fisher's Exact Probability Test showed non-significant 
differences (P=.36).
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Table 44 shows the frequencies for the improvers and non­
improvers for the variable of HbAlc and the fifth question, 
which is related to whether patients in the experimental 
group have incorporated the exercises in their daily life.
Table 44: Categorical Data between Improvers/Non-Improvers of 
Glycosylated Haemoglobin value and Q5 (incorporation of the 
exercises) from the Follow-up questionnaire, for the 
Experimental group.
EXPERIMENTAL GROUP 
Q-5 IMPROVERS NON-IMPROVERS
INCORPORATE THE
EXERCISES 7 4 11
ONLY AT THE
BEGINNING 7 1 8
DID NOT INCORPORATE 2 0 2
TOTAL 16 5 21
Fisher's Exact Probability Test revealed non significant 
results (P=.16).
Table 45 shows the frequencies for the improvers and non­
improvers for the variable of HbAlc and the sixth question, 
which is related to the participants' feelings in relation to 
the control of their diabetes, in the experimental group.
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Table 45: Categorical Data between Improvers/Non-Improvers of 
the Glycosylated Haemoglobin value and Q6 (patients' control 
over their diabetes) for the Experimental group from the 
Follow-up questionnaire.
EXPERIMENTAL GROUP
Q-6 IMPROVERS NON-IMPROVERS
A LOT OF
CONTROL 10 3 13
A LITTLE CONTROL 6 2 8
TOTAL 16 5 21
Fisher's Exact Probability Test showed non significant 
differences (P=.39).
Table 46 shows the frequencies for the improvers and non­
improvers for the variable of HbAlc and the seventh question 
from the follow-up questionnaire, which is related to personal 
estimates of the participants in relation to whether the 
exercises had helped them to achieve control over their 
diabetes, for the experimental group.
Table 46: Categorical Data between Improvers/Non-Improvers of 
Glycosylated Haemoglobin value and Q7 (whether exercises help 
achieve control) from the Follow-up questionnaire, for the 
Experimental group.
EXPERIMENTAL GROUP
Q-7 IMPROVERS NON-IMPROVERS
EXERCISES HELPED
ACHIEVE CONTROL 13 5 18
DID NOT HELP 3 0 3
TOTAL 16 5 21
Fisher's Exact Probability Test showed non-significant 
differences (p=.43).
T-tests were used, for two independent samples, to test for 
any significant differences on the dependent variables of 
State, Trait Anxiety scales and Glycosylated haemoglobin 
across the two groups, Experimental and Placebo.
The two tailed t-test for the State Anxiety Scale between the 
two groups revealed a significant difference (t=-2.50,df=36, 
p<.05), between experimental and placebo groups, during the 
follow-up study.
Table 47: t-test Analysis for the State Anxiety scale between 
Experimental and Placebo groups.
Number Mean Standard Standard
of Cases Daviation Error
Group 1 20 33.3 8.1 1.8
Group 2 18 39.0 5.3 1.2
Pooled Variance Estimate
t Degrees of 2-Tail
Value Freedom Prob.
-2.50 36 .017
Group 1 = Experimental 
Group 2 = Placebo
The two tailed t-test for Trait Anxiety scale revealed a 
significant difference (t=-2.67, df=36, p<.05) between 
experimental and placebo groups, during the follow-up.
Table 48 shows the t-test for the Trait Anxiety scale
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Table 48: t-test Analysis for Trait Anxiety scale between
Experimental and Placebo groups.
Number 
of Cases
Mean Standard Standard
Deviation Error
Group 1 20 34.8 7.08 1.5
Group 2 18 41.0 7.07 1.6
Pooled Variance Estimate
t
Value
Degrees of 
Freedom
2-Tail
Prob.
-2.67 36 .011
Group 1 = Experimental 
Group 2 = Placebo
The analysis of the HbAlc revealed non significant 
differences between the two groups (see Appendix XVI).
Correlation Coefficients between the parameters of State, 
Trait, Anxiety scales and Glycosylated Haemoglobin received 
as post-measurements, during the second study and the follow- 
up for both groups, were calculated, These analyses revealed 
only one significant correlation out of six, for the State 
scale in the Experimental group. This is positive 
(r=.44,df=20, p<.05).
The rest of the non-significant analysis can be seen in 
Appendix XVI.
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Discussion
One of the main hypothesis of the Follow-up study was 
that patients in the Experimental group would continue to 
have control over their diabetes in relation to their 
psychological and physiological parameters, while for the 
members of the Placebo group the above was not expected.
In relation to the above hypothesis the analysis performed on 
the follow-up check list across the two groups, revealed the 
following:
a) The frequency with which patients stopped using the 
exercises was different between the two groups. From the 
data it is evident that fewer patients stopped using the 
relaxation exercises immediately or few weeks after the 
program was. ended, compared with those of the placebo. 
Also, more patients in the experimental group stopped 
"only recently" to use the exercises compared with the 
placebo's.
b) The degree of control that parents have over their 
diabetes seems to be different in the two groups. More 
patients in the Experimental group felt in control of 
their diabetes compared with those in the Placebo group 
and fewer patients in the first group felt in "little" 
control over their diabetes compared to the Placebo's.
Thus, patients in the Experimental group reported having 
better control over their diabetes compared to those in the 
Placebo group.
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It was also hypothesised that participants in the 
Experimental group, who during the 2nd study showed 
improvement in their Trait and HbAlc scores, would continue 
to maintain improvement as well as practising the exercises 
and incorporating them into their daily routine.
To examine the data in terms of this main hypotheses, it was 
necessary to dichotomize patients of the Experimental group 
on the basis of their improved/non-improved status at the end 
of the intervention study (Experiment 2). Visual observation 
of the present data indicates that there is a trend 
supporting the above hypothesis. However, Chi-squares 
performed individually on all the above items as the follow- 
up questionnaire, across the dependent variables of Trait and 
HbAlc, did not reveal any significant changes. Thus, the 
degree of improvement does not seem to be related to:
a. the actual practise of the exercises on an on going 
basis;
b. subjective feelings of control over diabetes;
c. the use of the relaxation exercises, if required whenever 
under stress;
d. the control over their diabetes, through the use of 
relaxation exercises.
Concerning the self reported metabolic data, it was 
hypothesised that on the measurements of State, Trait and 
HbAlc the two groups would differ significantly.
The relevant t-test analyses revealed two significant
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differences out of three one for the State and the other for
( ; J
the Trait Anxiety scales between the experimental and placebo 
groups. The mean values, could suggest that the experimental 
group is distinctly superior.
A non significant change was found for the variable of HbAlc, 
although HbAlc was significantly different during the 
intervention study, between the two groups, this difference 
however, was not maintained for the follow-up study. A 
possible explanation of this finding could be, that half the 
members of the Experimental group (as it can be seen in the 
frequencies of the relevant question in the results' section) 
stopped applying the relaxation exercises between the time of 
the intervention and the follow-up study. However, the 
numerical data, show a tendency for HbAlc to drop for the 
Experimental group, but not significantly, over the 18 
months.
An additional hypothesis was that data on the metabolic 
measures of State, Trait and HbAlc collected during the 
second experiment would significantly correlate with the 
same variables collected during the follow-up study, for the 
experimental group. While for the placebo group these 
parameters were not expected to correlate significantly.
The statistical analysis revealed one significant correlation 
out of six for the State scale in the Experimental group. The 
analysis for the Trait scale and HbAlc showed non-significant 
relationships.
As expected non-significant correlations were revealed for
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the Placebo group for State, Trait Anxiety scales and HbAlc 
variable. The significant positive correlation, for the State 
Anxiety scales in the Experimental group showed that, when 
the score for the State scale (collected as a post 
measurement in the second study) was low, it correlated with 
a low State Anxiety score, (reported during the follow-up 
study) and vice versa. Therefore, this finding supports the 
hypothesis.
The fact that a non significant relationship was found for 
the Trait Anxiety scores between (the time of) the 
intervention study and the follow-up, was not surprising since 
Trait scores are expected not to change over time according 
to Spielberger (1974).
However, during the intervention study there was a 
significant drop in the Trait scale between the pre- and 
post-measurements. This, could be attributed to the 
procedures used, which may have influenced their subjective 
evaluation. In the case of Glycosylated Haemoglobin, it was 
also expected to correlate significantly, between the time 
of the 2nd and the follow-up study.
However, this relationship was not significant. As 
mentioned earlier, half of the patients stopped using 
relaxation exercises and this fact might have influenced the 
scores of the HbAlc over time.
Therefore, as far as the relaxation group was concerned, 
gains seemed to have been maintained through time, at least, 
as reflected in the psychological measurement of State
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Anxiety. As far as the placebo group is concerned, no such 
significant reduction was achieved even at the end of the 
intervention study, therefore, no changes were expected to be 
obtained at the follow-up.
It is interesting to mention that a major factor in 
maintaining treatment gains seems to be the degree to which 
patients (as well as therapists) recognise that changes are 
partially the result of effective patient effort.
For example, in a series of studies reported by the Johns 
Hopkins Psychotherapy Research Unit (as cited in Wilson et 
al., 1984), patients who attributed their improvement to 
medication (actually a placebo) were not able to maintain 
improvement, while those who understood improvement to be a 
result of their own efforts did maintain their gain (Frank, 
1976; Liberman, 1978). The findings are also consistent with 
maintenance of change in people who have psychosomatic 
problems such as tension headaches. Rather than long-term 
improvements resulting from a single course of treatment with 
biofeedback, those patients used relaxation techniques or 
cognitive coping strategies were able to maintain treatment 
gains after therapy had been terminated (Holdroyd and 
Andrarasik, 1982; Lambert, 1982).
Andrews and Harvey (1981) also found improvement to be stable 
over time. They concluded that improvement following 
treatment is stable for many months and then slowly declines, 
The patients follow-up rate at the 18 month assessment was 
80% (this figure does not include the two patients who died). 
In the present study,the present follow-up rate may be
regarded as a fairly large majority of the patients taking 
part in the study. It was reassuring to find a low attrition 
rate (20%) .
Attrition rate is a phenomenon that seems to occur with 
follow-up studies and is also supported in a book review 
(Wilson,1984),which mentions that attrition increases with the 
passage of time.
Potential sources of subject attrition which include, 
geographical relocation, lack of willingness to cooperate, 
death, inability to contact do not seem to apply to this 
sample. It is to be noted that higher attrition rates have 
been reported on comparable studies (La Porte et al., 1981). 
Furthermore, La Porte et al., (1981) tried to answer the
question of whether subjects who are difficult to follow-up 
have poorer treatment outcomes. He concluded that there is no 
difference in the outcome status of subjects more difficult 
to contact for follow-up and those who were not.
In the present study of those who replied, 10 patients did 
not reply to the follow-up questionnaire and to the STAI.
As mentioned in an earlier section, two of these subjects 
died and one replied after the present analysis was 
completed. Very little information could be obtained on the 
other 7 participants. Three of them had changed address and 
their general practitioners were not able to give information 
of their new residence. Of the remaining patients 4 did not 
reply at all, the reason for this drop out rate is not clear.
It is possible that these patients improved a great deal on
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their diabetes and felt there was no reason for them to 
answer, or similarly they did not improve at all and 
therefore, found no reason to be assessed.
This group of the 10 "drop-outs" were typical members of the 
group since:
a) they belonged to the same age group as the ones who
replied, e.g. the age of the drop-outs ranged between 25-
60 as compared to the respondents group which was between 
18-60,
b) they did not differ in the Type of their diabetes compared 
to the rest of the group, one of the 10 patients was type 
II and the rest type I,
c) in relation to their sex differences, 7 out of the 10 were
males as compared to the rest of the group of the 
respondents, who had 20 males and 18 females.
The ultimate goal of therapy is the permanent maintenance of 
improvement or recovery after the intervention period has 
been concluded. Follow-ups serve a very important purpose, 
because they show to what extent patients have been helped in 
a meaningful way and to what degree they have been able to 
maintain gains acquired during the intervention period.
Exclusive focus on long-term change has its potential 
limitations, one of them being attrition rate (Browell,1982). 
Unfortunately there is as yet no "magic pill" or simple 
insight that will bring about total improvement or 
recovery. Whatever improvement or recovery is achieved it is
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more likely to result from continued efforts on the part of 
the patient. There is reason to be optimistic in this 
respect, since evidence is accumulating of the lasting effects 
of therapy for some people.
What is needed is more research on the topic of maintenance. 
Specifically, clinicians and researchers should focus their 
attention on those parameters that help patients maintain the 
gains they achieved while in treatment.
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CHAPTER 9 
FINAL DISCUSSION
Chapter 9: Final Discussion
The findings of the studies reported in chapters 6, 7 and 8 
strongly suggest that relaxation training can improve 
emotional and metabolic control of patients with diabetes 
mellitus.
The general aims of this thesis were to identify ways of 
helping patients with diabetes mellitus to, firstly, learn to 
identify every day life stresses, which seem to account for 
raised blood glucose levels. Secondly to teach them to use 
relaxation training, which could ultimately help them control 
counter-regulatory hormones and to improve their metabolic 
and psychological control in general. Finally, to learn by 
using the above information to cope effectively with their 
physical disorder.
As has already been remarked in the literature review, the 
experience of a chronic physical disorder like diabetes can 
produce a daily stress for the patient who has to cope with 
his/her disease. This study has been designed to examine one 
method of alleviating this continuous level of hieghtened 
arousal.
Although patients in the present research were selected at 
least a year after being diagnosed and, therefore, their 
initial shock of discovering their diabetic status was no 
longer a salient factor, they still had to deal with their
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daily treatment routine and all its attendant stress. Usually, 
this consists of regular injections of insulin, a regular 
pattern of meals and a suitably adjusted life-style, for the 
rest of their lives. This long-term daily adjustment of 
routine appears to be a significant stressor for the patient 
with diabetes (Hartman, 1982).
Another component of stress that an individual can be faced 
with are the minor frustrations and annoyances in our daily 
lives. These common occurrences have been termed daily 
"hassles" and "uplifts" (Kanner et al, 1980). As has been 
suggested by McLean (1976), perhaps because the unit of stress 
is relatively small and the stressors so familiar, these kinds 
of stressors have been taken for granted and considered to be 
less important than more dramatic stressors. Clinical and 
research data indicate, however, that these 'micro-stressors', 
acting cumulatively and in the relative absence of 
compensatory positive experience, can be potent sources of 
stress. It is reasonable to suppose that patients suffering 
from a chronic medical disorder resistance to these micro­
stressors is reduced.
As Hinkle (1974) has suggested, major life events might owe 
their impact on health to the disruption of social 
relationships, habits and patterns of activity, as well as to 
some of the health related behaviours associated with them.
Therefore, major life events could operate by affecting
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the person’s pattern and number of daily hassles. 
Alternatively, as suggested by Kaplan (1979), they might 
operate through their affective significance for the person or 
by disrupting characteristic coping processes. They might even 
serve as a direct indication of how a person's routine is 
being affected by life changes and therefore be a better 
predictor of health status (Kanner et al 1980).
Individuals are expected to vary, however, in their access to 
resources. Some may have greater financial security, a 
supportive spouse, a large family network and a rewarding type 
of work. Others may have very few resources, being single, 
away from home, struggling with the job etc. The present 
study provided two potential resources to its experimental 
subjects:
a) help in appraising experiences as potentially 
stressful,
b) training in deep muscle relaxation.
These two resources were given in a constant fashion to all 
experimental subjects for the specified period.
Individuals with diabetes were taught to identify their 
stressors, and ultimately to reach the stage where they were 
able to recognise what was stressful and what was not prior to 
applying the relaxation exercises.
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Therefore, when a patient experienced stress and identified it 
as such, they could apply relaxation training. After deep 
muscle relaxation they may discover that they feel much better 
so it is more likely to identify the stressors next time and 
to apply the relaxation training and thus feel better. In 
effect, it is proposed that the sense of well-being after 
relaxation is a positive reinforcement for the patient to 
identify future stressor events and so effectively cope with 
them through relaxation. To ensure that, in fact, patients in 
the present study were using their resources and to check on 
the validity of the manipulation, the Diary Check List and the 
Mood Adjective Check List were administered to the patients in 
both experimental studies. Analyses of these variables did 
show that mood improved over time, for those diabetic patients 
who had undergone the relaxation training.
As to possible outcomes, the following possibilities are 
proposed:
a) The individual makes use of the suggestions to evaluate his 
or her state, through cognitive appraisal, prior to the 
intervention (relaxation training), which is now part of 
his/her material resources and therefore he/she succeeds in 
coping, thus leading him/her to a state of homeostasis.
b) The individual is successfully coping through already 
available external aided, not intervention related, i.e. 
family and social supports, and can, therefore, use these two
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resources independently or in combination so as to cope with 
his/her degree of stress in an adaptive fashion.
c) Although individuals may these resources available for a 
variety of reasons, they may fail to use them for coping 
purposes or do not have existing material or other 
psychological supports or both. In this case, the 
individual's metabolic and psychological states do not improve 
a condition which may lead him/her to experiencing a crisis.
In sum, applied to the present study, this reasoning is as 
follows.
Those subjects with diabetes in the Experimental group who 
utilized the relaxation technique were able to perceive and 
identify their muscular as well as their psychological 
tension. They can be classified as the ones who were able to 
cope and have better control of their diabetes. Those in the 
experimental group who had not learned to identify tension 
and, even if they did recognise it, did not use the additional 
resource could be classified as the ones who had difficulties 
in coping and achieving control over their diabetes. However, 
in the present study emphasis was placed on group analysis 
rather than individuals in order to evaluate the effects of 
stress and the efficacy of the therapeutic intervention. 
Therefore, little information is available on individual 
differences.
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Under this constraint only members of the Experimental group 
could have access to the relaxation training, patients in the 
Control and Placebo groups were more likely to be the non­
copers. The present findings seem to support this notion.
The extent to which the people with diabetes did or did not 
achieve control was evaluated by the pre-post differences of 
the psychological and physiological variables. In both the 1st 
and 2nd study, findings showed that patients who participated 
in the Experimental group had lower post-treatment scores for 
both parameters, compared with the post-treatment scores of 
those participating in the control and Placebo groups.
More specifically, the analysis of the 1st study revealed 
that, the psychological variables of State and Trait anxiety 
scales as well as the physiological variables of Blood Glucose 
and Glycosylated Haemoglobin, significantly dropped for the 
post measurements in the Experimental group, while the post 
measurements for the participants in the Control group, for 
the same parameters, did not significantly drop as compared 
with the pre-measurements.
The analysis of the 2nd study concerning the psychological 
parameter of Trait anxiety scale and the metabolic parameters 
of Glycosylated Haemoglobin, Fructosamine, Cholesterol and 
Blood Glucose levels, revealed significant reductions for the 
post-measurements in the Experimental and not for the Placebo 
group. Concerning the variable of High Density Lipoprotein the
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analysis revealed a significant increase for the Experimental
come in line with the hypotheses raised for the present 
research.
Consistent with these findings are the results of the 
follow-up study. Once again coping, as reflected in the 
psychological and metabolic easurements, was superior for the 
Experimental group.
Relaxation training as an additional resource, therefore, had 
a lasting and enduring effect for moot of the Individuals with 
diabetes in the experimental group. This point is further 
substantiated by anecdotal reports from the majority of the 
patients participating in the experimental groups who reported 
that they felt more relaxed after the program was completed 
and that they had generalized their relaxation response to 
other stressful situations.
At this point it is important to recognise some methodological 
issues that occurred in the present study.
In the first study, there was a major weakness in the design 
which was due to practical constraints placed upon the 
researcher by the clinic where subjects were recruited. 
Patients had been assigned to an experimental or a control
ft
group before^|hey were told about the study. Furthermore they 
were given different information about the study depending on
Furthermore all these findings
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what group they had been assigned to. Therefore the reasons 
why experimental group subjects agreed to take part in the 
study might not have been the same as the reasons why control 
group subjects agreed to take part. It can be said that 
effectively they were agreeing to take part in different 
studies. Even if all the subjects had agreed to participate we 
would still not be sure that if they had been assigned to the 
other group they would not have declined. Therefore, it is 
likely that different kinds of subjects might agree to 
participate in the monitoring only group from those who agreed 
to participate in the relaxation group.
In practice the groups probably were not influenced greatly 
by the design. However, for reasons that may or may not be 
related to this design problem, there were differences between 
the groups at baseline in a number of variables, i.e. the 
experimental group started with higher HbAlc levels than the 
patients in the control group. This problem has been 
recognized and has been mitigated by emphasising the 
interaction effects where differential change becomes the 
major focus.
A third problem that occurred with this design was the 
possibility that the different levels of interaction between 
the experimenter and the two groups might have influenced the 
results.
All the above problems had been recognised in study one and
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attempts were made to reduce any biasing effects in study two.
In the second study the design fault of study one was 
corrected by giving written Information to the subjects prior 
to their selection. Therefore, in this way we eliminated the 
possibility of having different subjects agree to participate 
in the placebo group from those agreeing to participate in the 
relaxation group.
Although this methodological issue was taken care of, we still 
found baseline differences in a number of psychological and 
physiological variables. Again in this case the proper focus 
were the interaction effects so these initial differences were 
of less direct importance. However, it may be suggested that 
these present baseline differences were independent of the 
aforementioned design problem.
Given that the research reported here describes what are 
essentially field studies, it is not particularly surprising 
that initial differences occur. This lack of perfect control 
is counter balanced by the benefit of using a rather larger 
sample than would have been feasible in a strictly 
experimental study. Nevertheless, it is an important proviso 
for the present study and makes the interpretation of simple 
main effects more difficult.
In order to eliminate the different levels of interaction
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a placebo group was employed in which blood circulation 
exercises were taught as a placebo treatment. However, it 
could be suggested that blood circulation exercises could 
have been a non-effective placebo treatment since there is a 
possibility to increase skin blood flow and thus to influence 
insulin absorption. However, we believe that the influence of 
these exercises on insulin absorption, could only be minimal, 
since they were not vigorous enough to enhance this effect.
An important point related to the present research is the fact 
that both research studies gave emphasis to group changes 
rather than individual differentiation. In this way important 
information on individual variability was not available. In 
the present study for example the information obtained from 
the individual correlational analysis revealed considerable 
variation in response to relaxation treatment. As discussed in 
chapter 7, this could suggest that relaxation training was 
least useful for those subjects whose glycaemic control was 
good to start with and most useful when used by subjects who 
not only had poor control of diabetes but also felt that 
stress was a factor in disrupting their control.
9.1 Conclusions and Suggestions for Future Research
From the foregoing discussions the following conclusions can 
be drawn:
a) The aim of the intervention to reduce anxiety levels
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and have an impact on diabetes was realised.
b) These two studies show that in the management of 
diabetes, there is a role for relaxation therapy, 
because the effect of relaxation therapy an diabetes 
was distinguishable from the "non-specific attendance 
Factor", which was in existence for the placebo group.
c) It can be additionally suggested that the most likely 
area in which relaxation therapy can have an influence 
is in coping with stress. Although stress may not be 
entirely responsible for inducing diabetes, however, 
it could precipitate it and increase the strength of 
its symptoms.
d) The Findings of this study could serve as a catalyst 
which might Influence medical professionals and health 
care providers to utilize and study relaxation 
techniques as an adjunct to the medical treatment of 
diabetes. Furthermore, the present study adds to the 
existing research studies and constitutes an extension 
of existing evidence.
The results of both psychological and physiological variables 
obtained during the post-treatment period show that patients 
have reasonably good control over their diabetes as a result 
of the intervention. These post-measurements could be used as 
an a-priori prediction and then checked at six, twelve and
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twenty four months reassessment stages. These screening 
procedures will enable Future research to concentrate on 
different samples to the one used in this study (eg., 
diabetics suffering from Coronary Heart Disease problems).
The present researcher is aware of the possible affects of 
experimenter bias (Orne, 1982; Rosenthal, 1963; Rosenthal 
and Fode 1963). However, every reasonable precaution was 
taken, at every step of the study, to forestall possible 
contamination. Even so, there is no way of being absolutely 
certain that no other underlying variables such as possible 
motivation and enthusiasm, no matter how well controlled and 
subdued, did not influence the patients in their frequent 
interaction with the researcher. This is inevitable whenever 
researchers find themselves in the treble roles of designer, 
executor and evaluator of any research undertaking. It serves 
to emphasise the need for constant vigilance during the 
experimetal process for possible sources of systematic bias.
The analyses reported here have suggested possible extensions 
for subsequent research. One such would be to conduct a 
series of multiple measures of psychological and physiological 
parameters during each of the eight weekly sessions, in order 
to graph the changes. It might be, for example, that the Blood 
Glucose Levels progressively become lower with each relaxation 
session or that a specific number of relaxation sessions is 
necessary before a change occurs. It is also possible that 
there may be a specific point in the intervention beyond which
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the relaxation training sessions does not produce additional 
changes in Blood Glucose Levels.
In terms of future studies, it will also be interesting to 
investigate more systematically the role of material, family 
and social well being as well as perceived locus of control, 
self concept and positive thinking.
One clear indication for future research is an evaluation of 
the effects of stress and the efficacy of therapeutic 
intervention at the individual level. This could allow us to 
understand why some individuals in the present study continued 
to practice the relaxation exercises until the follow-up study 
and why others failed to do so. This point has been made 
forcefully by Bradley (1980) who states that 'by focusing 
attention on individual differences and working within a more 
complex model of relationships between stress and diabetes 
control we can begin to identify individuals for whom stress 
management is included as a useful addition to their diabetes 
treatment regimen'.
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A p p e n d ix  I : ( a )  I n s t r u c t i o n s  an d  t e s t  i te m s  o f  fo rm  X-1 o f  t h e  
S t a t e - T r a i t  A n x ie t y  I n v e n t o r y .
SELF-EVALUATION QUESTIONNAIRE
D ev e lo p e d  b y  C. D . Sp ielberger, R . L. G orsuch and  R . L u sh en e
s t a ! f o r m  X-1
N A M E   ------------------------------------------ :_____________________ DATE_-_______ .__________
DIRECTIONS: A number of statements which people have 
used to describe themselves are given below. Read each state­
ment and then blacken in the appropriate circle to the right of 
the statement to indicate how you feel right now, that is, at  
this moment.  There are no right or wrong answers. Do not 
;pend too much time on any one statement but give the answer 
,vhich seems to describe your present feelings best.
1. I feel ca lm ......................................................................................    ® ® © ©
2. I feel secure .......................................................    © @ © 0
3. I am tense  ...............................................................................................................  © ® © ©
4. I am regretful  ................     CD ® @ ©
.7. I feel at ease ............................................................................... .............................
(>. 1 feel upset  ......................................................................    (D CD ® ©
7. I arn presently worrying over possible m isfortunes   © (?) • © ©
8. J feel rested .....     Q) CD CD ©
9. I feel anxious ................................... ......... ........... ............................................. .
0. 1 feel comfortable...................... ..... ....................................................................... .
1. I feel soil-confident ..................................... ..................................................
2. I fool nervous ................................      © © CD
'L I am jittery .... .       CD ® CD ©
4, I feel “high strung” ................. .................................................. ............. .............
rK I am relaxed  ................ ........................................................... ............................
A I feel content ..........................    ©
7. J. am worried          © ® © ©
i. I foci over-excited and “rattled”-          © ©
A I feci joyful ...............................      -............ .............. .............. ..............
). T feel pleasant...................................................      •. .....
)!«>■' .  CO NSULTING  PSY C H O L O G IST S P R E S S
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© © ©
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© © ©
09 © 0)
© (?) © 0)
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© • ©
© CD CD
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0) © © 0
CD © v®
© © (i)
© ©
© '. CD (j» ©
© © CD 0
CD © ©
CD ©
CD © ©
© © CD ©
© © © ©
Appendix I:(b) Instructions and test items of form X-2 of the
State-Trait Anxiety Inventory.
STAl FORiVi X-2
N A M E ___________________________________________ DATE
•D IR EC TIO N S: A number of sta tem en ts which people have
used to describe them selves are given below. R ead each sta te ­ >
m ent and-then blacken in the appropriate circle to the right of 5
V
o
the statem ent to indicate how you g e n e ra lly  feel. There are no o O n
right, or wrong answers. D o not spend too m uch tim e on any O
one statem ent but give the answer which seem s to describe § 3how you generally fool. b
WV. VI
21. I feel p le a sa n t ..................................................................................................................... © © © ©
22. I tire quickly .................. ...................................................................................................... <D © ©
22. I feel like c r y in g ...... ..................................... ....................................................................... 0 © © ©
24. T wish I could be as happy as others seem  to b e ................................. ................... © © ©
25. 1 am losing ou t on things because I can’t m ake up m y m ind soon enough .... (D © ©
26. I feel r e s te d .................................. .......................................................................................... (D © © ©
27. I am “calm, cool, and co llected ” ... ........................... ............................................. . © © (j; i'd
28. I feel that difficulties are piling up so th a t I cannot, overcom e th e m ........... CD Cl) ©
29. 1 worry too much over som ething that really doesn't, m a t te r ......................... CD © ©
80. I am happy .................................................... .............................. ............... ................ ......... CD (V ©
31. I am inclined to take things hard ......................................................................... . © © © ©
32. 1 lack se lf-co n fid en ce ...................................................................................................... CD (i> (is) i* ■
28 T fee! soomre (7\ (2' hi-
34. I try to avoid facing a crisis or d ifficu lty ..................................... ........ .......... ......... CD © t?.’ ©
35. I feel blue .................................... ................................. ....................................................... © ®
36. I am content ..................................................................... ........ ............. -............ <D < 2 i (h
37. Som e unimportant; th ou gh t runs through m y m ind and bothers m e ..... . ... CD (?) © ©
38. I take disappointm ents so keen ly  th a t I can’t  put them  out of m y m ind ... © © fV: ©
39. I am a steady person ...................................................... ....... .......... ................................ CO C.D tv CD
*10.  ^ got in a s ta le  of tension or turm oil as I th ink over m y recent concerns and
interests ................................................... © U: © CD
( . 'o p y n i’h t c o  p.niH by  d i a r i e s  J.). S pie lberger .  I t r  p ro d u c t io n  of th is  teat or  a n y  port ion  
ttnaun,f b y  n a y  process  w ithou t w r i t te n  perm iss ion  of the  P u b l ish e r  h  p ro h ib i ted .
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Appendix I: (c) Scoring system of the State-Trait Anxiety
Inventory.
ITEMS SCORED DIRECTLY 
SUBSCALES TEST ITEMS
STATE SUBSCALE 3 4 6 7 9 12 13 U  17 18
TRAIT SUSCALE 22 23 25 28 29 31 32 34- 37 38 40
ITEMS SCORED IN A REVERSE NAY 
SUBSCALES TEST ITEMS
STATE SUSCALE 1 2 5 1 0 1 1 1 5 1 0 1 9  20 
TRAIT SUBSCALE 24 26 27 30 33 35 36 39
t
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Appendix II: Instructions and test items of the 
Mood Adjective Check-List
Each of the following words describes feelings o r  mood. Please use the lis t to de­
scribe your feelings at the moment you read each word. If the word definitely de­
scribes how you feel at the moment you read it, circle the double check (w ) to the right 
of the word. For example, If the word is  relaxed and you a re  definitely feeling relaxed 
a t the moment, clrclfe the w  as follows:
relaxed (vv) v ? no. (This means you definitely feel relaxed at the moment.)
If the word only slightly applies to your feelings at the moment, circle the single 
check v as follows:
relaxed w  (v ) ? no. (This means you feel slightly relaxed at the moment)
If the word is not c lear to you o r you cannot decide whether or not It applies'to your 
feelings at the moment, circle the question m ark as follows:
relaxed w  v (? )  no. (This means you cannot decide whether you a re  relaxed
o r no t)
If you definitely decide the word does not apply to your feelings a t the mom ent 
circle the no as follows:
relaxed w  v ? (u?) (This means you a re  definitely not relaxed at the moment.)
Work rapidly. Your f irs t reaction Is b e s t  Work down the firs t column, then go to 
the n ex t Please mark all words. This should take only a  few minutes. Please begin.
angry vv v ? no
clutched up w  v ? no
carefree vv v ? no
elated w  v ? no
concentrating w  v . ? no
drowsy w  v ? no
affectionate w  v ? no
' regretful w  v ? no
dubious w  v ? no
boastful w  v ? no
active vv v ? no
defiant w  v ? no
fearful vv v ? no
playful w  v ? no
overjoyed w  v ? no
engaged in thought w  v ?
sluggish w  v ? no
no
kindly w  y ? no
sad w  v ? no
skeptical w  v ? no
egotistic w  v ? no
energetic w  v ? no 
rebellious w  . v ? no
jittery  w  v ? no
witty w  v ? no
pleased w  v ? no
Intent w  v ? no
tired w  v ? no
warmhearted w  v ? no
■ sorry  w  v ? no
suspicious w  v ? no
self-centered w  v ? no
vigorous w  v ? /no »
Scoring system of Mood Adjective Check-List 
ITEMS SCORED IE A REVERSE MAY
VV V ? no = 4 3  2 1
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APPENDIX III:Instructions and test item of the Daily-Diary 
.y Diary-Card Name:
h 'day please put a tick next to the answer Date:
ch best describes your feelings.
Check
List
r day was A) Extremely Relaxed
-CO
Definately Relaxed
Neither Particularly Relaxed 
or Stressed 
"Sbnfewliat''“sltressecl
i21
i c
SP
.d you keep to 
diet today
Definately "Stressed" 
Exfn^ 
cry I)epres’sxvd" 
Fairly Depressive 
‘SaTisfactory””
P a i r Xy CheerfuI"".
Very "ITheef f ii 1
1. Yes very strictly
2. Yes more or less
3. No but not badly
4. Hot at a.ll
 JLb)
— S k i-
 _ . _ o i
 1 2 l
  B.i
_cal
(5)
M. T. W. T. F.
I. Inactive
i would you
.be your phy- ■ I LITE ” 7
| 2 : Slightly active
activity today iy," .  ‘ :
• : .3. verv active
S. M. T, W. T. F.
r— r
you practise | 
*
exercises today!
[
what, time did ■
1. Yes
2. No
3. A little
art listening i . -
I Please write the actual
iur
. J . . .
rii-t**
 4.
cassette. i
i tim e.
hat time did |i
n off your jPlease write the actual
e. (time.\      _
many hours sleep A lot
it get: last: {hours of sleep approximately
Iverc" "little
{hours of sleep approximately 
•Just the right amount 
hours uL sleep approximately
-i-H—
. . . J —
j__ L
1
I
.I- -JL
— .JL
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Appendix IV: Daily Recordings of Urine Glucose Levels 
Urine Sugar Sample
Morning Sample
(When you wake up)
Afternoon Sample
(Two hours after lunch) 
(approximately)
Evening Sample
(Before going to bed)
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A p p e n d i x  U =  R e l a x a t i o n  E x e r c i s e s
a) Part One : Tense and Relax
You will soon be able to tell your whole body to let
go, to relax in the same way you told your arms to relax a
•Few moments ago.
Notice the heaviness in your arms, the warm, heavy 
■Feeling that comes when your arm muscles are relaxed. File 
away in your mind whatever it was you did to cause that sen­
sation of relaxation and enjoy the good Feeling as the ten­
sion leaves your arms. As they become more relaxed, they 
will begin to Feel warmer and heavier.
To Feel tension in the muscles in the back oF your neck 
and shoulders, stretch your arms out to the side and hold 
them there (pause). With time they will become very heavy 
and the muscles across the top oF your shoulders will become 
tired and Fatigued (pause 10 seconds). When you are aware oF 
this sensation, let go and Feel the good Feeling, the warm 
Feeling in your muscles as tension is replaced by relaxation 
(pause)=
Move the points oF your shoulders Forward and together; 
Feel the muscles tighten slightly From the points oF your 
shoulders down to your breast bone (pause). Now relax them 
(pause). Let go and relax. Feel a wave oF relaxation spread 
around your shoulders as the tension leaves all oF these
A . 8
muscles (pause).
Push your head backwards against the back o-F your chair 
or mat (pause). Feel the muscles tense somewhat down the
back oF your neck (pause). Now let your whole neck relax.
Let the muscles in your neck relax so deeply that iF a
breeze came along it would blow your head From one side to 
the other like a leaF on a tree. Make it Feel almost as 
though you had no bones in your neck. Just let the chair or 
cushion support your head. The chair can take Full respon­
sibility For holding it up (pause).
Leaving your neck relaxed and working From your 
shoulders down to your pelvis, try raising your back
(pause). Arch your back a little (pause). Feel the muscles
along your spine work as you slightly tense them (pause). 
Now, relax and sink back into the chair or mat and allow 
yourselF to simply be supported by it. Let yourselF sink 
deeper and deeper into the chair as your muscles become more 
and more relaxed.
Each time you do one oF these exercises, notice what 
you do to relax your muscles. Jot away in your memory the
Feeling oF tension leaving. It is this Feeling that you will 
soon be able to control. You will eventually be able to 
recreate or turn on this Feeling oF relaxation without First
creating tension in your muscles For contrast (pause).
Next tighten your buttocks. This is an easy set oF 
muscles to Feel because it includes the largest muscle group 
in your body (pause). Relax and sink back into yoiir chair
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(pause). Next, tighten all oF the muscles in your thighs 
just enough to become aware oF some tension (pause). Study 
the pattern oF tension (pause). Now let go and pay attention 
to the warmth in them as tension is replaced by a good Feel­
ing as they become more and more relaxed (pause). Feel these 
muscles—gradually stretch and lengthen, smooth out, expand, 
and relax (pause).
Move your toes downwards in a direct line with your 
shin bone and Feel the tension in your calves (pause). Note 
the pattern oF tension as the muscles become a little tense 
(pause). Now let go and relax (pause). Point your toes up 
toward your head and Feel the muscles work in the Front oF 
your legs, (pause) and relax (pause).
Make a Fist with your toes by curling your toes under 
your Feet. Feel the muscles work under your arch (pause), 
and relax. Feel those muscles smoothing out and relaxing.
By now, you are beginning to be very relaxed From your 
neck and head to the tip oF your toes. Continue to let all 
oF vour muscles relax more and more while we work on a Few 
additional muscle groups (a minute pause).
Now, slightly tense your abdominal muscles (pause). 
Study the pattern oF tension in your abdominal wall. Feel 
the tension in all those muscles as they work (pause), and 
then relax (pause).
For the remainder oF the relaxation tape, rest your 
head on the back oF the chair and try to get as comFortable 
as possible.
A. 10
Raise your eyebrows and wrinkle your -Forehead- This 
will help you -feel the tension from your -Forehead, up to the 
top o-F your scalp- Don’t wory i-F you can’t -Feel this im­
mediately- For some people it is a very diF-Ficult muscle to 
sense- Now let your -Forehead relax- Just -Feel it smoothing 
out and enjoy that good kind o-F creeping sensation as the 
muscles in your -Forehead and scalp relax- Once more, raise 
your eyebrows and try to touch the top of your head with 
them- Feel the muscles at work (pause). Now, let the tension 
Flow out. Just enjoy the good Feeling as your Forehead 
relaxes- Let it smooth out, and relax deeper, and deeper 
(pause) .
Now try to pull your eyebrows together across the top 
oF your nose and make a Frown (pause). Feel the muscles work 
as your eyebrows are pulled together- It almost makes you 
Feel angry to mimic the Frown oF an angry person- Now let it 
go all the way, and Feel that angry Feeling dissipate and be 
replaced by a warm Feeling oF relaxation in those Facial 
muscles (pause).
Next, gently close your eyes iF they are still open- For the 
remaining relaxation exercises, please leave your eyes 
closed- This will help you attend to the sensations in the 
muscles oF your Face, and become more relaxed without the 
interFerence oF visual patterns or distractions- IF you Find 
sitting with your eyes closed uncomFortable, open then For a 
second to get your bearings, and close them again- Try to 
keep them closed as much as possible-
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The muscles that control the movement o-F your eyes are 
among the most precise in your body. They have many nerve 
endings that sense exact levels o-F tension. This enables you 
to coordinate your eye movements. To become aware of your 
eye muscles, try to look at the top o-F your nead with your 
eyes shut. Look upwards with your eyes closed (pause). Hold 
this tension -For a -Few seconds, and then relax by returning 
your gaze to center. Repeat this. Look up and -Feel the ten­
sion (pause), then return your eyes to rest and -Feel the 
tension leave your eyes (pause).
Now, with your eyes still closed, pull your Tips back 
and show your teeth, as though you were going to brush them. 
You will -Feel two muscles when you do this exercise; one 
li-Fts up the middle o-F your lip and the other pulls back the 
corners o-F your mouth. Feel these muscles tense a bit as 
they work (pause). Now relax and observe the sensation oF 
tension leaving these muscles; the good Feeling as the 
muscles relax (pause).
Your jaw muscles are among the most powerFul muscles in 
your body. When they are tense you can actually hear the 
tension. Slightly clench your teeth, Feel the muscles work. 
Feel the tension spread up into your temples, and attend to 
the Feeling oF tension in your jaw bones and teeth (pause). 
Now, let go and Feel a wave oF relaxation spreading through 
these muscles. Feel the relaxation as tension is taken oFF 
your teeth and oFF your jaw. Enjoy it (pause).
Now I want you to practice a different kind oF breath­
ing For the remainder oF the exercise. Use your muscles only 
to breathe in, hold your breath brieFly to sense the tension 
in your chest, and then let the air Flow out passively by 
simply letting go and relaxing. Breathe a little more deeply 
and a little bit more slowly than usual. Each time you 
breath out, with each exhalation, say the word "relax" to 
yourselF. Let this exhalation be a signal to relax every 
muscle in your body. You will Feel a sense oF relaxation in 
your chest, between your ribs each time you let go. With 
each exhalation let this Feeling oF relaxation spread 
throughout your chest, around to your backbone, up your 
spine, into your neck and head, and down From your chest to 
your abdomen, legs, and Feet. With each exhalation you 
should become more relaxed and driFt more and more into a 
state oF total quiet.
It may help to use a square pattern oF breathing. 
Breathe in while you count slowly to Four (pause), hold your 
breath to a count oF Four (pause), breathe out on a count oF 
Four while-saying "relax", hold your breath out For the same 
count. Breathe in (Four second pause), hold your breath 
(Four second pause), breathe out while saying "relax", etc. 
IF you continue this regular pattern oF breathing, you can 
become more relaxed than you have ever been in your liFe.
While you are doing your breathing exercises, attend to 
the sensations that are coming From your muscles. IF you 
Find some residual tension, search around to try and Find a
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switch to turn it oFF. Try to achieve release From the 
residual tension by simply letting go. With time this will 
be your way oF relaxing. Without tensing First, you will be 
able to let go progressively and became more and more 
relaxed. When you Feel anxiety coming, breathe slowly and 
with each exhalation, say "relax", and let the tension go.
To increase your overal1 Feeling oF relaxation I am 
going to count backwards From 10 to zero. With each count I 
would like you to become a little bit more relaxed and per­
haps a little bit more drowsy; a little bit more sleepy, but 
not quite asleep. Ten (pause), 9 (pause), 8 (pause), 7
(pause), 6 (pause), 5 (pause), 4 (pause), 3  (pause), 2
(pause), 1 (pause), 0 (pause).
Now just continue relaxing like this, deeper and 
deeper, and let the Feeling oF relaxation permeate your en­
tire existence. Stay relaxed in this dream-like state For 
another Few minutes. Enjoy it and take it with you.
A. 14
Appendix V Continued
b) Part Two : Relax Only
Get comFortable in your chair, loosen any tight cloth­
ing, and as I count backward From ten to one, try to get go 
oF your tension without First contracting your muscles. Ten 
(pause), 9 (pause), 8 (pause), 7 (pause), 6 (pause), 5 
(pause), 4 (pause), 3 (pause), 2 (pause), 1 (pause).
Continue relaxing while I ask you to check diFFerent 
segments oF your body For residual tension. Don't worry iF 
you don't Find any tension. Keep relaxing as I talk. IF you 
do Find an area is tense, try to let that Feeling Flow away 
From those muscles. IF necessary, tense them brieFly to get 
in touch with the tense Feeling, and then let go (pause).
First, check your Forehead (pause). Let it smooth out. 
Let the Furrows in your brow Flatten out and the tensions 
leave that part oF your Face (pause). Feel the lack oF ten­
sion in your eyebrows. Let this Feeling spread to the 
muscles around your eyes, to your eyelids, and eye muscles, 
and then Flow down into your cheeks, lips? and tongue 
(pause). Let your jaw hang slack and allow the relaxed Feel­
ing to spread up into your temples (pause). With those 
structures relaxed, imagine yourselF humming a very low note 
(pause). Let the low restFul vibrations oF your voice relax 
your vocal apparatus and your throat (pause). When tension 
leaves this area, along with it go many oF the disturbing
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thoughts that people repeat over and over to themselves 
(pause).
Let your neck muscles go limp. Let your head and neck 
be supported by the chair (pause). Let the tension go From 
your neck muscles on the right, From the leFt, the Front, 
and back (pause). Let your shoulders droop and give up their 
load; the chair can take responsibility For supporting your 
body (pause) .
Relax your shoulder blades, and allow that good Feeling 
to spread over your shoulders into your arms. Forearms, and 
hands. Let them sink more and more heavily onto the arms oF 
your chair (pause). Allow your relaxed Feeling to spread 
From your shoulders and neck down your spine to your but­
tocks (pause). Be aware oF the support oF your chair and how 
comFortable it is to be passively supported (pause).
Let the Feeling oF relaxation go on down your legs and 
calves. Your Feet can rest on the Floor and any residual 
tension will Flow out oF them (pause).
Now, check your abdominal muscles (pause). Relax any 
tension you Find there. Try to pay attention to the varying 
abdominal sensations as you breathe in and out, all oF the 
time letting go oF any tenseness you Feel (pause).
Relax your chest and breathing muscles (pause). When 
you breath in (pause), Feel the tension in the muscles be­
tween your ribs. When you hold your breath, this tension in­
creases (pause), and when you breath out, this tension 
vanishes (pause). With each breath out, you can Feel the
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tension in your chest and throughout your body decrease 
(pause). IF any tension remains in groups oF muscles, let it 
go. These muscles, and the smooth muscles in your body that 
govern your digestion and blood pressure will all relax with 
time.
Finally, with each exhalation say the word “relax" to 
yourselF, and allow yourseIF. to become more and more calm 
(pause). As I count backwards From ten to one, take a deep 
breath and slowly let it go with every other number. Each 
time you exhale, say the word “relax" to yourselF. Ten 
(pause), 9 (pause), 8 (pause), 7 (pause), 6 (pause), 5
(pause), 4 (pause), 3 (pause), 2 (pause), 1 (pause).
Enjoy the heavy, warm Feeling that comes with relaxa­
tion. Enjoy the time out From the tension oF every day liFe 
(pause). With practice, you will be able to achieve this 
state by pairing a Few deep breaths with the word "relax". 
Try it when you are waiting For red lights, appointments, 
telephone calls, or when you are Feeling tense. It is a 
skill you can use in any situation. (Pause 10 seconds).
Continue to permit the rest and relaxation... to 
develop all over. Feel that good, heavy Feeling now... Try 
to Feel comFortable sensations oF warmth Flowing through 
your entire body. Feel the serenity, an enjoyable Feeling oF 
being enveloped by restFullness, heaviness, warmth, so that 
nothing can disturb you. Feel this inner restFulness deepen­
ing. Feel as you relax and get these sensations that you 
will gain strength and conFidence From this inner restFul-
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ness. Feel the muscles yielding, relaxing all over... con­
tractions loosening... Try to Feel more at rest... Let your 
breathing come easily arid Freely without any eFFort. Try to 
capture the Feeling that, as you relax now, nothing would 
excite-you, nothing would upset you. Just concentrate on the 
Feelings oF relaxation... Try not to pull back From relaxa­
tion, try to surrender to the good Feelings all over... (10 
secs).
Now, you should be ready For word connections. Hear the 
word CALM... think about this word Fully, now... CALM and 
Feel it more and more... Just let this word reverberate, 
CALM, is the word now. Think oF the word, hear the word iF I 
say CALM... let it sink right in. Imagine the word, C-A-L-M, 
written down on a blackboard in Front oF you. Feel the 
pleasant Feelings, whatever you associate with CALM, try to 
capture the calm within yourselF... (10 secs).
Now hear the word, CONFIDENCE, and go with it now... 
capture that CONFIDENCE, that comes when you relax and when 
you Feel CALM... Now, hear the word SERENITY, and add the 
CALM, CONFIDENCE, SERENE Feelings, serenity prevails. As you 
achieve more and more relaxation. Now on to the word 
SERENITY, Go with it... (10 secs).
Now take the word COURAGE... and achieve a CALM CON­
FIDENCE with SERENITY and COURAGE... (10 secs). Now you
should be ready For some relaxing imagery. The idea behind 
the relaxing image is you imagine a scene that you Find 
especially relaxing and you immerse yourselF in it. It
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should help you achieve a greater degree of relaxation. Just 
use your imagination, use your mind's eye.
Imagine, if you will, that you are walkin in a lovely 
forest which is warmed by rays of sunlight filtering through 
the trees during this sunny spring day. You spot a pic­
turesque winding stream and you decide to rest near it. You 
place a blanket on the soft green grass near this babbling 
brook and you are resting now in the warm sun, enjoying the 
sourroundings of nature. You are sharing this peaceful scene 
with someone who is very close to you. The brook and its 
surroundings are very beautiful and tranquil. Your thoughts 
are also very calm and serene. You notice the sun's rays 
that are filtering through the stately trees and sparkling 
on the water as the stream trickles over mossy stones.
You can hear an occasional bird singing in the back­
ground, and you notice a young fawn and its mother gently 
graze and then approach the brook for a cool drink. Bright 
spring flowers catch your attention as they are sprinkled 
here and there among the gentle green grass.
The sounds of the water are very tranquil and relaxing 
to you. You feel very happy and contented, basking in this 
pleasant scene. Just continue to immerse yourself in this 
scene or in any scene that is pleasing to you such as being
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on a beach or in a mountain cabin in front of a warm fire. 
Just imagine any scene that is enjoyable to you. Continue to 
relax for as long as you like and really go with it. Really 
allow your imagination to work.
End of Relaxation Part Two
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Appendix V Continued
c) Part Three : Everyday application of the exercises
This exercise will teach you to relax while sitting, 
standing, and walking.
All right, now will you please sit up. It is probably 
best to sit in an ordinary chair. Now while sitting up, try 
to relax as -fully as you can. Now, while relaxing as -Fully 
as you can, raise up your right arm, and hold it up so that 
you are now sitting in a chair... with the rest of your body 
as relaxed as possible, but with your right arm raised up so 
that you feel the tension again. Studying it once more, and 
noting the contrast in feelings— Now let your arm flop down 
to your side, and relax it further... and further, feeling 
again the difference in the feelings and sensations... Now, 
raise up your left arm and hold it up, feeling the tension 
in- youi^ - left arm now, as distinct from relaxation in the 
rest of body... feel the tension, and again let the left arm 
flop down to your side, and let it relax further and fur—  
ther... and now again you notice the difference in your 
feelings... between tension and relaxation... Sitting like 
that now, I would like you to raise both arms... and as the 
arms are raised up, study the tension again... where do you 
feel the tension? Study this... and then let the arms down, 
and then feel the tension evaporating, disappearing. Now ex­
hale, and take in a deep breath, and hold it. Now, while you
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are holding your breath, raise both arms, and contract all 
the muscles in your body... -Feel the tension, now. Now 
breath out, let your arms down, relax your whole body and 
Feel the difference again...
(10 secs)
Now I would like you to stand up, and while you are 
standing up, try to relax again as much as you can... Now, 
you are standing up and relaxing as much as you can... drop 
your shoulders, loosen your stomach, let your arms hang 
loosely... Relax like that for a while, standing up.
(40 secs)
All right, now that you've gotten some feeling for 
relaxation standing up, I would like you to just walk back 
and forth, relaxing as much as you can while doing so... 
Just walk back and forth, let your arms swing gently, and 
switch off all unnecessary effort and tension... Nd w , notice 
the parts of your body that you can relax as you walk back 
and forth... Study this careful1ly... letting go as much as 
you can while walking back and forth...
(40 seconds of silence)
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Nd w , I would like you to just stand still again, relaxing as 
•Fully as you can, getting the -Feeling o-F di-F-Ferential 
relaxation, trying to get the knack o-F relaxing those parts 
o-F your body which are not in use. Now you should be stand­
ing with your head -Forward... eyes closed... and your whole 
•Face and scalp and eyes, jaws loose, lips slightly parted, 
tongue resting comfortably in your mouth, breathing easily. 
Neck and throat and shoulders are -Fully relaxed now... 
arms... all the way down to the tips of your fingers, all 
fully relaxed now. Chest... easy rhythmic breathing. Upper 
back relaxing, and the stomach area... completely relaxed... 
Try to relax... your lower back, buttocks and thighs as best 
you can... and even try to feel the relaxation down your 
legs... as best you can while standing... Now again, taking 
the stimulus words CALM... CONFIDENCE... SERENITY and 
COURAGE just think of each word in turn, CALM... CON­
FIDENCE... SERENITY and COURAGE, and let this augment, and 
add to the overall relaxation. Try to get the knack of 
relaxation while standing. Just go with it, get the CALM 
feelings, let them develop and grow... (10 seconds).
Now, I would like you to return to total relaxation and 
see how very quickly you can regain the deep, calm sensa­
tions... So lie down again; let your whole body relax com­
fortably and fully, and rapidly go back into that heavy 
feeling all over; return to those comfortable sensations of 
warmth throughout your entire body... Go back to that deep
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security and restfullness. .. Get that "nothing can disturb 
you" feeling... Recapture as quickly as you can this inner 
restfullness which deepens--- Get back to that inner 
strength and confidence which comes from the inner restfull­
ness.-- Feel all the muscles yielding and relaxing as the 
contractions loosen everywhere .- - So that you begin to feel 
completely at rest with your breathing coming easily and 
freely... And feel that total relaxation--- and back 
again--. for a few moments into your own personal relaxing 
image, now take it deeply, enjoy it to the full, bathe your­
self in your personal relaxing image---
(120 seconds of silence)
All right, now to get the differential relaxation effects--- 
slowly get up again and sit on the chair--- and while sit­
ting on the chair, relax as fully as you can in this sitting 
position--- Try, while sitting down, now to approximate the 
relaxation which you achieved while lying down totally 
relaxed.
(40 seconds silence)
All right, now try to finish off this segment of relaxation 
training by standing up... And relaxing as fully and as 
deeply as you can in the standing position--- So you stand 
up now, and capture as much of that relaxation as you can in
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the standing position--- more and more, deep and satisfying 
relaxation spreading all over.
(20 seconds silence)
So now you should try to carry yourself--- in as relaxed a 
position as possible-.- whenever you remember to do so--- 
While sitting, walking, standing, whatever you do, you can 
relax those parts of your body which are not in use each 
time you remind yourself to let go.
End of Relaxation Part Three
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Appendix VI : A- Posteriori Test
The stundentized Range statistic was used as an a posteriori test 
for the mean scores of State and Trait Anxiety scales for both 
Experimental and Control groups.
For the State score t = 6 .7 1 ,  and t = 2.18
There is a significant difference for the scores in the
Experimental group ( t= 6.71, df=46, p<.0005 ) while there is not a
significant difference for the Control.
For_t.he Xrait score t = 9.16, and t = 2.38
There is a significant difference for the scores in the
Experimental group ( t=9.16, df=46, p<.0005 ) and not for the
Control group.
The same a-posteriori test was used for the Insulin Mono 
Evening for the Experimental and Control groups.
For the Insulin Mono Evening t = .31, and t = .34 
Both values are not significant.
X1 - X2
t
Ms Error ( 1 + 1 )
!
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Appendix VII s Analysis o-f Variance and Summary data
between the scores of the High Density Lipoprotein and 
Experimental/Control Group, Type of Medication and Time
a) H.D.L. 7. ( ANOVA)
Source Ss df MS F Sg
Group 3.31 1 3.31 .007 NS
Type 55.0 1 55.0 . 130 NS
Group x Type 164. 1 164. .388 NS
Error 18574. 44 422. NS
T ime 491.0 1 491 1.94 NS
Time x Group 120. 1 120. « NS
Time x Type 34. 1 34. . 13 NS
Time x Group i•: Type 124. 1 124. .49 NS
Error 11133. 44 253.
Total 3069 95 1666 3.55
b) H.D.L. ’/. (Mean and Standard Deviations)
Experimental Control
Pre Measurement Mean 55 53
_ Standard Deviation 19.7 14.8
Post Measurement Mean 47 50
Standard Deviation 17.5 19.6
Appendix VII— (Continued): Analysis o-f Variance and
Summary data between the scores o-f the
Cholesterol (mg X) and Experimental/Control
Group, Type of Medication and T ime
a)( Cholesterol (mg X) ( ANOVA)
Source Ss d-f MS F Sg
Group 8760. 1 8760. 2.02 NS
Type 791. 1 791. . 18 NS
Group x Type 444. 1 444. . 10 NS
Error 190651. 44 4332.
Time 1314. 1 1314. .62 NS
Time x Group 2377. 1 2377. 1. 12 NS
Time x Type 1846. 1 1846. .87 NS
Time x Group x Type 4167. 1 4167. 1.98 NS
Error 92602. 44 4167. 1.98 NS
Total 3039 95 281 8. 15
b) Cholesterol (mg X.) (Mean and Standard Deviations)
Experimental
Pre Measurement Mean
Standard Deviation 
Post Measurement Mean
Standard Deviation
195 
65. 1 
174 
48.7
Control
206
52.0
209
58.2
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Appendix VII (Continued): Analysis o-f Variance and Summary
data between the scores o-f the Triglyceride 
(mg %) and Experimental/Control Group, Type 
oF Medication and Time
a) Triglyceride (mg %) ( ANOVA)
Source Ss d-f MS F
Group 376. 1 376. .03 NS
Type 26906. 1 26906. 2.78 NS
Group x Type 27687. 1 27687. 2.86 NS
Error- 425311. 44 9666.
Time 59118. 1 59118. 9.28 NS
Time x Group 23584. 1 23584. 3.70 NS
Time x Type--- 22525. 1 22525. 3.53 NS
Time x Group x Type 24334. 1 24334. 3.82 NS
Error 280074. 44 6365.
Total 843 95 428 26
i
b) Triglyceride (mg %) (Mean and Standard Deviations)
Experimental Control
Pre Measurement Mean
Standard Deviation 
Post Measurement Mean
Standard Deviation
99.7
43.5
196.7
73.9
132.5
37.9
154.4
72.8
Appendix VIII: Analysis of Variance and Summary data 
between the scores of Systolic Blood Pressure and 
Experimental/Control Group, Type of Medication 
and Time
a) Systolic Blood Pressure ( ANOVA) 
Source Ss df MS Sg
Group
Type
Group x Type 
Error
15.6 
183.8
49.7 
17570.
1
1
1
44
15.6 
183.8
49.7 
399.
01
46
12
NS
NS
NS
Time .23 1 .23 .00
Time x Group 104. 1 104. .74
Time x Type 7.4 1 7.4 .05
Time x Group x Type 77.7 1 77.7 .55
Error 6145. 44 139.6
Total 24153. 95 977. 1.96
NS
NS
NS
NS
b) Systolic Blood Pressure (Mean and Standard Deviations)
Experimental Control
Pre Measurement Mean
Standard Deviation 
Post Measurement Mean
Standard Deviation
16.0 
24. 2 
13.4 
17.6
12.5 
1.3
14.9
21.5
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Appendix VIII (Continued): Analysis oP Variance and
Summary data between Diastolic Blood 
Pressure and Experimental/Control Group, 
Type oP Medication and Time
a) Diastolic Blood Pressure ( ANOVA)
Source Ss dP MS F Sg
Group .02 1 .02 .01 NS
Type 3.5 1 3.5 2.9 NS
Group x Type .28 1 .28 .23 NS
Error 52. 1 44 1.9
Time .43 1 .43 1.6 NS
Time x Group .52 1 .52 1.9 NS
Time x Type . 02 1 .02 . 07 NS
Time x Group x Type - 04 1 .04 . 17 NS
Error 11.5 44 .26
Total 68.4 95 6.9 9.4
b) Diastolic Blood Pressure (Mean and Standard Deviation)
Experimental Control
Pre Measurement Mean 7.7 7.6
Standard Deviation .8 .8
Post Measurement Mean 7.4 7.6
Standard Deviation .7 .6
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Appendix VIII(Continued): Analysis of Variance and
Summary data between the scores o-f the Body 
Weight and Experimental/Control Group,
Type o-f Medication and Time
a) Body Weight ( ANOVA)
Source Ss d-f MS F Sg
Group 1537.7 1 1537.7 6.8 NS
Type 12.8 1 12.8 .05 NS
Group x Type 496.8 1 496.8 2.2 NS
Error 9866. 44 224.
T ime .43 1 .43 .30 NS
Time x Group 1.8 1 1.8 1.2 NS
Time x Type .23 1 .23 . 16 NS
Time x Group >{ Type .05 1 .05 .03 NS
Error 63.5 44 1.4
Total 2113.3 95 2051.2 10.7
b) Body Weight (Mean and Standard Deviations)
Experimental Control
Pre Measurement Mean 59 69
Standard Deviation 11-4 9-3
Post Measurement Mean 59 69
Standard Deviation 11-1 9.4
Appendix VIII (Continued): Analysis o-F Variance and
Summary data between the scores o-F the 
Insulin Actrapid Morning Dosage and 
Experimental/Control Group, Type o-f 
Medication and Time
a) Insulin Actrapid Morning Dosage f ANOVA)
Source Ss d-F MS F Sg
Group 486. 1 486. 2.0 NS
Error 11066. 46 240.
Drug 18. 1 18. 1.5 NS
Group x Drug 5. 1 5 .  .4 NS
Error 545. 46 11.
Total 12120. 95 760. 3.9
b) Insulin Actrapid Morning Dosage (Mean and Standard Deviations)
Experimental Control
Pre Measurement Mean 7.8 2.8
Standard Deviation 15.5 5.4
Post Measurement Mean 6.5 2.4
Standard Deviation 14.3 5.0
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Appendix VIII (Continued) Analysis oF Variance and 
Summary data between the scores o-F the 
Insulin Actrapid Evening Dosage and 
Experimental/Control Group, Type of 
Medication and Time
a) Insulin Actrapid Evening Dosage (ANOVA)
Source Ss d-F MS F Sg
Group 27.09 1 27.09 .76 NS
Error 1635.14 46 35.54
Drug .26 1 .26 .02 NS
Group x Drug 2.34 1 2.34 .23 NS
Error 454.89 46 9. 88
Total 2119.72 95
b> Insulin Actrapid Evening Dosage (Mean and Standard Deviations)
Experimental Control
Pre Measurement Mean
Standard Deviation 
Post Measurement Mean
Standard Deviation
2.20 
4. 1 
2. 62 
6.9
1.45
3.7
1.25
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Appendix VIII (Continued): . Analysis of Variance and
Summary data between the scores of the 
Insulin Mono Morning Dosage and 
Experimental/Control Group, Type of 
Medication and Time
a) Insuline Mono Morning Dosage ( ANOVA)
Source Ss df MS F Sg
Group 1935. 1 1935- 4.0 NS
Error 22139. 46 481.
Drug 1-7 1 1-7 .03 NS
Group x Drug 4.5 1 4-5 . 10 NS
Error 2098. 46 45.6
Total 21982- 95 2467- 4. 13
b) Insulin Mono Morning Dosage (Mean and Standard Deviations)
Experimental Control
Pre Measurement Mean 17-6 17-6
Standard Deviation 18-1 14-6
Post Measurement Mean 8-6 8-6
Standard Deviation 17-2 14-5
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Appendix VIII (Continued): Analysis oF Variance and
Summary data between the scores o-F the 
Insulin Lente Morning Dosage and 
Experimental/Control Group, Type o-F 
Medication and Time
a) Insulin Lente Morning Dosage ( ANOVA)
Source 5s d-F MS F Sg
Group 450.66 1 450.66 1.10 NS
Error 18779.29 46 408.24
Drug 22.04 1 22.04 .58 NS
Group x Drug 24.00 1 24.00 .64 NS
Error 1723.95 46 37.47
Total 20999.94 95
b) Insulin Lente Morning Dosage (Mean and Standard
Experimental Control
F're Measurement Mean 6.16
Standard Deviation 12-4
Post Measurement Mean 6-20
Standard Deviation 12-4
11.50
17.0 
9.54
17.0
i
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Appendix VIII (Continued): : Analysis of Variance and
Summary data between the scores of the 
Insulin Lente Evening Dosage and 
Experimental/Control Group, Type oF 
Medication and Time
a) Insulin Lente Evening Dosage ( ANOVA)
Source Ss dF MS F Sg
Group 26.04 1 26.04 1.00 NS
Error 1197.91 46 26.04
Drug 26.04 1 26.04 1.00 NS
Group x Drug 26.04 1 26.04 1.00 NS
Error 1197.91 46
Total 2473.93 95
b) Insulin Lente Evening Dosage (Mean and Standard Deviations)
Experimental Control
Pre Measurement Mean .00 .00
Standard Deviation .00 .00
Post Measurement Mean .00 2.OB
Standard Deviation .00 10.2
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Appendix VIII (Continued): Analysis o-F Variance and
Summary data between the scores o-F the 
Insulin Protophane Morning Dosage and 
Experimental/Control Group, Type of 
Medication and Time
a) Insulin Protophane Morning Dosage ( ANOVA)
Source Ss df MS F Sg
Group 37.50 1 37.50 1.86 NS
Error 925.00 46 20. 10
Drug 37.50 1 37.50 1.86 NS
Group x Drug 37.50 1 37.50 1.86 NS
Error 925.00 46 20. 10
Total 1962.5 95
b) Insulin Protophane Morning Dosage (Mean and Standard Deviations)
Experimental Control
Pre Measurement Mean .0 .0
Standard Deviation .0 .0
Post Measurement Mean .0 2.5
Standard Deviation .0 8.9
I
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Appendix VIII (Continued): . Analysis o-F Variance and
Summary data between the scores of the 
Insulin Protophane Evening Dosage and 
Experimental/Control Group, Type o-f 
Medication and Time
a) Insulin Protophane Evening Dosage (ANOVA)
Source Ss dP MS F Sg
Group 2.34 1 2.34 1.00 NS
Error 107.81 46 2.34
Drug 2.34 1 2.34 1.00 NS
Group x Drug 2.34 i 2.34 1.00 NS
Error 107-81 46 2.34
Total 222.63 95
b) Insulin Protophane Evening Dosage (Mean and Standard Deviations)
Experimental Control
F're Measurement Mean -00 -00
Standard Deviation -00 .00
Post Measurement Mean -00 .62
Standard Deviation -00 3.10
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Appendix VIII (Continued): Analysis o-F Variance and
Summary data between the scores o-F the 
Table Dosage and Experimental/Control Group, 
Type o-F Medication and Time
a) Table Dosage ( ANOVA)
Source Ss d-F MS F Sg
Group 1-26 1 1-26 -46 NS
Error 125.97 46 2.73
Drug - 09 1 -09 1-00 NS
Group x Drug .09 1 -09 1-00 NS
Error 4-31 46 .09
Total 131.72 95
b) Table Dosage (Mean and Standard Deviations)
Experimental Control
Pre Measurement Mean 0-37 0-66
Standard Deviation 1-0 1-2
Post Measurement Mean - 5 - 66
1-3 1.2
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Appendix IV ; Crosstabu1 ation between Insulin Mono Morning 
Dosage (pre-treatment measurement) across 
Experimental/Contro1 Groups
In cases where the expected frequencies dropped below 5, 
then Fisher’s Exact Probability Test was applied and data 
were dichotomised at below median dosage.
Insulin Mono-Morning 
Dosage (pre-treatment) 
measurement
Experimental
Group
Contro1 
Group
Row
Total
10. 1 0 1
15. 0 1 1
20. 2 1 3
25. 1 1 2
30. 4 0 4
32. 1. 0 1
35. 1 1 2
40. 3 0 3
42. 1 0 1
50. 0 2 2
TOTAL 24 24 48
Fisher’s Exact Probability Test showed non-significant 
differences (p =.35)
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Appendix IX (Continued) ; Crosstabulations between Insulin
Mono Evening Dosage (pre-treatment 
measurement) across Experimental/ 
Control Groups
Insulin Mono-Evening 
Dosage (pre-treatment) 
measurement
Experimental
Group
Contro1 
Group
Row 
To ta 1
5 . 2 0 2
10. 3 1 4
12. 1 0 1
16. 1 0 1
18. 1 0 1
20. 3 0 3
35 . 1 0 1
TOTAL 24 24 48
Fisher's Exact Probability Test showed non-significant 
differences (p = .61)
Appendix IX (Continued) : Crosstabulations between Insulin
Actrapid Mono Morning Dosage 
(pre-treatment measurement) across 
Experimental/Contro1 Groups
Insulin Actrapid Mono 
Morning Dosage (pre- 
treatment measurement)
Experimental
Group
Contro1 
Group
Row 
Tota I
3. 1 0 1
5. 1 1 2
7 . 0 2 2
8. 2 1 3
10. 0 2 2
12. 1 0
14. 1 0
15. 0 1
20. 1 0 1
25. 0 1 1
30. 1 0 1
70. 1 0
TOTAL 24 24 48
Fisher’s Exact Probability Test showed non-significant 
differences (p = .28)
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Appendix IX (Continued) : Crosstabu 1 at ions between Insulin
Actrapid Mono Evening Dosage 
(pre—treatment measurement) 
across Experimenta1/Contro1 Groups
Insulin Actrapid Mono 
Evening Dosage (pre- 
treatment measurement)
Experimental
Group
Control
Group
Row 
Tota I
5. 2 1 3
6 . 1 0 1
8. 0 0 1
10. 2 0 2
12. 2 0 2
15. 0 1 1
TOTAL 24 24 48
Fisher's Exact Probability Test showed non-significant 
differences (p = .55)
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Appendix IX (Continued) : Crosstabulations between Insulin
Lente Morning Dosage 
(pre-treatment measurement) 
across Experimental/Contro1 Groups
Insulin Lente Morning 
Dosage (pre-treatment 
measurement)
Exper imentaI 
Group
ControI 
Group
Row 
To ta 1
20, o 1 1
25. 1 0 1
26 , 0 1 1
OCO 1 1 2
32. 1 0 1
i! 
CO 
! 
CO o 1 1
35. 2 1 3
40. 0 2 2
43. 0 1 1
TOTAL 24 24 48
Fisher’s Exact Probability Test showed non-significant
differences (p = .32)
!
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Appendix IX (Continued) : Crosstabulations between Oral
Antidiabetic Morning Dosage 
(pre-treatment measurement) 
across Experimental/Control Groups
Oral Antidiabetic 
Morning Dosage 
(pre-treatment)
ExperimentaI 
Group
Control
Group
Row
Total
0.5 2 1 3
1. 2 4 6
1.5 0 1 1
2. 0 3 3
3. 0 1 1
TOTAL 24 24 48
Fisher’s Exact Probability Test (p = .21, p >.05)
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Appendix IX (Continued) : Crosstabu1 ations between Oral
Antidiabetic Afternoon Dosage 
(pre-treatment measurement) 
across Experimental/ControI Groups
Oral Antidiabetic 
Afternoon Dosage 
(pre-treatment)
Exper i menta1 
Group
Contro1 
Group
Row
Total
1. 0 1 1
1. 1 0 1
TOTAL 24 24 48
Fisher’s Exact Probabi1ity Test (p = .50, p >.05)
Appendix IX (Continued) : Crosstabu1 ations between Oral 
Antidiabetic Evening Dosage 
(pre-treatment measurement) 
across Experimenta1/Contro1 Groups
Oral Antidiabetic 
Evening Dosage 
(pre-treatment)
Exper i mentaI 
Group
Contro1 
Group
Row
Total
1. 0 1 1
1. 2 2 4
2 . 0 1 i
TOTAL 24 24 48
Fisher’s Exact Probability Test (p = .66, p >.05)
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Appendix IX (Continued) : Crosstabu 1 ations between Insulin
Actrapid Morning Dosage 
(pre-treatment measurement) across 
Experimenta1/PIacebo Groups
Insulin Actrapid 
Morning Dosage (pre- 
treatment measurement)
Exper imenta1 
Group
Contro1 
Group
Row
Total
4. 1 0 1
5. 2 1 3
6 . 1 0 1
7 . 0 2 2
8. 1 1 2
10. 3 4
15. 1 1 3
20. 1 0 1
70. 0 1
TOTAL 24 24 48
Fisher’s Exact Probability Test (p = .36, p >.05)
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Appendix IX (Continued) : Crosstabu1 at ions between Insulin
Actrapid Evening Dosage 
(pre-treatment measurement) across 
Experimental/Placebo Groups
Insulin Actrapid 
Evening Dosage (pre- 
treatment measurement)
Experimenta1 
Group
Control
Group
Row 
To ta 1
5. 2 1 3
6 . 1 0 1
7 . 0 1 1
8. 1 0 1
10. 1 0
15. 0 1 1
32. 1 0 1
TOTAL 24 24 48
Fisher’s Exact Probabil ity Test (p = .53, p >.05)
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Appendix IX (Continued) : Crosstabulations between Insulin
Mono Morning Dosage (post- 
treatment measurement) across 
Experimental/PIacebo Groups
I nsu1 in Mono 
Dosage (post­
measurement )
Morning Experimental 
•treatment Group
Contro1 
Group
Row 
To ta 1
10. 1 0 1
14. 1 0 1
15. 1 0 1
20. 0 1 1
22. 2 0 2
25. 0 1 1
26. 1 0 1
30. 2 0 2
35. 2 1 3
40. 4 2 6
45. 0 1 1
TOTAL 24 24 48
F i sher1s Exact Probabi1ity Test (p = .38, p >,05)
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Appendix IX (Continued) : Crosstabu I ations between Insulin
Mono Evening Dosage (post­
treatment measurement) across 
Experimental/PIacebo Groups
I nsu1i n Mono 
Dosage (post 
measurement)
Evening
-treatment
Exper imenta1 
Group
Contro1 
Group
Row
Total
4. 1 0 1
•5. 2 0 2
10. 2 1 3
12. 1 0 1
15. 2 0 2
18. 1 0 1
20. 2 1 3
25. 0 1 1
TOTAL 24 24 48
Fisher's Exact Probability Test (p = .40, p >.05)
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Appendix IX (Continued) : Crosstabulations between Insulin
Lente Morning Dosage (post­
treatment measurement) across 
Experimenta1/P1acebo Groups
Insu1i n Lente Morni ng Exper i menta1 Cont ro1 Row
Dosage (post­treatment Group Group Total
measure men t )
3. 1 0 1
25. 0 1 1
26 . 0 1 1
28. 1 0 1
30. 1 1 2
33. 0 1 1
35. 1 1 2
40. 0 1 1
45. 0 1 1
48. 0 1 1
TOTAL 24 24 48
F i sher*s Exact Probab i1ity Test (p = .24, p >.05)
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Appendix IX (Continued) : Crosstabulations between Insulin
Lente Evening Dosage (post- 
treatment measurement) across 
Experimenta1/Contro1 Groups
Insulin Lente Evening Experimenta1 ControI Row
Dosage (post-treatment Group Group To ta 1
measurement)
50. 1 0 1
TOTAL 24 24 48
Appendix IX (Continued.) : Crosstabulations between Insulin
Protophane Morning Dosage 
(post-treatment measurement) 
across Experimental/ControI Groups
Insulin Protophane Experimental Control Row
Morning Dosage (post- Group Group Total
treatment measurement)
2 0 . 0 1 1
40. 1 0 1
TOTAL 24 24 48
Fisher’s Exact Probability Test (p = .05, p <.05)
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Appendix IX (Continued) : Crosstabu 1 atdons between Insulin
Protophane Evening Dosage 
(post-treatment measurement) 
across Experimental/Control Groups
Insulin Protophane Experimental Cont ro1 Row
Evening Dosage (post- Group Group Total
treatment measurement)
15. 1 0 1
TOTAL 24 24 48
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Appendix IX (Continued) : Crosstabulations between
Oral Antidiabetic Morning Dosage 
(post-treatment) across 
ExperimentaI/Contro1 Groups
Oral Antidiabetic 
Morning Dosage 
{post-treatment)
Exper i mentaI 
Group
Contro1 
Group
Row
Total
1 . 1 0 1
1 . 2 4 6
2 . 0 2 2
2. 0 3 3
TOTAL 24 24 48
Fisher's Exact Probabil ity Test (p = .15, p >.05)
Appendix IX (Continued) : Crosstabu 1 ations between Oral 
Antidiabetic Afternoon Dosage 
(post-treatment) across 
ExperimentaI/Contro1 Groups
Oral Antidiabetic Experimental Control Row
Afternoon Dosage 
(post-treatment)
Group Group Total
1 . 1 0 1
TOTAL 24 24 48
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Appendix IX (Continued) : Croestabu1 at ions between
Oral Antidiabetic Evening Dosage 
{post-treatraent) across 
Experimental/Control Groups
Oral Antidiabetic 
Evening Dosage 
(post-treatment)
Experimental
Group
Contro1 
Group
Row
Total
1. 2 2 4
2. 0 1 1
TOTAL 24 24 48
Fisher's Exact Probability Test (p = .6, p >.05)
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Appendix X:Covering letter given to the patients'at St.Lukes Hospital
f M  U N I-VE R SITY  OF SURREY
\ |  1 / Guildford Surrey GU2 5XH Telephone(0483) 571281 Telex859331
X - e x t : 2897
Department o f Psychology
Dear,
My mame is Tonia Paschali and I am a Medical Psychologist carying out 
research at the University of Surrey*Guildford.I have already done research 
that examines the psychological factors involved in the control of Diabetes 
Mellitus.  —
In a study which I conducted recently, I found that methods other than diet 
insulin or tablets, particularly relaxation therapy, can help patients by 
lowering blood sugar levels and that this often results in a reduction in 
insulin requirements or dose of tablets. In collaboration with Dr. MJ Smith 
and Dr. Wright,at St. Lukes Hospital^, I nox* hope to extend these studies and 
to assess some new developments.
Specifically, I plan to teach a number of patients how to practise relaxation 
therapy themselves and to monitor the effect*which this has on diabetic control 
( and treatment. In addition, some patients will be taught special exercises 
designed to improve the circulation of blood to the legs which is often 
impaired in diabetes.
I should be very grateful if you would agree to take part and I enclose some 
further information outlining the details of the study.
When you have read this enclosed information would you please let me know 
if you are willing to discuss taking part in this project. I will be available 
in the dio.betic clinic on the day of your appointment.
I do hope you will agree to take part in this study which I believe will 
benefit diabetic, patients in the future.
Yours Sincerely
Tonia Paschali
Research Medical Psychologist.
A p p e n d i x
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X(a): Inf ormation about Diabetes given to the patients
Guildford Surrey GU2 5XH Telephone (0483) 571281 Telex 859331
ext:2897
Department of Psychology
Information
It is becoming increasingly clear that good control reduces the risk of many 
of the long-term complications of diabetes. In addition to conventional 
treatment other approaches may also help prevent complications. It is well 
known that diabetic control can be adversely affected by emotional stress.
My previous studies have shown that a programme of relaxation exercises can 
help to reduce such effects and improve' control.
This study will assess the effects of two forms of training on diabetic control. 
Patients who agree to participate in this study will be allocated into one of 
two programmes.
In the first programme, patients will be taught a series of relaxation 
exercises.
The second programme will assess the benefits of a series of exercises, designed 
to improve circulation in the lower limbs, which is known to be impaired in a 
number of patients with diabetes.
Patients in both programmes will be asked to attend a maximum of seven training 
sessions to be held at St. Lukes Ilospital^possibly at the University of 
Syrrey, if this is more convenient. The times of these sessions will be arranged 
to suit individual patients. Participants will be aslced to practise the exercises 
at home every day for a total of 7 weeks, during which their diabetic control 
will be monitored, by taking a single blood specimen at the beginning and at 
the end of the study. In addition patients will be asked to fill in a brief 
personality questionnaire and also to complete a daily diary-card.
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Appendix XI : Blood Circulation Exercises 
Exercises for the Legs.
1st Exercise: hold on to a chair and raise and lower your 
self on the spot ten times, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10.
2nd Exercise: stand with one leg slightly raised, on a book
for example while holding on to a chair swing the other leg
to and from ten times, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10.
And now the other leg, 1, ... 10.
3rd Exercise: Do deep knee bends five times while holding on 
to a chair. 1, 2, 3, 4, 5.
4th Exercise: Lean with the palms of your hands against the
wall keeping your feet some distance away, the heels firmly 
on the floor bend your arms ten times keeping your back and 
legs strights, 1, ... 10.
5th Exercise: Get up on your toes and on your heels ten
t imes. 1, ... 10.
Now, I would like you to sit onto a chair and will proceed 
with the sixth exercise.
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6th Exercises Sit back on your chair comfortably, and I 
would like you to lift a book by placing it on your feet and 
turning your toes upwards and 1ifting both your legs from 
the ground five times, try to keep your legs straight, 1, 
,..5 and repeat 1, ... 5.
7th Exercise: Now, I would like you to shake your feet until 
you feel relaxed and warm, first the right leg, try to 
circulate it first towards your right hand side, 1, ... 5
and now towards the left, 1, ... 5. Now proceed with the
left leg, towards the right side first, 1, ... 5 and towards
the left side 1, ... 5.
8th Exercise: Raise your self up from the chair ten times,
keeping your arms crossed, 1, ... 10.
9th Exercise: Try to grab a pencil with your toes, first 
with your right leg, 1, ... 5, and now with your left leg,
1, ... 5.
10th Exercice: Take a tennis ball' and roll it under your 
feet, roll the ball under each foot for five times. Right 
foot first, 1,... 5 and now the left foot 1, ... 5.
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Exercises for the arms and hands.
1st Exercise: Circulate your arms and hands rotate your arms 
forwards and backwards five times each, first forward, 1, 
... 5, and now backwards, 1, ... 5. Now the other hand
forward first 1, ... 5 and backwards, 1, ... 5.
Now both arms and hands together first forwards, 1, ... 5,
and backwards, 1, ... 5.
2nd Exercise: Flick your fingers all together ten times,
1, ... 10.
3rd Exercise: grab a tennis ball with your hands try to work
the ball in your hands, ten times in each hand, right one
first 1, ... 10 and left 1, ... 10.
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Appendix XII: Analysis of Variance and Summary
data of the Short Acting Insulin (Evening Dosage) 
and Experimental/Placebo Group over Time.
a) Short Acting Insulin (Evening Dosage) ( ANOVA)
Source Ss df Ms F sg
Group .01 1 .01 .00 NS
Error 3522. 44 76.
Time 23.9 1 23.9 1.3 NS
GR_X Time 71.2 1 71.2 3.8 NS
Error 847.7 44 18.4
Total K464.8 91
b) Short Acting Insulin (Evening Dosage) (Mean and
Deviations)
EXPERIMENTAL PLACEBO
Pre Measurements
Mean 8.1 6.3
Standard Deviation 10.1 4.9
Post Measurements
Mean 5.3 5.5
Standard Deviation 7.0 5.0
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Appendix XII (Continued): Analysis of Variance and
Summary data of the Insulin Long 
Acting . (Morning Dosage) 
and Eperimental/Placebo Group over 
Time
a) Insulin Long Acting (Morning Dosage) ( ANOVA)
Source Ss df Ms F sg
Group 856. 1 856. 1 .5 NS
Error 24702. 44 537.
Time .12 1 .12 . 16 NS
Gr x Time
.33
1
.33 .4-2
NS
Error 36.5 44 1.80
Total
1140.1
91
b) Insulin Long Acting (Morning Dosage) (Mean and
Standard Deviations)
EXPERIMENTAL PLACEBO
Pre Measurements
Mean 3 3 . 8  1 3 . 7
Standard Deviation
Post Measurements
19.6 19.3
Mean 1 3 # 6  13-1
Standard Deviation
19.7 19-3
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Appendix X I I  (C o n t in u ed ): Analysis of Variance and 
Summary data of the Tablet 
Horning Dosage
and Eperimental/Placebo Group over 
Time
a) Tablet Morning Dosage (ANOVA)
Source Ss df Ms F Sg
Group 6.1 1 6.1 .96 NS
Error 292. 44 6.3
Time .0 1 .0 NS
Gr x Time .0 1 .0 NS
Error 44
Total 298.1 91
b) Tablet Morning Dosage
Standard Deviations)
(Mean and
EXPERIMENTAL PLACEBO
Pre Measurements 
Mean
Standard Deviation
Post Measurements 
Mean
Standard Deviation
• 96
• 45
.96
• 45
2.0 
1 .4
2.0 
1 .4
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Appendix XII (Continued): Analysis of Variance and
Summary data of the Tablet 
Evening Dosage
and Eperimenta1/Placebo Group over 
Time
a) Tablet Evening Dosage ( ANOVA)
Source Ss df Ms F sg
Group .59 1 .59 .19 NS
Error U 0 . 44 ■3.0
Time .0 1 .0 • NS
Gr x Time •0 1 .0 • NS
Error 44
Total U 0 . 5 9  91
b) (Mean and
Standard Deviations)
EXPERIMENTAL PLACEBO
Pre Measurements 
Mean
Standard Deviation .38 1.3
. 22 1 . 0
Post Measurements 
Mean
Standard Deviation .38 1.3
.22 1 . 0
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Appendix X I I  (C o n t in u e d ): Analysis of Variance and 
Summary data of the Blood 
Pressure Systolic 
and Eperimental/Placebo Group over 
Time
a) Blood Pressure Systolic 
Source Ss df Ms
( ANOVA) 
F Sg
Group 2791 . ! 2791. 2 ns
Error --4.3307. 44 94-1 .
Time .0 1 .0 NS
Gr x Time • 0 1 -0 NS
Error .0 44 .0
Total 4-6098. 91
b) Blood Pressure Diastolic (Mean and
Standard Deviations)
EXPERIMENTAL PLACEBO
Pre Measurements
Mean 12$. 23-4.
Standard Deviation
136. 19-4-
Post Measurements
Mean 125. 24-4
Standard Deviation
136. 19.4
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Appendix X I I  (C o n tin u e d ): Analysis of Variance and 
Summary data of the Blood 
Pressure Diastolic 
and Eperimental/Placebo Group over 
Time
a) Blood Pressure Dia stolic (ANOVA)
Source Ss df Ms F Sg
Group 130. 1 130. .32 NS
Error 18365. 44 399.
Time .0 1 .0 NS
Gr x Time .0 1 .0 NS
Error .0 44 .0
Total 1 84-95. 91
b) Blood Pressure Diastolic
Standard Deviations)
(Mean and
EXPERIMENTAL PLACEBO
Pre Measurements 
Mean
Standard Deviation
Post Measurements 
Mean
Standard Deviation
70.3
72.7
70.3
72.7
15.3
12.5
15.3
12.5
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Appendix XIII: Correlation Cce-F-Ficients -For the 26 subjects 
o-F the Experimental Group between the Urine 
T= (mg/littre) measurement and Qi (degree 
o-F relaxation) -From Daily—Diary Check—List 
(D.C.L.)
R-VALUE SIGNIFICANCE
- 0.28 NS
-0.23
-0,17
- 0.09 
0 . 0 1  
0.02 
0.03 
0.07 
0. OS 
0. 18 
0, 19 
0.21 
0.21 
0.27 
0.29 
0.33 
0.36 
0.41 
0.48 
0.62 
0.64
Key s NS — Non Signi-Ficant
— = missing data
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Append!x
i
Key ~ NS
XIII (continued)
R—VALUE
- 0.46
- 0.42
- 0.37
-  0.37
- 0.26
- 0.26
- 0.23
-  0.21
- 0. 17
- 0. 16
-  0.11
- 0. OS
- 0.05
- 0.04
- 0.03 
0. 00 
0.01 
0. 12 
O. 16 
0.23 
0.41
= Non Signi-Ficant
= missing data
Correlation Coe-F-Ficients -For 
the 26 subjects o-F the 
Experimental Group between the 
Urine Ts (mg/littre) measure­
ment .and'. Q2 (degree o-F 
depression) -From Dai ly-Diary 
Check-List (D.C.L.)
SIGNIFICANCE
NS ■ . '
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Appendix XIII (continued) :Correlation Coe-F-Ficients -For the
26 subjects o-F the Experimental Group 
between the Urine T2 <mg/littre) 
measurement and Gs (Sadness factor) -From 
MACL
R-VALUE SIGNIFICANCE
- 0.59 NS
-0.31
- 0.24
- 0.22
-  0.21
-  0 .  20
- 0. IS
- 0. 15
- 0. 13
- 0.13
- 0.09
- 0.04 
0 = OS 
0.09 
0.10 
0. 10 
0. 19 
0.19 
0.25 
0.37 
0.44
Key : NS = Non significant 
— = missing data
I
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A p p endix XIII (continued) : Correlation Coe-F-Ficients -For 
the 26 subjects o-F the ex­
perimental group between the 
Urine T2 (mg/littre) measure­
ment and Q3 (Surgency -Factor) 
-From Mood Adjective Check List 
(M.A.C.L.)
R-VALUE SIGNIFICANCE
- 0=33 NS 
-0.32
- 0.26 
0.54 
0.54 
0.79 
0.91
NS  =  N on S i g n i f i c a n t
— = missing data
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Appen d i x  X I 1I (continued) Correlation Coefficients be­
tween Urine T2 (mg/littre) and 
Qi (degree o-F relaxation) -From 
the Daily Diary Check List for 
the Placebo Group
R-OALUE SIGNIFICANCE
0. 15 
0. 06 
0. 05 
0.00 
0.00 
0.00 
0.02 
0.02 
0.05 
0.06 
0.07 
0. 10 
0. 10
m
Key s NS = Non S i g n i f i c a n t
— = missing data
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Appendix XIII (continued) :
R-VALL1E
- 0. 62
- 0.61
- 0.55
- 0.55
- 0.40
- 0.37
- O. 15 
0.01 
0,04 
0.11 
O. 14 
0. 16 
0.25 
0.29 
0.31 
0.35 
0.40 
0. 59
Correlation CoeFFicients be­
tween Urine Ts (mg/littre) and 
07 (Social AFFection -Factor) 
•From M.A.C.L. For the Ex­
perimental Group
SIGNIFICANCE
NS
Key : NS = Non SigniFicant
- = missing data
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Appendix XIII (continued) :
R-VALUE
- 0, 24
- 0. 24
— 0- 04
— 0- 04
0. 00
0. 06
0.07
0. 09
0- 17
0. 18
0. 18
0. 21
0, 34
0. 35
0.38
0. 50
0. 58
Key : NS = Non S i g n ificant
— = missing data
Correlation Coe-F-F ic ients be­
tween Urine T2 (mg/littre) and 
Q n  (Vigur -Factor) -From 
M.A.C.L. -For the Experimental 
Group
SIGNIFICANCE
NS
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Appendix XIII (continued) ; Correlation CoeF-Ficients be­
tween Urine T2 (mg/littre) and 
02 (Anxiety -Factor) -From 
M.A.C.L- -For the Placebo Group
R-VALUE SIGNIFICANCE
-0.64 NS
- 0.41
- 0. 35
- 0. 33
- 0.23
- 0. 16 
-0.14 
- 0.05
0. 12 
0.18 
0. 18 
0.22 
0.35 
0.36 
6.38
Key : NS = Non SigniFicant
— = missing data
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Appendix XIII (continued) :
R-VALUE
- 0-32
- 0-28 
- 0-26
- 0-25
-  0.22 
- 0.16
- 0. 15
- 0-14
- 0.13
- 0-13
- O. 12
- 0-07
-  0.02 
-  0.01
0.02 
0- 06. 
0.07 
0. 13 
0. 17 
0.34
Correlation Coe-F-Ficients -for 
the 22 Subjects o-F the Placebo 
Broup between Urine T= 
(mg/littre) and Ge» (Sadness 
-Factor) -From MACL
SIGNIFICANCE
NS
Key NS = Non Signi-Ficant
- = missing data
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Appendix XIII (continued)
R-VALUE
- 0.29
-0.26
- 0.25
- 0.25
- 0.24
-  0.20
- 0.17
-  0.08
- 0.06
- 0.06
- 0.04
-  0.01 
0.04 
0.08 
0.15 
0.29 
0.36 
0.39 
0.59 
0.62
Correlation Coe-F-Ficients be­
tween Urt2 (mg/littre) and Q2 
(degree o-F depression) -From 
Daily-Diary Check—List -For the 
Placebo Group
SIGNIFICANCE
NS
Key : NS = Non S i g n i -F i c a nt
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Appendix XIII (continued) : Correlation Coefficients for
the 22 Subjects of the Placebo 
Group between the Urine T= 
(mg/littre) and Qi (Agression 
factor) From MACL
R-OAL.UE SIGNIFICANCE
-0.36 NS
- 0.31
- 0. 30
- 0.29
- 0.23
- 0.16 ■ . .
- 0. 12
- 0.06
- 0. 04
- 0.04
-  0.01 
0.02 
0.05 
0.09 
0.21 
0.21 
0.26 
0.40 
0.43 
0.52
Key : NS = Non Significant
- — missing data
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Appendix XIII (continued) ;
R-VALUE
- 0.28 
- 0.26 
-  0.01 
0.00 
0.04 
0.07 
0.15 
0- 16 
0. 17 
0.22 
0.23 
0.24 
0.26 
0.31 
0.33 
0.36 
0.51 
0.52 
0.60
Key : NS = Non Signi-Ficant
- = missing data
Correlation Coe-F-Ficients be­
tween Urine Ts» (fng/littre) and 
O n  (Vigor -Factor) for the 
Placebo Group
SIGNIFICANCE
NS
A.79
Appendix XIII (continued) : Correlation Coe-F-Ficients be-
- tween UrT2 (mg/littre) and 04
(Elation -Factor) -From M.A.C.L. 
•For the Placebo Group
R-VALUE SIGNIFICANCE
- 0 .63 NS
- 0.46
- 0.39 
-0.36
- 0. 29
- 0. 28 
- 0.23 
- 0.11
0.03 
0.05 
0.07 
0. 13 
0.19 
0.20 
0.45 
0.54
I
Key : NS = Non Significant
— = missing data
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Appendix XIII (continued :
R—VALUE
- 0.30
- 0.27
- 0.24
- 0.23
- 0.23
- 0.23
-  0.22
-  0.21
- 0. 10
-0.18
- 0. 14
- 0. 13
- O. 13
-  0.01 
0.02 
0. 12 
0. 12 
0. 13 
0.26 
0.30 
0.34 
0.34 
0.38
Key s NS = Non Signi-Ficant
— = missing data
Correlation Coe-F-Ficients be­
tween Urine T2 (mg/littre) and 
01 (Agression -Factor) -From 
M.A.C.L. -For the Experimental 
Group
SIGNIFICANCE
NS
Apjgendix XIV: Covering letter sent to the patients, of the,
Follow-up study.
am UNIVERSITY OF SURREY
( .uildlord Snnvv Gl»2 5X1C Tele-phone (0483) 571281
Department o f I’syehology Direct Line (0483) 509175
Telex 859331 
Fax 0483 32813
Daviii Canter, fle.nl of Deparunent ami Professor of Psychology 
ll.n rv  M rfh irk, Piolrssor of Developmental Psychology
27 November 1989
Dear
I would like you to know that the research you helped me with/at the University of 
Surrey, was very successful and my results were positive. Now, at last, I ’m coming to 
the end of my work. However, I need to add one more piece of material and here I 
need your cooperation in filling in a simple form (which is enclosed). This will help 
me to keep trac.. .'f what has been happening to you since we last were in contact. I 
would also like you to fill in a questionnaire which will help me understand your 
present state in'relation to stress.
1 would be grateful if  you could answer these two questionnaires before the 22 
December, and send them back to me. I enclose a stomped addressed envelope for you 
to return your answer sheets in.
1 would like to express my gratitude to you for participating in my research in the first 
place and for helping me now to complete it.
Best wishes for the future.
Yours sincerely
Antonia Paschal i
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Appendix XIV: The Follow-up Questionaire.
Full Name: ........................    1,2
Sex (M, F): .........................  ......3
 4
Do you remember taking part in relaxation OR blood circulation 
exercises? (Please tick)
Yes ___ ___5
No __  6
If  ’Yes’ are you still practising the exercises? (Please tick)
Yes _   7
No  8
I f  ’Yes’, how often do you practise? (Please tick)
Once a day    9
About once a week      10
About once a month    11
About once every 6 months    12
Other reply (Please write in)  13
If  ’No’ when did you stop? (Please tick)
Immediately after the programme ____ 14
A few weeks after    15
Only recently ___ ___16
Other reply (Please write in)  ___   17
Do you feel that you have managed to incoporate the 
relaxation/blood circulation exercises into you 
everyday life? (Please tick)
Yes    18
Only at the beginning __   19
Not at all    20
Other reply (Please write in) ___  21
How much do you feel in control of your diabetes now?
A lot of conttol _   22
A little control ____ ___23
Not, but not badly ___ .  24
No control at all ____ ___25
Other reply (Please write in)   26
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7. What do you feel about participating in these exercises?
Helped me achieve control
over diabetes    27
Didn’t help me at all ___  28
Other reply (Please write in )_ _    29
8. Are you still taking medicine? Please state your 
present dosage.
Morning     31,34
Afternoon ___  35,38
Evening ___  .39,42
9. What are your latest physiological results 
(taken at St Luke’s Hospital - Please write the
actual physiological number next to each measurement) 
in relation to your:
Blood sugar levels _______   _ 5 0 ,5 2
Urine sugar levels ________   53,55
Haemoglobin A^C ________   56,59
Cholesterol    60,62
HDL - Cholesterol ________   63,65
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Appendix XV: Sparse Data from Table 34, of the Follow-up study, 
reduced into a full category, in order for 
Chi-squared analysis to be performed.
Experimental Placebo
Q3
ONCE A DAY & 2 3
ONCE A WEEK
ONCE A MONTH & 8 2
ONCE EVERY SIX MONTHS
TOTAL 10 5
Appendix XV (continued): Sparse Data from Table 36, of the Follow-
up study, reduced into a full category 
in order for Chi-squared analysis to be 
performed.
EXPERIMENTAL PLACEBO
Q5
YES 11 5
ONLY AT THE BEGINNING 9 13
&
DID NOT INCORPORATE THE 
EXERCISES
TOTAL 20 18
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Appendix XV (continued): Sparse Data from Table 37, of the 
Follow-up study, reduced into a full 
category, in order for Chi-squared 
analysis to be performed.
Q6
A LOT IN CONTROL
EXPERIMENTAL
12
PLACEBO
5
A LITTLE CONTROL 
&
NO BUT NOT BADLY 
&
NO CONTROL AT ALL
8 13
TOTAL 20 18
In exactly the same way, the equivelent tables, which follow in 
the results section of the follow-up study and in which data were 
sparse, were reduced into a full category.
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Appendix
Group 1 
Group 2
Group 1= 
Group 2=
XVI: t-test Analysis for HbA1c between Experimental and
Placebo groups.
Number Standard Standard
of Cases Mean Deviation Error
18 8.9 1.6 .4
14 9.4 1.3 .3
Pooled Variance Estimate
t Degrees 2-Tail
Value of Freedom Prob.
-.98 30 .335
Experimental
Placebo
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Appendix XVI: Correlation Matrix between the Second
and the Follow-up study, of the Trait Anxiety scales and the 
Glycosilated Haemoglobin scores for the Experimental group.
FOLLOW-UP TRAIT HbA1c
2nd STUDY
 TRAIT .07 -.19
P=.39 P=.20
HbA1c .20 -.23
P=.21 P=.16
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Appendix XVI (continued): Correlation Matrix between the Second 
and the Follow-up study, of the State Anxiety scale, the Trait 
Anxiety scale and the Glycosilated Haemoglobin for the Placebo 
group.
FOLLOW-UP STATE TRAIT HbA1c
2nd STUDY
STATE -.19 .07 -.17
P= .22 P=.38 P=.30
TRAIT -.08 .04 -.43
P = .36 P=.43 P=.08
HbA1c -.28 .00 .12
P = .13 P= .50 P=.35
